Skip to content
Artwork for Tick Boot Camp
MedicineAlternative Health

Tick Boot Camp

Matt Sabatello and Rich Johannesen

Tick Boot Camp is a Lyme disease and tick-borne illness podcast featuring interviews with leading doctors, researchers, scientists, patients, advocates, and experts. Explore Lyme disease symptoms, testing, diagnosis, treatment, recovery, chronic Lyme disease, coinfections, PANS/PANDAS, MCAS, neurological symptoms, emerging research, and the latest advances in tick-borne disease care. Through expert education and powerful patient stories, Tick Boot Camp provides hope, validation, practical information, and a community for people navigating Lyme disease and complex chronic illness.

Play
  • 79 episodes
  • daily
  • Avg 49 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • S1 · E614
    October 29 · 23 min

    Episode 614: Long COVID or Lyme Disease? The Hidden Infection Connection – Dr. Ben Sinclair | LIVE from ILADS

    Could some people diagnosed with long COVID also be dealing with Lyme disease, Bartonella, Babesia, or other infections that have gone undetected? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich sits down with Dr. Ben Sinclair, founder of Dr. Finlay's Private Practice in the United Kingdom, to explore the complex relationship between long COVID, Lyme disease, tick-borne infections, immune health, and chronic illness. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation examines how Dr. Sinclair's own debilitating illness following COVID-19 transformed his medical career and led him to investigate Lyme disease and associated infections. After becoming severely ill with COVID-19 while working as a medical director within the UK's National Health Service (NHS), Dr. Sinclair spent approximately three months largely confined to bed. His symptoms included profound fatigue, neurological difficulties, and a remarkable period during which he struggled to speak English but could communicate in German. Initially believing he was experiencing long COVID, he later pursued testing for Lyme disease, Bartonella, and other infections. His personal experience inspired a broader clinical focus on patients with persistent fatigue, neurological symptoms, and complex post-infectious illnesses. Rich and Dr. Sinclair discuss the three Bs—Borrelia, Bartonella, and Babesia—along with tick exposure in the UK, climate change, deer populations, neurological symptoms, nervous system regulation, nutrition, and the challenges of accessing Lyme disease care through the NHS. Throughout the conversation, Dr. Sinclair emphasizes the importance of looking at the whole patient rather than focusing exclusively on a single diagnosis. Meet Dr. Ben Sinclair: Founder of Dr. Finlay's Private Practice Dr. Ben Sinclair is a UK physician and founder of Dr. Finlay's Private Practice, a multidisciplinary private healthcare practice serving patients with complex chronic illnesses, including long COVID and suspected tick-borne infections. The practice operates primarily from London, near Oxford Street, with additional clinical services in Birmingham and other parts of the United Kingdom. Dr. Sinclair previously worked within the NHS, including serving as a regional medical director overseeing healthcare services across approximately 14 prisons. Alongside his NHS responsibilities, he developed an interest in preventive medicine, nutrition, health optimization, and integrative approaches to chronic illness. His practice now brings together healthcare professionals from several disciplines, including: Physicians with interests in functional and integrative medicine Clinicians experienced in evaluating Lyme disease Psychologists Nutritionists Breathing specialists Physiotherapy and rehabilitation professionals Dr. Sinclair explains that the practice offers in-person and virtual consultations, including support for patients who are housebound or bedbound. When a Doctor Becomes the Patient: Dr. Sinclair's Long COVID Journey Dr. Sinclair's interest in complex post-infectious illness became deeply personal after he contracted COVID-19. Before becoming ill, he describes himself as physically fit and health-conscious. He grew up on an organic farm, spent time in the military, and maintained an active lifestyle. Despite this background, his COVID-19 illness was followed by debilitating symptoms. He recalls spending approximately three months largely confined to bed. His symptoms included severe fatigue, cognitive difficulties, and problems with speech. One particularly unusual experience involved temporarily struggling to speak English. Although English is his native language, he found that he could communicate more easily in German, a language he had previously learned. His wife spoke German, allowing them to communicate during this period. Dr. Sinclair believes neurological inflammation may have contributed to these symptoms, although the interview does not establish the underlying neurological mechanism. His experience gave him a new understanding of what patients face when everyday activities become overwhelming. From Long COVID to a Lyme Disease Diagnosis Initially, Dr. Sinclair believed his symptoms were related to long COVID. As he began seeing patients with similar complaints, however, he noticed that some were not improving with the approaches his practice commonly used. Many reported persistent fatigue, neurological symptoms, and difficulty returning to their previous level of functioning. Dr. Sinclair began asking more detailed questions about potential tick exposure. To his surprise, some patients recalled previous tick bites or activities that placed them at increased risk of exposure. He also reconsidered his own history. Dr. Sinclair describes spending time outdoors during military service, traveling extensively, and experiencing tick bites during childhood, including one in a Canadian forest when he was approximately eight years old. He subsequently pursued testing for Lyme disease and other infections. After attending an ILADS conference in Europe, he reports receiving a Lyme disease diagnosis. He also describes laboratory findings involving Bartonella and Epstein-Barr virus. Dr. Sinclair believes these findings helped him better understand his illness and influenced his clinical approach. However, the presence of antibodies or other laboratory markers does not necessarily establish active infection or prove that an infection caused long COVID symptoms. Research continues to investigate how SARS-CoV-2 infection, immune responses, and other infectious conditions may contribute to prolonged illness. Can COVID-19 Trigger or Reactivate Other Infections? One of the central questions in the interview is whether COVID-19 can influence previously acquired infections. Dr. Sinclair discusses the possibility that immune changes following COVID-19 may contribute to the reactivation of certain pathogens or the emergence of symptoms associated with other illnesses. He specifically raises questions about: Lyme disease and Borrelia Bartonella Babesia Epstein-Barr virus (EBV) Other possible contributors to post-infectious illness Some research has identified associations between long COVID and evidence of Epstein-Barr virus reactivation or altered immune responses. However, the hypothesis that COVID-19 routinely reactivates persistent Borrelia, Bartonella, or Babesia infections remains unproven. Dr. Sinclair describes these possibilities as part of his evolving clinical perspective. The conversation highlights the importance of investigating other potential diagnoses when patients experience persistent symptoms rather than automatically attributing every symptom to long COVID. The Three Bs: Borrelia, Bartonella, and Babesia Rich and Dr. Sinclair discuss three pathogen groups frequently mentioned in the Lyme disease community. Borrelia: The Bacteria Associated With Lyme Disease Borrelia burgdorferi and related bacteria cause Lyme disease. Infections can produce symptoms involving the skin, joints, nervous system, and cardiovascular system. Bartonella: A Group of Bacterial Infections Bartonella species can cause several different human diseases. Dr. Sinclair discusses Bartonella in relation to neurological symptoms and complex chronic illness. He also raises questions about possible exposure through fleas, lice, and other arthropods. Transmission pathways vary by Bartonella species, and some proposed routes remain uncertain. Babesia: A Tick-Borne Parasite Babesia parasites infect red blood cells and can cause babesiosis. Symptoms may include fever, chills, fatigue, sweating, and anemia. Severe disease can occur, particularly in people with certain underlying health conditions. Dr. Sinclair explains that he has become increasingly interested in identifying possible Babesia infections among patients with overlapping symptoms. Rich observes that more Tick Boot Camp guests have discussed diagnoses involving multiple pathogens in recent years. They consider whether this reflects greater awareness, changes in testing, increased exposure, or other factors. Importantly, not every Lyme disease patient has Bartonella or Babesia, and overlapping symptoms do not establish the presence of multiple infections. Why Tick-Borne Diseases May Be Increasing in the UK Dr. Sinclair discusses several environmental factors he believes may contribute to changing patterns of tick exposure in the United Kingdom. These include: Climate change and milder winters Changes in seasonal tick activity Expanding or changing deer populations Migratory birds transporting ticks Greater awareness and reporting of tick-borne diseases Changes in land use and human exposure to tick habitats He notes that his practice sees patients from areas associated with forests, deer populations, and known tick habitats. He also discusses the New Forest and Bournemouth area, where tick exposure is an established concern. Dr. Sinclair believes that environmental changes deserve more attention in public health planning. While climate and wildlife ecology can influence tick distribution, the specific contribution of each factor varies by location and requires careful research. Deer, Sheep, Migratory Birds, and Tick Exposure Rich asks Dr. Sinclair about the relationship between wildlife populations and tick-borne diseases. Dr. Sinclair describes observations from areas of England where deer populations have increased. He recalls growing up near Knole Park, a historic deer park, and describes changes in the surrounding environment following a major storm in 1987. He believes changes in deer movement and habitat may have influenced local tick exposure. The conversation also turns to sheep farming and Babesia. Dr. Sinclair notes that parts of southwestern England, including Cornwall, Devon, and Somerset, have substantial sheep populations. He discusses possible ecological relationships involving livestock, ticks, and Babesia species. These relationships are complex. Different Babesia species have different animal reservoirs and transmission cycles, and the presence of deer or sheep does not automatically establish the source of human infection. The discussion underscores the importance of understanding local ecology when investigating tick-borne disease risks. Why Tick Prevention Matters Beyond the Woods Dr. Sinclair and Rich emphasize that tick exposure is not limited to remote forests or wilderness areas. People can encounter ticks while gardening, walking in parks, visiting rural properties, or spending time in areas frequented by wildlife. Changing tick habitats make prevention education increasingly important. Practical precautions include checking for ticks after outdoor activities, using appropriate repellents, wearing protective clothing, and removing attached ticks promptly. For step-by-step prevention and tick bite guidance, explore Tick Boot Camp's Tick Bite Blueprint. A Multidisciplinary Approach to Complex Chronic Illness Dr. Sinclair explains that his private practice was designed to bring different healthcare disciplines together. He believes that patients with complex illnesses may benefit from coordinated care addressing multiple aspects of health. His team includes physicians, psychologists, nutrition professionals, breathing specialists, and rehabilitation providers. The practice considers: Medical evaluation: Investigating possible infections, post-infectious conditions, and other causes of symptoms. Nutrition: Supporting adequate dietary intake and addressing relevant nutritional concerns. Sleep: Identifying sleep disturbances and improving sleep routines where possible. Psychological support: Helping patients cope with medical trauma, uncertainty, and the emotional effects of prolonged illness. Breathing and rehabilitation: Addressing breathing-pattern difficulties, autonomic symptoms, and functional limitations. Dr. Sinclair emphasizes that patients should not be reduced to a single symptom or laboratory result. His approach reflects a broader philosophy of individualized, multidisciplinary care. Medical Trauma, Stress, and the Nervous System Rich and Dr. Sinclair discuss the psychological burden of living with an illness that is difficult to diagnose or treat. Dr. Sinclair explains that his practice includes psychologists because patients may experience significant emotional distress after prolonged illness, repeated medical appointments, and feeling dismissed by healthcare professionals. He also discusses how chronic stress, poor sleep, and autonomic nervous system disturbances can influence overall well-being. The conversation recognizes that psychological support may be valuable even when a patient's primary illness is physical. Medical trauma and emotional distress do not mean symptoms are imaginary or that patients are responsible for their illness. Supporting mental health can be an important part of comprehensive care without replacing appropriate medical evaluation or treatment. For a related conversation, listen to Tick Boot Camp's interview with Cathleen King about Primal Trust and nervous system regulation. Breathwork, Dysautonomia, and Long COVID Recovery Dr. Sinclair describes becoming interested in breathwork during his own recovery. While largely confined to bed, he listened to podcasts discussing breathing techniques, including approaches associated with Wim Hof. He subsequently incorporated breathing support into his practice. His team works with patients experiencing breathing-pattern difficulties and certain autonomic symptoms. He mentions approaches such as: Box breathing Slow, paced breathing Concordant breathing Individualized breathing exercises Dr. Sinclair emphasizes that more intense methods, including Wim Hof-style breathing, are not appropriate for everyone. This distinction is particularly important for people experiencing dysautonomia, post-exertional symptom exacerbation, dizziness, or other complex symptoms. Breathing exercises may help some patients manage stress or breathing-pattern difficulties, but they are not established cures for Lyme disease or long COVID. Patients should seek individualized guidance and avoid techniques that provoke significant symptoms. Nutrition, Sleep, and Immune Health Dr. Sinclair describes several lifestyle strategies he incorporated during his own recovery. These included paying closer attention to nutrition, sleep, stress management, and daily routines. He discusses: A diet emphasizing fiber and nutrient-rich foods Adequate sleep and consistent sleep patterns Natural daylight exposure to support circadian rhythms Meditation and relaxation Appropriate physical activity within individual limitations Breathwork and stress management He also mentions experimenting with cold-water immersion. However, cold-water immersion can pose risks, especially for people with cardiovascular problems or autonomic dysfunction, and it is not an established treatment for Lyme disease or long COVID. Dr. Sinclair believes that supporting general health can complement medical treatment. Lifestyle measures may contribute to overall well-being, but they should not be presented as substitutes for evidence-based treatment of active infections or other diagnosed conditions. Treating Housebound and Bedbound Patients One of the challenges Dr. Sinclair's practice addresses is access to care for people who cannot easily travel. He explains that some patients are housebound or bedbound because of severe fatigue, neurological symptoms, or other functional limitations. His team offers virtual consultations and, where available, home visits. They may also work with family members and caregivers to coordinate care. Dr. Sinclair says the practice serves patients throughout the UK and internationally, subject to professional and insurance restrictions. At the time of the interview, he explains that the practice could not provide services to patients in the United States or Canada because of insurance limitations. Children, Long COVID, and Complex Illness Dr. Sinclair also discusses the growing number of children seen by his practice. He explains that parents receiving care sometimes sought help for children experiencing persistent symptoms after COVID-19. Drawing on his background in family medicine, he expanded the practice's work with pediatric patients. He describes an interest in understanding whether some children with prolonged symptoms may have other medical conditions requiring investigation. The conversation includes his clinical observations about possible infections such as Bartonella. However, his estimates regarding the proportion of long COVID patients with co-infections are preliminary impressions from his practice, not established population-level findings. Pediatric patients with persistent symptoms require careful, individualized assessment, and proposed infectious explanations should be evaluated using appropriate clinical evidence. Lyme Disease Recognition and Treatment in the United Kingdom Rich asks Dr. Sinclair whether Lyme disease awareness and medical support in the UK are improving. Dr. Sinclair acknowledges growing recognition of tick-borne disease risks. He also expresses concern that UK clinical guidance and healthcare systems have not evolved as quickly as he would like. He discusses challenges involving: Access to specialized diagnostic testing Limited awareness of complex presentations Differences in clinical perspectives Financial constraints within the NHS The pace of research and guideline development Professional scrutiny surrounding controversial treatment approaches Dr. Sinclair believes international conferences such as ILADS provide opportunities for clinicians to exchange research findings and learn from colleagues. His comments reflect his personal assessment of the UK healthcare environment. Established clinical guidance, emerging research, and contested treatment approaches should be distinguished when evaluating care options. Why Dr. Sinclair Attends ILADS Dr. Sinclair explains that ILADS provides an opportunity to connect with physicians and researchers from around the world. He attends to learn about developments in testing, treatment, and scientific understanding of Lyme disease and associated conditions. He values discussions with clinicians who work with patients experiencing complex symptoms. The conference also allows him to compare his clinical experiences with those of practitioners in other countries. Dr. Sinclair believes this international collaboration is especially valuable as research into post-infectious illness continues to evolve. How to Work With Dr. Ben Sinclair Dr. Sinclair is the founder of Dr. Finlay's Private Practice. The practice provides private medical consultations focused on complex chronic illness, preventive medicine, and multidisciplinary care. Services discussed in the interview include: In-person consultations in the United Kingdom Virtual medical consultations where permitted Evaluation of persistent symptoms and possible tick-borne infections Nutrition and lifestyle support Psychological support Breathing and rehabilitation services Coordination with patients' existing healthcare professionals Dr. Sinclair explains that the practice operates on a self-pay basis and is not covered by insurance. He emphasizes that his team cannot promise a cure but aims to provide individualized care and support. Visit Dr. Finlay's Private Practice to learn more about services, locations, and appointment availability. Key Takeaways Dr. Sinclair's own illness changed his medical career. After COVID-19, he experienced severe fatigue and neurological symptoms that left him largely bedbound for three months. Long COVID and other illnesses can have overlapping symptoms. A thorough evaluation may be necessary when patients experience persistent or unexplained problems. He later received a Lyme disease diagnosis. His personal experience influenced his interest in tick-borne and vector-borne infections. The three Bs are an important discussion topic. Borrelia, Bartonella, and Babesia can cause different illnesses with some overlapping symptoms. COVID-related immune changes remain an active research area. Proposed relationships between long COVID and persistent tick-borne infections require further investigation. Environmental changes may affect tick exposure. Climate, wildlife, habitat, and human activity can influence tick distribution. Medical trauma deserves recognition. Psychological support can help patients cope with the emotional burden of chronic illness. Multidisciplinary care may provide broader support. Dr. Sinclair's practice combines medical evaluation with nutrition, psychology, breathing support, and rehabilitation. Patients with severe limitations need accessible care. Virtual appointments and home visits may help those unable to travel. Hope and scientific curiosity can coexist. Dr. Sinclair encourages continued investigation while acknowledging that no treatment can guarantee recovery. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this conversation features Dr. Ben Sinclair, founder of Dr. Finlay's Private Practice in the United Kingdom. Rich and Dr. Sinclair discuss his experience with long COVID, his subsequent Lyme disease diagnosis, possible co-infections, tick-borne disease awareness in the UK, and his multidisciplinary approach to complex chronic illness. The interview also explores the role of nutrition, sleep, nervous system support, and coordinated healthcare in helping patients manage persistent symptoms. Discover additional conversations with international physicians, researchers, and patient advocates through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E613
    October 28 · 24 min

    Episode 613: New Lyme Disease Test Detects 3 Infections at Once – Dr. Jennifer Miller | LIVE from ILADS

    What if one blood test could detect Lyme disease, Bartonella, and Babesia at the same time—without relying on the body's antibody response? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich sits down with Dr. Jennifer Miller, PhD, of Galaxy Diagnostics to discuss a new generation of direct detection tests designed to help doctors identify Lyme disease and other difficult-to-detect vector-borne infections. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores why conventional Lyme disease testing can miss infections, how Borrelia may interfere with antibody development, and how digital PCR technology can search for Borrelia, Bartonella, and Babesia DNA in a single blood sample. Dr. Miller explains how Galaxy Diagnostics developed a digital PCR assay that divides a blood sample into approximately 26,000 individual reactions, increasing the analytical ability to detect small amounts of pathogen DNA. She also announces that the assay became commercially available in March 2025 and explains how patients can work with their healthcare providers to access testing. For patients who have experienced years of diagnostic uncertainty, this conversation offers an encouraging look at emerging technologies that could help improve the diagnosis of Lyme disease and associated infections. Meet Dr. Jennifer Miller, PhD Dr. Jennifer Miller, PhD is Vice President of Clinical and Scientific Operations at Galaxy Diagnostics, a laboratory specializing in diagnostic testing for difficult-to-detect vector-borne infections. Her work focuses on developing and validating diagnostic technologies for pathogens such as Borrelia, Bartonella, and Babesia. Dr. Miller has extensive experience researching vector-borne pathogens and translating laboratory discoveries into clinical diagnostic tools. During the interview, Rich mentions a previous conversation with Galaxy Diagnostics CEO Nicole Bell, who helped introduce him to the company's work. Dr. Miller discusses returning to Galaxy Diagnostics and working with its scientific team to develop more sensitive direct detection methods. Their shared goal is to provide clinicians with better diagnostic tools while helping patients avoid unnecessary delays, repeated testing, and prolonged uncertainty. Why Lyme Disease Testing Can Miss Infections Rich begins by addressing one of the most frustrating challenges facing the Lyme disease community: patients can experience significant symptoms while repeatedly receiving negative laboratory results. He asks Dr. Miller to explain why Lyme disease testing remains difficult and what researchers are doing to improve it. Dr. Miller begins by describing two fundamentally different approaches to infectious disease testing. Indirect testing looks for the body's immune response to a pathogen. Direct testing searches for material associated with the pathogen itself, such as its proteins or genetic material. Understanding the difference is important because these tests answer different questions. Indirect Lyme Disease Testing: Looking for Antibodies Most commonly used Lyme disease blood tests are indirect tests. They look for antibodies produced by the immune system after exposure to Borrelia, the bacteria responsible for Lyme disease. Dr. Miller uses a simple analogy to explain the limitations of antibody testing. An antibody is like a sign left behind by someone who visited a location. The sign says: “I was here.” But it doesn't tell you whether that visitor is still present or whether they left months or years earlier. Similarly, Lyme disease antibodies may remain detectable after an infection has been treated. A positive antibody test therefore does not necessarily establish that a person currently has an active infection. Conversely, someone with a recent infection may not yet have produced enough detectable antibodies for a test to become positive. This creates a diagnostic window during which early Lyme disease can be missed. For more information about testing limitations, explore Tick Boot Camp's Lyme disease testing resources. Sensitivity, Specificity, and Cross-Reactivity Dr. Miller explains that diagnostic tests are evaluated using two important measurements. Sensitivity describes how effectively a test identifies people who have a particular condition. A test with inadequate sensitivity may produce false-negative results. Specificity describes how effectively a test identifies people who do not have that condition. A test with inadequate specificity may produce false-positive results. She also discusses cross-reactivity, which occurs when an antibody recognizes a target that resembles something other than the intended pathogen. Dr. Miller compares antibody testing patterns to a barcode. Different parts of the barcode represent responses to different proteins. However, some proteins may be shared across related organisms or resemble proteins from other infectious agents. This can complicate test interpretation. She emphasizes that both the biological behavior of Borrelia and the design of the assay influence how well a test performs. IgM vs. IgG: Understanding the Immune Response Rich asks Dr. Miller to explain why different antibody classes matter when diagnosing Lyme disease. IgM Antibodies IgM antibodies are commonly associated with the early immune response. Dr. Miller describes IgM as a broad responder that can recognize certain targets before the immune system develops a more refined response. This broad recognition can be useful during early infection but can also contribute to cross-reactivity. IgG Antibodies IgG antibodies commonly develop as the immune response matures. Through biological processes known as affinity maturation and class switching, the immune system can produce antibodies that recognize specific targets more effectively. Dr. Miller explains that the timing and quality of these responses can affect the performance of antibody-based diagnostic tests. However, neither IgM nor IgG results alone can reliably determine whether Borrelia remains actively present after treatment. How Borrelia May Interfere With Antibody Development One of the most scientifically interesting parts of the conversation explores how Borrelia may influence the immune system. Dr. Miller discusses research suggesting that Borrelia infection can disrupt processes involving B cells, the immune cells responsible for producing antibodies. She explains that an effective antibody response involves several steps. First, the immune system recognizes a pathogen. Next, B cells begin producing antibodies. Over time, the immune response can become more refined, generating antibodies that bind more effectively to their targets. Dr. Miller describes how Borrelia may interfere with these processes. She uses an analogy involving rooms and doors. Imagine that a B cell needs access to different rooms to develop and improve its antibodies. In her analogy, Borrelia interferes with access to those rooms, disrupting the processes needed for antibody maturation. This may help explain why some immune responses to Borrelia develop differently than expected. Dr. Miller also discusses how these effects could influence the transition from IgM to IgG antibodies. These mechanisms remain an active area of scientific investigation, and experimental findings do not mean that every patient with Lyme disease experiences the same immune dysfunction. Direct Detection: Looking for the Pathogen Itself Rich then asks Dr. Miller to explain the alternative to antibody-based testing. Rather than measuring the immune response, direct detection methods look for evidence of the pathogen. Dr. Miller describes two approaches being developed or offered by Galaxy Diagnostics. Urine Antigen Testing An antigen is a molecule associated with a pathogen, often a protein. Dr. Miller explains that Galaxy has developed testing designed to detect certain Borrelia antigens shed into urine. The goal is to identify pathogen-associated material without relying on antibody production. PCR Testing Polymerase chain reaction, or PCR, detects specific sequences of genetic material. For Lyme disease, PCR testing attempts to identify Borrelia DNA. However, Borrelia can be difficult to detect in blood because the organism may circulate at very low concentrations. Dr. Miller explains that Galaxy's newer approach uses digital PCR, a technology designed to improve the detection of small amounts of genetic material. Direct detection has important limitations as well. A negative result does not necessarily exclude infection, and detecting DNA does not automatically establish that live organisms are present. Digital PCR: Finding the Needle in 26,000 Haystacks One of the interview's most memorable explanations involves searching for a needle in a haystack. Rich recalls how Nicole Bell described Galaxy's digital PCR technology. Traditional PCR can be compared to searching for a tiny needle in a large pile of hay. Digital PCR divides the sample into thousands of smaller sections, making it easier to identify a target when very little genetic material is present. Dr. Miller explains that Galaxy's assay partitions a sample into approximately 26,000 individual reactions. Each partition is analyzed for the presence or absence of specific pathogen DNA. Rather than analyzing everything in one reaction, the technology evaluates thousands of smaller reactions. This can improve analytical sensitivity under appropriate conditions. However, the technology cannot detect pathogen DNA that is absent from the collected sample or present below the assay's detection threshold. One Blood Test for Borrelia, Bartonella, and Babesia The biggest announcement in the interview concerns Galaxy's ability to investigate three major pathogen groups using one blood sample. Borrelia: Lyme Disease and Relapsing Fever Borrelia includes bacteria responsible for Lyme disease and certain forms of relapsing fever. Dr. Miller explains that Galaxy's assay is designed to recognize genetic sequences shared across different Borrelia organisms. This includes targets associated with Lyme disease Borrelia and relapsing fever Borrelia. Bartonella: A Difficult-to-Detect Bacterial Infection Bartonella is a group of bacteria associated with several human illnesses. Different Bartonella species can cause different clinical manifestations, including cat-scratch disease and certain bloodstream infections. Dr. Miller discusses how genus-level genetic targets may help identify members of the Bartonella group without requiring a completely separate assay for every species. Babesia: A Tick-Borne Parasite Babesia is a group of parasites that infect red blood cells. Babesiosis can cause fever, chills, fatigue, anemia, and potentially serious complications, particularly in vulnerable patients. Dr. Miller explains that Galaxy's assay can investigate Babesia genetic material alongside Borrelia and Bartonella. The ability to test for all three pathogen groups in one sample may provide additional information when clinicians suspect overlapping infections. It does not mean every person with Lyme disease has all three infections or that every patient requires testing for all three. What Is Genus-Level Detection? Rich asks Dr. Miller whether Galaxy's assay can detect different species and strains within each pathogen group. Dr. Miller explains that the test uses genetic targets shared by members of a particular genus. She compares this to recognizing a family rather than identifying each individual cousin. For example, different Bartonella species may share genetic sequences that allow them to be recognized as belonging to the same broader group. By targeting those shared sequences, an assay can potentially detect multiple related organisms. This approach may broaden detection while reducing the need for separate targets for every species. However, genus-level detection does not necessarily identify the exact species or strain responsible for an infection. Actual coverage depends on the assay's design and validation. Why Testing for Multiple Infections Matters Rich discusses how Tick Boot Camp interviews have increasingly featured patients reporting diagnoses involving multiple tick-borne or vector-borne infections. He explains that earlier conversations often focused primarily on Borrelia. More recently, patients have frequently discussed Bartonella and Babesia alongside Lyme disease. Dr. Miller agrees that clinicians sometimes need to investigate more than one possible infection because symptoms can overlap. For example, fatigue, headaches, and other nonspecific symptoms may occur with several different illnesses. Testing for multiple pathogens may help clinicians narrow their differential diagnosis when a patient's history supports that evaluation. She also emphasizes the financial consequences of repeatedly visiting providers and undergoing separate tests. Better diagnostic tools could potentially help streamline this process. However, the prevalence of co-infections varies by geographic region, exposure history, and pathogen. The experiences of podcast guests should not be interpreted as evidence that most Lyme disease patients have all three infections. Can Direct Testing Distinguish a Past Infection From a New Infection? Rich shares his history of numerous tick bites over several decades. He explains that one of his concerns about antibody testing is its inability to reliably determine when an infection occurred. Dr. Miller agrees that prior infections can complicate interpretation because antibodies may persist long after the original exposure. She discusses how direct detection may provide different information by searching for pathogen-associated genetic material rather than antibodies. This could be especially useful when evaluating someone with a history of previous tick-borne infections and new symptoms. However, a positive PCR result does not always distinguish live infection from residual DNA, and a negative result cannot exclude every active infection. Clinical history, examination findings, and other testing remain important. Galaxy's Digital PCR Test Became Available in March 2025 Rich asks when patients will be able to access the new technology. Dr. Miller shares that Galaxy's digital PCR assay had already completed laboratory validation and became commercially available in March 2025. She explains that the laboratory operates under clinical laboratory quality requirements and that the scientific team had worked extensively to validate the assay. She expresses excitement about making the technology available to healthcare professionals investigating difficult-to-detect infections. Commercial availability and laboratory validation are important milestones, but they do not establish that the assay can detect every infection or that it outperforms all other diagnostic methods in every clinical situation. Independent clinical performance data remain important when evaluating new testing technologies. Can Patients Order Galaxy's Digital PCR Test Directly? Rich asks a practical question that many listeners will have. Can patients order the test themselves, or does a healthcare professional need to request it? Dr. Miller explains that, at the time of the interview, the test required an order from a practitioner. Galaxy Diagnostics provides educational resources that patients can share with their healthcare professionals. These include information about available tests, scientific literature, frequently asked questions, and provider ordering procedures. Patients interested in learning more can visit Galaxy Diagnostics. Current test availability, ordering requirements, and pricing should be confirmed directly with the laboratory. Could Better Lyme Disease Testing Reduce Healthcare Costs? Dr. Miller discusses the financial and emotional burden of diagnostic uncertainty. Patients may spend years visiting multiple healthcare professionals, undergoing repeated tests, and searching for explanations. Each additional appointment can create expenses, delays, and frustration. She hopes that improved direct detection technologies will help clinicians make more informed decisions sooner. Rich emphasizes the importance of making diagnostic testing more accessible and efficient for patients. The conversation reflects a shared goal: reducing the time people spend searching for answers and helping them access appropriate care. Whether any specific new test reduces costs or improves long-term patient outcomes requires further study. The Future of Lyme Disease Diagnostics Dr. Miller describes Galaxy's work as part of an effort to develop the next generation of direct detection tools. She believes technologies such as digital PCR may help address limitations associated with antibody-based testing. The conversation also highlights the importance of scientific collaboration, continued validation, and patient-centered research. Rich expresses hope that accurate and affordable testing will eventually become more accessible to people living in regions where tick-borne diseases are common. For patients who have experienced diagnostic uncertainty, the development of new testing approaches offers reasons for cautious optimism. Key Takeaways Conventional Lyme disease testing has limitations. Antibody tests may miss early infections and cannot reliably distinguish past exposure from current infection. Direct and indirect tests answer different questions. Indirect tests measure immune responses, while direct tests search for pathogen-associated material. Borrelia may affect antibody development. Dr. Miller discusses research into how infection can interfere with B-cell function and antibody maturation. Digital PCR uses thousands of reactions. Galaxy's technology partitions a sample into approximately 26,000 individual reactions. One sample can be tested for three pathogen groups. The assay targets Borrelia, Bartonella, and Babesia. Genus-level detection may identify multiple related species. The approach targets shared genetic sequences rather than every strain individually. Relapsing fever Borrelia is also part of the discussion. Galaxy designed its assay to investigate a broader range of Borrelia organisms. The assay became commercially available in March 2025. Dr. Miller describes the laboratory's validation and launch. Practitioner ordering was required at the time of recording. Patients can review Galaxy's resources with their healthcare providers. Better diagnostics could reduce uncertainty. Continued research is needed to determine how emerging tests affect patient care and outcomes. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this conversation features Dr. Jennifer Miller, PhD, of Galaxy Diagnostics, discussing advances in Lyme disease and vector-borne infection testing. Rich and Dr. Miller explore the limitations of antibody testing, the science of immune responses, urine antigen testing, digital PCR, and the ability to investigate Borrelia, Bartonella, and Babesia in a single blood sample. Discover additional interviews with scientists, physicians, and diagnostic innovators through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E612
    October 27 · 17 min

    Episode 612: Lyme Disease Nearly Took Her Life. Now She's Funding Treatment – Darlene O'Connor | LIVE from ILADS

    After seeing approximately 22 medical practitioners, undergoing more than a dozen procedures, and facing a possible ALS diagnosis, Darlene DeBauer O'Connor finally received a Lyme disease diagnosis that changed her life. Today, she's helping other families overcome one of the biggest barriers to healing: the cost of care. In this LIVE from ILADS interview, Tick Boot Camp co-host Rich sits down with Darlene DeBauer O'Connor, Executive Director of the Northeast Lyme and Associated Diseases (NELAD) Resource Foundation, to discuss her family's experience with Lyme disease, the devastating consequences of delayed diagnosis, and a new nonprofit providing financial assistance for testing and treatment. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores Lyme disease misdiagnosis, ALS-like symptoms, neurological complications, family-wide tick-borne illness, treatment costs, patient advocacy, and financial grants of up to $3,000 per person annually. Darlene shares how her diagnosis on October 16, 2013, led to other family members seeking answers, why her brother's death strengthened her commitment to advocacy, and how years of educational outreach revealed a critical problem: Knowing where to find help means little when patients cannot afford to access it. Her story is one of resilience, family, community, and turning personal suffering into practical support for others. From Possible ALS to a Lyme Disease Diagnosis In her 40s, Darlene was working as a public school teacher in Massachusetts when she began experiencing increasingly debilitating symptoms. What started as fatigue and headaches progressed into a frightening combination of physical, neurological, and psychological problems. Her symptoms included: Extreme fatigue and difficulty getting out of bed Severe headaches and recurring fevers Migrating pain throughout her body Muscle weakness, tripping, and falling Difficulty walking Bladder control problems Neurological and psychological symptoms Darlene consulted approximately 22 medical practitioners across multiple specialties, including cardiology, neurology, and infectious disease. She underwent more than a dozen procedures while searching for an explanation. Eventually, clinicians began considering amyotrophic lateral sclerosis (ALS), a progressive neurological disease. The possibility was devastating. Darlene remembers becoming increasingly frightened as her condition worsened and her independence disappeared. Ten Negative Lyme Tests Before Getting Answers Despite living in a region where Lyme disease is common, Darlene reports receiving approximately 10 negative Lyme disease tests during her diagnostic journey. On October 16, 2013, her sister brought her to a practitioner in Wilton, Connecticut. After reviewing her symptoms and medical history, the practitioner diagnosed her clinically with Lyme disease and investigated possible additional infections. Darlene describes that appointment as the turning point in her life. She calls the anniversary her personal “D-Day,” meaning Diagnosis Day. For the first time, she felt she had an explanation for the illness that had disrupted her life. She began treatment and gradually experienced improvements, although she also recalls difficult reactions during the process. Her experience highlights the importance of interpreting Lyme disease testing alongside clinical findings and exposure history. Antibody tests can produce false-negative results, particularly early in infection. However, repeated negative results later in an illness require careful consideration of other possible diagnoses as well. For more information, explore Tick Boot Camp's Lyme disease testing resources. When One Diagnosis Leads an Entire Family to Seek Answers Darlene's diagnosis had consequences far beyond her own health. She is the youngest of five children in a close-knit Italian-American family. After learning more about Lyme disease and associated infections, she began recognizing similarities between her experiences and symptoms reported by siblings, nieces, nephews, and other relatives. Family conversations increasingly focused on tick exposure, unexplained symptoms, and the possibility of tick-borne illness. Darlene describes a cascade of additional diagnoses among family members. She explains that relatives were evaluated by different healthcare professionals rather than a single practitioner. Over time, she reports that most affected family members experienced meaningful improvement. The family's experiences strengthened her belief that education and early recognition are essential. Importantly, similar symptoms within a family do not necessarily establish a shared infection. Tick exposure, other medical conditions, and individual diagnostic findings must be evaluated separately. Losing Her Brother and the Questions Surrounding Lewy Body Dementia One of the most emotional moments in the interview comes when Darlene discusses the death of her brother. She believes complications associated with vector-borne illness contributed to his neurological decline and eventual diagnosis of Lewy body dementia. She describes a period during which he appeared to improve, followed by worsening symptoms and rapid deterioration. His death remains a profound loss for the family. Darlene's experience raises questions about the relationship between infectious diseases, neurological inflammation, and neurodegenerative conditions. However, a causal relationship between Lyme disease or other tick-borne infections and Lewy body dementia has not been established. Her brother's story reflects the family's understanding of his illness and the grief that continues to motivate their advocacy. Why Tick Prevention Education Matters Before becoming ill, Darlene believed she understood tick prevention. She had worked as an education coordinator for Mass Audubon and was familiar with outdoor safety. However, she admits that her understanding of Lyme disease was limited. She believed avoiding heavily wooded areas and removing visible ticks would provide adequate protection. Her perspective changed dramatically after her diagnosis. Darlene also recalls a tick bite involving her son at a Massachusetts hospital and wishing the tick had been saved for identification. Rich and Darlene discuss the importance of recognizing that tick exposure can occur in ordinary environments, including residential yards, gardens, and recreational spaces. They also reflect on how little Lyme disease education they received during their school years in the Northeast. Their conversation emphasizes that prevention education should begin long before someone becomes ill. For practical guidance on tick checks, tick removal, and what to do after a bite, visit Tick Boot Camp's Tick Bite Blueprint. Turning Lyme Disease Into a Mission As Darlene began recovering, she and her sister became involved with Central Mass Lyme, a Massachusetts organization focused on education and awareness. Darlene served on its conference committee, while her sister participated on the organization's board. Together with other advocates, they helped organize four educational conferences. One conference attracted approximately 500 attendees. Speakers included prominent Lyme disease clinicians and researchers such as: Dr. Stephen Phillips Dr. Daniel Cameron Dr. Neil Spector Dr. Bill Rawls These events connected patients, caregivers, healthcare professionals, authors, and advocates. Darlene also began speaking publicly about her family's experience. Her presentations resonated with people who had spent years searching for answers. But as more patients approached her after speaking engagements, she noticed a recurring problem. People weren't simply asking what Lyme disease was. They wanted to know how to find a knowledgeable practitioner and how to pay for testing and treatment. The Missing Piece: Financial Assistance for Lyme Disease Patients Darlene and her sister realized that education alone could not solve the challenges facing many families. Even when patients identified a healthcare professional they wanted to see, financial barriers often prevented them from obtaining care. Some practitioners had long waiting lists. Others required out-of-pocket payments that families could not afford. Testing, medical appointments, medications, and supportive therapies could create substantial financial strain. Darlene and her sister decided to establish an organization that would combine education and emotional support with direct financial assistance. That decision led to the creation of the Northeast Lyme and Associated Diseases Resource Foundation, commonly known as NELAD. What Is the NELAD Resource Foundation? The NELAD Resource Foundation is a nonprofit organization focused on helping people affected by Lyme disease and associated illnesses. Its mission includes three interconnected areas: Education and awareness: Helping patients, families, and communities better understand Lyme disease and associated conditions. Emotional support: Connecting individuals and families through support groups and shared experiences. Financial assistance: Providing grants to help eligible patients access testing and treatment. Although NELAD is based in New England, particularly Massachusetts and Rhode Island, Darlene explains that its assistance is not limited to those states. At the time of the interview, the foundation had already provided funding to recipients in 10 additional states, including Texas. Darlene emphasizes that the organization focuses on families and does not impose an age limit on applicants. NELAD Grants: Up to $3,000 Per Person Per Year One of the most valuable parts of the interview is Darlene's explanation of NELAD's financial assistance program. At the time of recording, the foundation offered grants of up to $3,000 per person, per year, subject to eligibility, available funding, and the organization's approval process. Because the program supports individual family members, more than one person within a household may potentially qualify. Darlene also explains that previously funded applicants may reapply in subsequent years. The grants are intended to reduce financial barriers to Lyme disease-related testing and treatment. Darlene describes assistance for conventional medical care as well as certain integrative services when supported by documentation from a practitioner. The foundation evaluates applications and determines funding based on its own criteria. Grant availability, covered services, and funding limits may change. Applicants should confirm current requirements directly with NELAD. How to Apply for NELAD Financial Assistance Darlene explains that the foundation deliberately designed its application process to be manageable for people dealing with significant illness. Applicants can begin through the organization's website. The process she describes includes: Complete a preliminary application. Applicants can submit the form online or print and mail it. Provide basic information. The initial form allows the foundation to review the request before collecting extensive documentation. Indicate willingness to provide supporting records. These may include tax documents, disability information, or a practitioner's recommendation. Wait for application review. The foundation evaluates requests and determines eligibility and available assistance. Darlene emphasizes that patients do not need to gather every supporting document before beginning the preliminary process. This approach is intended to make applying less overwhelming for people already managing difficult health circumstances. Visit NELAD.org to learn about financial assistance and apply. Donated Lyme Disease Testing and Additional Support Darlene also announces that a specialty laboratory, identified in the transcript as IGeneX, committed to donating 10 Lyme disease tests annually to support the foundation's work. She describes this partnership as an important opportunity to help patients who cannot afford certain diagnostic services. The interview also discusses NELAD's willingness to consider different treatment-related expenses when supported by a healthcare practitioner's recommendation. These may include medications and certain complementary approaches. However, the foundation's willingness to fund a service should not be interpreted as evidence that the service is medically effective. Patients should discuss the risks, benefits, and supporting evidence for any proposed treatment with qualified healthcare professionals. Why Lyme Disease Advocacy Requires Collaboration Darlene repeatedly emphasizes the importance of organizations working together. Although NELAD developed from her experiences with Central Mass Lyme, she continues to value that relationship. She believes the challenges facing the Lyme disease community are too significant for any one organization to address alone. Education, patient support, research, financial assistance, and public policy advocacy all serve important purposes. Rich agrees and invites Darlene and her sister to return for a longer Tick Boot Camp interview. He wants listeners to learn more about the family's experiences and the resources available through NELAD. Their conversation demonstrates how different advocacy organizations can complement one another while helping patients find the support they need. Key Takeaways Lyme disease can be difficult to diagnose. Darlene saw approximately 22 practitioners and received numerous negative tests before her diagnosis. Severe symptoms deserve thorough evaluation. Her illness included neurological problems, weakness, difficulty walking, and symptoms that raised concerns about ALS. A diagnosis can affect an entire family. Darlene's experience prompted relatives to investigate their own unexplained symptoms. Loss can inspire advocacy. Her brother's death strengthened her commitment to helping others. Education is essential. Her work with Central Mass Lyme helped bring conferences and patient resources to the community. Financial barriers can prevent access to care. Darlene and her sister founded NELAD after recognizing that many patients could not afford testing and treatment. NELAD provides direct financial assistance. At the time of the interview, grants were available for up to $3,000 per person annually. Families are a priority. The foundation considers applicants of all ages and may assist multiple members of a household. Patients can apply online or by mail. NELAD designed its preliminary application to minimize the initial paperwork burden. Collaboration strengthens advocacy. Patient organizations can work together to expand education, financial assistance, and community support. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this conversation features Darlene DeBauer O'Connor, Executive Director of the Northeast Lyme and Associated Diseases Resource Foundation. Rich and Darlene discuss her 2013 Lyme disease diagnosis, her family's experiences with tick-borne illnesses, the emotional impact of losing her brother, and the creation of a nonprofit dedicated to helping patients access care. The interview provides practical information about NELAD's grant program and its efforts to support families facing the financial burden of Lyme disease. Explore additional patient stories, advocacy organizations, and healthcare professionals through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E611
    October 26 · 21 min

    Episode 611: Why Lyme Disease Tests Miss Patients – Dr. Liz Horn on Breakthrough Research | LIVE from ILADS

    What if the biggest obstacle to diagnosing Lyme disease isn't a lack of symptoms—but the limitations of the tests doctors rely on? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich sits down with Dr. Liz Horn, PhD, Principal Investigator of the Lyme Disease Biobank, a research program of the Bay Area Lyme Foundation, to explore why Lyme disease testing remains challenging and how new diagnostic technologies could change the future of patient care. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation covers early Lyme disease testing, antibody detection, FDA-cleared diagnostics, persistent symptoms after treatment, tissue donation, and the research needed to better understand Borrelia and other tick-borne pathogens. Dr. Horn explains how researchers are using donated blood, urine, and human tissue samples to develop more accurate tests, investigate persistent symptoms, and study what tick-borne pathogens may be doing inside the body. She also shares encouraging developments involving IGeneX, emerging multiplex antibody tests, and a growing research network that gives patients meaningful opportunities to contribute to scientific progress. Her message is hopeful: Better Lyme disease diagnostics are possible, and patients can play an important role in making them a reality. Meet Dr. Liz Horn, PhD Dr. Liz Horn is the Principal Investigator of the Lyme Disease Biobank, a research initiative of the Bay Area Lyme Foundation. She began working on the biobank in 2013, with biological sample collection beginning in 2014. The program was created to address a major obstacle in Lyme disease research: scientists often lack access to well-characterized patient samples needed to develop and validate diagnostic tests. Dr. Horn explains that a survey conducted in January 2025 found that approximately 85% of participating researchers still lacked some of the samples they needed. Through the biobank, her team collects, processes, and distributes samples to qualified researchers investigating Lyme disease and associated infections. At the time of the interview, the program had enrolled more than 1,250 participants and supported over 115 research projects. Why Lyme Disease Testing Remains So Difficult Dr. Horn explains that most commonly used Lyme disease diagnostic tests do not directly detect the bacteria responsible for the infection. Instead, they measure the body's immune response. This distinction is especially important during early infection, when the immune system may not yet have produced detectable antibodies. She describes two major categories of diagnostic testing. Direct Testing: Looking for Borrelia Itself A direct test attempts to identify the pathogen or its genetic material. For Lyme disease, that means detecting evidence of Borrelia rather than measuring the immune system's response to it. Dr. Horn explains that researchers still need better direct detection methods. The development of reliable direct tests could provide new opportunities for diagnosing infection, particularly in situations where antibody testing is inconclusive. Indirect Testing: Looking for Antibodies Indirect tests, including commonly used Lyme disease serology tests, measure antibodies produced in response to infection. The challenge is that antibodies take time to develop. Dr. Horn explains that a person may have Lyme disease before their immune response becomes detectable through laboratory testing. This creates a diagnostic window during which an infected patient may test negative. A negative Lyme disease antibody test early after infection does not necessarily rule out Lyme disease. For more information about testing limitations, explore Tick Boot Camp's Lyme disease testing resources. Why Two Lyme Disease Tests Can Produce Different Results One of the interview's most revealing discussions concerns differences between laboratory assays. Dr. Horn explains that two FDA-cleared first-tier antibody tests may not identify exactly the same patients. A sample that tests negative using one assay may test positive using another. This means the specific test used by a laboratory can influence whether an infection is detected. Dr. Horn describes how the Lyme Disease Biobank's well-characterized samples help researchers evaluate these differences. Her work underscores why test sensitivity, specificity, timing, and clinical context all matter when interpreting Lyme disease results. New Lyme Disease Tests: IGeneX and Multiplex Antibody Technology Dr. Horn discusses several promising diagnostic developments supported by biobank samples. IGeneX and FDA-Cleared Lyme Disease Testing She highlights an IGeneX diagnostic assay that received FDA clearance with the help of clinical samples provided by the Lyme Disease Biobank. These samples allowed researchers to evaluate how the test performed in people with documented clinical histories. Dr. Horn emphasizes that access to carefully characterized samples is essential for developing and validating new diagnostic technologies. FDA clearance does not mean a test is perfect or appropriate for every clinical situation, but it represents an important regulatory milestone. Multiplex Testing: Looking at More Than One Antibody Target Dr. Horn also describes research involving InBios. Its experimental approach examines multiple Borrelia antibody targets rather than relying on a single target. She explains that Borrelia expresses different proteins, known as antigens, that may trigger different antibody responses. A multiplex test can examine several antibody targets simultaneously. Dr. Horn uses a simple analogy: Looking at one target is like taking one photograph. Looking at ten targets provides ten different snapshots. Researchers hope this broader approach may improve the ability to detect Lyme disease at different stages of infection. However, these approaches still require rigorous validation to establish their accuracy and clinical usefulness. Could New Lyme Tests Detect Infection Earlier? Dr. Horn discusses research involving two experimental single-tier serology tests. According to the findings she describes, these approaches showed promise for identifying Lyme disease earlier than some conventional testing methods. She references the possibility of detecting infection approximately one week after symptom onset in certain study settings. That would represent a meaningful advance for patients who currently face uncertainty during the early stages of infection. However, these findings do not mean that every patient can currently obtain a reliable positive test one week after infection. Larger studies, regulatory review, and clinical validation are necessary before new diagnostic approaches can become widely adopted. Why Some Patients Don't Develop the Expected IgG Antibody Response Dr. Horn describes research involving patients who received treatment for early Lyme disease. She explains that clinicians often expect an IgG antibody response to develop as time passes. However, her research found that some treated patients did not develop the anticipated detectable IgG response. This process, known as seroconversion, can be affected by the timing of infection and treatment. Dr. Horn explains that antibiotic treatment may change the development of measurable antibodies. This is particularly important when interpreting follow-up testing. The absence of a later positive IgG test does not necessarily mean an earlier Lyme disease diagnosis was incorrect. Likewise, antibody results alone cannot reliably establish whether an infection remains active after treatment. One in Five Patients Still Had Symptoms Three Months Later Dr. Horn discusses a study involving patients with early Lyme disease who were followed after treatment. She reports that approximately 20% continued experiencing symptoms three months later, despite receiving treatment early in their illness. These patients had been evaluated at clinical sites experienced in recognizing early Lyme disease. The finding raises important questions about why some people experience persistent symptoms even after timely diagnosis and treatment. Dr. Horn believes further research is needed to understand the biological mechanisms involved and develop better tools for evaluating patients who remain ill. Persistent symptoms after Lyme disease treatment are real and deserve appropriate medical attention, but they do not by themselves establish that live Borrelia bacteria remain present. For additional research and patient perspectives, explore Tick Boot Camp's Lyme Persists educational resources. What Is the Lyme Disease Biobank? Rich asks Dr. Horn to explain the biobank in practical terms for patients and caregivers. She describes it as a collection of biological samples donated by people who participate voluntarily in research. The program includes samples from individuals with early Lyme disease and people experiencing persistent symptoms. Depending on the study, participants may provide: Blood samples Urine samples Information about symptoms and medical history Follow-up samples over time Certain tissues collected during qualifying surgical procedures These materials are processed and made available to researchers developing diagnostic tests and investigating disease mechanisms. Dr. Horn explains that scientists benefit from knowing the clinical background associated with each sample. Without that information, it becomes much harder to determine whether a diagnostic test accurately identifies the patient population it is intended to serve. The Lyme Disease Tissue Bank: Studying Borrelia and Bartonella Inside the Body One of the most important initiatives discussed is the Lyme Disease Tissue Bank, launched in 2019. The program collects selected tissues donated after death by people who had Lyme disease or other tick-borne infections. At the time of the interview, Dr. Horn reports that 27 individuals had donated tissues, including brain tissue. Additional tissue types may include: Heart Liver Spleen Bladder Muscle Peripheral nerves and other nervous system tissues These donations allow researchers to investigate where pathogens or their components may be found and how they might relate to disease processes. Dr. Horn emphasizes that the program is not a whole-body donation program. Instead, it coordinates the recovery of specific tissues for scientific study. Participants interested in postmortem donation must register in advance so arrangements can be made. The program can coordinate donations across much of the United States. How Tissue Donations Could Help Explain Persistent Lyme Symptoms Dr. Horn believes studying human tissue may help answer questions that cannot be resolved through blood testing alone. Researchers are interested in understanding whether Borrelia, Bartonella, or other pathogens—or evidence of their prior presence—can be identified in specific tissues. The findings could help scientists investigate disease mechanisms, improve diagnostic methods, and identify future research priorities. The tissue bank also provides an opportunity to study neurological and other organ-specific complications associated with tick-borne illnesses. However, finding bacterial material in tissue does not automatically establish active infection or prove that the organism caused a particular symptom. These questions require careful scientific investigation. More Than 115 Research Projects Supported Dr. Horn explains that the biobank has supported more than 115 research projects. Not every project produces a successful diagnostic test. Some experimental approaches fail to demonstrate adequate accuracy. She emphasizes that these negative findings are still valuable. They help researchers identify which approaches are unlikely to work and avoid repeating unsuccessful experiments. The biobank also asks participating researchers to share performance data from their studies. This allows the program to build knowledge about how different tests perform using its samples. Dr. Horn believes this collaborative model accelerates research by allowing scientists to focus on developing and evaluating new technologies rather than independently recruiting every patient needed for early investigations. How Lyme Disease Patients Can Contribute to Research Near the end of the interview, Rich asks how Tick Boot Camp listeners can help advance Lyme disease research. Dr. Horn explains that participation opportunities depend on the specific study and the patient's circumstances. Donate Blood or Urine Eligible participants in certain geographic areas, including the San Francisco Bay Area, may be able to donate biological samples through participating clinical sites. The process typically involves informed consent, health-history questions, and sample collection. Consider Tissue Donation Some individuals may be eligible to contribute tissue collected during specific surgical procedures. Dr. Horn also discusses the possibility of registering for postmortem tissue donation. These contributions can support research into the effects of tick-borne pathogens on different organs and tissues. Support Patient-Powered Research Rich also highlights MyLymeData, a patient-powered research initiative that allows people affected by Lyme disease to share information about their experiences. These opportunities provide ways for patients to contribute to research, even when their own health circumstances limit other forms of advocacy. For current eligibility requirements and donation information, visit the Lyme Disease Biobank or contact the Bay Area Lyme Foundation. When Will Better Lyme Disease Tests Become Available? Rich asks Dr. Horn when patients might begin seeing significant improvements in Lyme disease diagnostics. Speaking in 2025, she expresses optimism that better tests could begin emerging within approximately two years, with additional progress over the following five years. She credits the availability of well-characterized samples, collaboration among research groups, and growing interest in new diagnostic technologies. These are research expectations rather than guaranteed development or approval timelines. Still, her message is encouraging. The tools needed to improve Lyme disease testing are being developed, and patients are helping make that work possible. Key Takeaways Current Lyme disease tests have important limitations. Antibody tests may miss infections before a detectable immune response develops. Direct detection remains a major research priority. Scientists need better methods for identifying Borrelia itself. Different FDA-cleared tests may produce different results. The choice of assay can influence detection. Multiplex antibody testing shows promise. Evaluating multiple Borrelia antigens may improve diagnostic performance. Early treatment can affect antibody development. Some treated patients may not develop the expected later IgG response. Persistent symptoms require more research. Dr. Horn discusses findings showing that approximately one in five early-treated patients still reported symptoms after three months. Patient donations are advancing science. Blood, urine, and tissue samples help researchers investigate diagnostic and biological questions. The Lyme Disease Biobank supports collaboration. More than 115 research projects had used its resources at the time of the interview. Patients can help drive progress. Voluntary research participation and advocacy can contribute to the development of better diagnostic tools. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this conversation features Dr. Liz Horn, PhD, Principal Investigator of the Lyme Disease Biobank. Rich and Dr. Horn discuss the limitations of Lyme disease testing, new diagnostic technologies, FDA-cleared assays, persistent symptoms after treatment, and how donated biological samples are helping advance scientific research. They also explore opportunities for patients to contribute to studies that may improve the future of Lyme disease diagnosis and care. Discover additional interviews with researchers and healthcare professionals through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E610
    October 25 · 21 min

    Episode 610: Why Is Chronic Lyme Disease Harder on Women? – Dr. Anne VanCouvering | LIVE from ILADS

    Why do so many women with chronic Lyme disease struggle to get answers—and could stress, hormones, immune function, and medical gaslighting help explain their experiences? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich sits down with Dr. Anne VanCouvering, ND, a Vermont-based naturopathic doctor who treats patients with Lyme disease, tick-borne infections, mold-related concerns, and complex chronic illness. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores why women are so heavily represented in the chronic Lyme disease community, how prolonged stress may affect immune function, and why patients with multisystem symptoms are frequently dismissed by healthcare professionals. Dr. VanCouvering also shares her personal journey into Lyme disease medicine, including her son's seven-year struggle with unexplained symptoms, her family's experiences with tick exposure on Long Island, and how ILADS helped shape her clinical approach. Their discussion raises important questions about Bartonella, Babesia, neuroinflammation, autism-like symptoms, PANS/PANDAS, environmental exposures, nervous system regulation, and the limitations of conventional medical care. Throughout the interview, Dr. VanCouvering emphasizes a principle that every patient deserves to experience: The goal isn't for a doctor to be right. The goal is to help the patient get well. Meet Dr. Anne VanCouvering, ND Dr. Anne VanCouvering is a naturopathic doctor based in central Vermont who provides telemedicine services to patients in Vermont, New Hampshire, and Massachusetts. Her clinical interests include Lyme disease, tick-borne infections, mold-related illness, autism, PANS/PANDAS, and complex chronic health conditions. Before attending naturopathic medical school, she operated a massage therapy practice in the Hamptons on Long Island. Her interest in medicine developed partly from her desire to understand her son's health challenges. She began attending ILADS conferences in 2014, seeking additional education about Lyme disease and associated infections. Dr. VanCouvering describes witnessing the growth of integrative and naturopathic approaches within the ILADS community, including increasing discussions of herbal medicine and supportive therapies. A Mother's Search for Answers: Seven Years of Unrecognized Lyme Disease Dr. VanCouvering's journey into Lyme disease medicine began with her son. During his teenage years, he experienced a collection of symptoms that initially appeared unrelated: Excessive sleeping and debilitating fatigue Anxiety and behavioral changes Knee pain Persistent headaches Cognitive difficulties and trouble completing sentences Purple stretch-mark-like skin changes that she later associated with Bartonella She initially explored autism and other possible explanations for his symptoms. Despite consulting multiple healthcare professionals, she struggled to obtain a diagnosis that explained his overall condition. Eventually, a discussion with another physician about purple striae prompted her to reconsider his symptoms. She began investigating tick-borne infections and concluded that Lyme disease might be contributing to his illness. By that point, approximately seven years had passed since his symptoms began. His condition eventually became so severe that, while attending college in Oregon, he reportedly spent three months largely confined to bed. Dr. VanCouvering describes traveling to California for additional medical support at Gordon Medical Associates, although the financial burden made continued care difficult. She credits a combination of medical care and lifestyle changes with helping her son improve. Her experience highlights how difficult it can be for families to navigate complex symptoms, particularly when multiple body systems appear to be affected. Clinical context: Purple striae are not diagnostic of Bartonella infection, and symptoms such as fatigue, anxiety, and cognitive changes have many possible causes. Lyme disease requires appropriate clinical evaluation. From Long Island to Vermont: A Family History of Tick Exposure Dr. VanCouvering discusses her family's extensive history on Long Island, including time spent on Shelter Island. Her husband served as a Scoutmaster and experienced frequent tick bites over many years. She describes how repeated exposure shaped her awareness of Lyme disease and the practical challenges of tick prevention. Rich, also from Long Island, connects with her over the region's history of tick-borne disease research. Their conversation highlights how Lyme disease can affect families with extensive outdoor exposure, including hikers, gardeners, hunters, park employees, and other people who spend time in wooded or grassy environments. Repeated tick exposure increases opportunities for infection, but it does not mean everyone living in an endemic area has Lyme disease or carries Borrelia. For practical prevention and next steps after a tick bite, explore Tick Boot Camp's Tick Bite Blueprint. Lyme Disease, Bartonella, Babesia, and the Total Burden of Illness Dr. VanCouvering explains that she approaches complicated patient cases by considering more than one possible contributing factor. Her evaluations may include: Lyme disease and other tick-borne infections Bartonella and Babesia Environmental mold exposure Possible heavy metal exposure Chronic viral illnesses Stress and nervous system function Individual medical history and genetic factors She uses a memorable analogy involving The Godfather and his associates. In her metaphor, addressing one major infection may not resolve a patient's symptoms if other medical problems remain unrecognized. She believes clinicians should evaluate contributing factors methodically rather than assuming that every symptom has a single explanation. However, the presence of multiple symptoms does not establish multiple infections, mold toxicity, or impaired detoxification. Each suspected condition requires appropriate evaluation, and not every proposed testing or treatment approach is clinically validated. Chronic Stress, Fight-or-Flight, and the Immune System One of the interview's central discussions focuses on the relationship between stress and chronic illness. Rich asks whether prolonged stress could affect the immune system in ways that influence a person's response to tick-borne infections. Dr. VanCouvering explains the body's stress response using the familiar example of escaping a tiger. During a perceived threat, the sympathetic nervous system prepares the body for immediate action. Processes such as digestion and other routine functions may temporarily change as the body prioritizes responding to danger. She believes prolonged stress may complicate recovery for some patients with chronic illness. The conversation also explores the balance between sympathetic and parasympathetic nervous system activity. Scientific context: Chronic stress can influence immune signaling, sleep, pain perception, and overall health. However, stress does not simply switch off the immune system, and evidence does not establish that psychological stress causes persistent Borrelia infection or Lyme disease relapse. For a related discussion, listen to Tick Boot Camp's interview with Cathleen King about nervous system regulation and Primal Trust. Why Are More Women Represented in the Chronic Lyme Disease Community? Rich shares an observation from hundreds of Tick Boot Camp interviews: women make up a substantial majority of the patients and practitioners featured on the podcast. He asks Dr. VanCouvering whether biological differences, stress, or social expectations could help explain that pattern. She identifies several possible contributors. Women May Carry More Caregiving and Household Responsibilities Dr. VanCouvering discusses the additional responsibilities many women manage outside paid employment. These may include raising children, caring for aging relatives, and organizing household responsibilities. She believes these demands can contribute to prolonged stress and affect a person's overall well-being. Rich also raises the possibility that social media may increase stress for some women. Dr. VanCouvering cautions that the issue is more complicated than social media alone. Men May Be Less Likely to Seek Medical Care Dr. VanCouvering notes that social expectations may discourage some men from discussing symptoms or seeking help. She treats men who spend significant time outdoors, including gardeners, hunters, and people working in wooded environments. She estimates that her own practice serves approximately 60% women and 40% men. This observation raises an important distinction: The demographics of patients seeking treatment do not necessarily reflect the actual distribution of Lyme disease infections. Hormonal Changes and Medical Dismissal Dr. VanCouvering also discusses hormonal fluctuations and their possible effects on symptoms. She believes women may face additional challenges when reporting fatigue, pain, or other difficult-to-explain health problems. Both Rich and Dr. VanCouvering express concern that women's physical symptoms are sometimes attributed to anxiety or depression without adequate investigation. The discussion raises questions about how medical research, gender bias, and differences in healthcare utilization influence patient experiences. Importantly, the interview does not establish that women are biologically more likely than men to develop persistent symptoms after Lyme disease. Medical Gaslighting: When Patients Are Told It's All in Their Heads Dr. VanCouvering describes patients arriving at her practice in tears after repeatedly being told that their symptoms are psychological. She believes medical dismissal can result from limited education, insufficient appointment time, or clinicians' reluctance to acknowledge uncertainty. Rich asks whether the problem reflects individual arrogance or broader failures within the healthcare system. They discuss how insurance reimbursement, short appointments, demanding schedules, and fragmented specialty care can make it difficult for healthcare professionals to thoroughly evaluate complicated cases. Dr. VanCouvering believes that when clinicians cannot explain a patient's symptoms, they should be willing to acknowledge uncertainty and help the patient find appropriate additional care. She summarizes her philosophy with a memorable statement: “It's not about me being right. It's about getting it right.” Her message is that healthcare should prioritize patient outcomes over professional ego. Why Multisystemic Illness Requires a Broader Perspective Dr. VanCouvering argues that complex chronic illness can be difficult to understand when individual symptoms are evaluated separately. A patient may experience neurological, gastrointestinal, musculoskeletal, cardiovascular, and psychological symptoms simultaneously. Different specialists may focus on individual organs or systems without developing a coordinated understanding of the overall clinical picture. She believes longer appointments, careful listening, and collaboration between practitioners can help identify overlooked medical concerns. Rich agrees that the medical system needs better ways to recognize and investigate illnesses involving multiple body systems. Their discussion emphasizes the importance of comprehensive medical histories, appropriate testing, and collaboration rather than assuming every unexplained symptom has the same cause. Autism, PANS/PANDAS, and Neuroinflammation Dr. VanCouvering explains that her original interest in naturopathic medicine involved understanding her son's developmental and behavioral symptoms. She continues to see some patients with autism and PANS/PANDAS in addition to those with tick-borne illnesses. The interview briefly explores the possibility that inflammatory and infectious conditions can sometimes produce neurological or behavioral symptoms. PANS and PANDAS are clinical syndromes associated with the abrupt onset of certain neuropsychiatric symptoms, although their diagnostic evaluation and proposed mechanisms remain subjects of ongoing research. Autism is a neurodevelopmental condition and should not be equated with Lyme disease or presumed to be caused by tick-borne infections. For a related conversation, explore Tick Boot Camp's interview with Dr. Somer DelSignore about pediatric Lyme disease, autism, PANS/PANDAS, and neuroinflammation. How ILADS Changed Dr. VanCouvering's Medical Career Dr. VanCouvering first attended ILADS in 2014, when she was still learning how to evaluate Lyme disease and associated infections. She remembers that discussions of herbal and integrative approaches initially occupied relatively small conference spaces. By the following year, attendance at those sessions had grown substantially. She credits ILADS with introducing her to clinicians and educational resources that influenced her approach to complex patient cases. Rich and Dr. VanCouvering also discuss how continuing education helps practitioners remain open to new ideas. Their conversation illustrates why clinicians need to evaluate emerging research critically while continuing to provide compassionate, evidence-informed care. Key Takeaways Lyme disease can affect multiple body systems. Dr. VanCouvering's son's experience motivated her to pursue additional medical education. Delayed diagnosis can profoundly affect families. Her son experienced years of symptoms before she began investigating Lyme disease. Other conditions may complicate recovery. She discusses co-infections, environmental exposures, and stress as factors she considers in selected patients. Stress and immune function are connected. The relationship is complex and does not establish that stress causes persistent Lyme infection. Women's experiences deserve greater attention. The interview explores caregiving demands, hormonal changes, healthcare utilization, and medical dismissal. Men also experience Lyme disease and diagnostic challenges. Social expectations may affect when people seek care. Medical gaslighting can damage trust. Patients deserve clinicians who listen, investigate, and acknowledge uncertainty. Complex illness requires collaboration. Coordinated care can be especially important when symptoms involve multiple systems. Education remains essential. Dr. VanCouvering credits ILADS with helping expand her knowledge of tick-borne diseases. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this conversation features Rich and Dr. Anne VanCouvering discussing Lyme disease, chronic stress, gender differences, medical gaslighting, and the challenges of treating complex chronic illness. The interview also explores her son's health journey, the history of tick exposure on Long Island, and her evolving approach to patient care. Rich concludes by inviting Dr. VanCouvering to return for a longer discussion about how Lyme disease should be defined and understood. Discover more physician, researcher, and patient conversations through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E609
    October 24 · 44 min

    Episode 609: Ticking Point: Filmmaker Reece Robinson on Alpha-Gal Syndrome, Lone Star Ticks & a Growing Tick Crisis

    What happens when an Emmy-winning documentary filmmaker turns his camera toward one of the fastest-changing tick problems in the Northeast? In this episode of the Tick Boot Camp Podcast, Matt Sabatello, Tick Boot Camp Co-Founder, sits down in person with Emmy-winning filmmaker Reece Robinson, director of the upcoming documentary Ticking Point, to explore the rise of lone star ticks, Alpha-Gal Syndrome, Lyme disease, and what communities can do to fight back. For Reece, the story is personal. His older brother experienced severe chronic Lyme disease, including Bell’s palsy, cognitive problems, significant pain, intravenous antibiotics, and a period of being bedridden. Years later, Reece watched another tick-related threat begin transforming life on Martha’s Vineyard: the rapid expansion of lone star ticks and growing concern about Alpha-Gal Syndrome. Now he is documenting it. From Chronic Lyme Disease to Ticking Point Reece shares how watching his brother struggle with Lyme disease left a lasting impression on him long before he became a professional filmmaker. His career eventually led him into character-driven documentary storytelling and work on National Geographic’s The First Wave, which documented healthcare workers and patients during the earliest months of the COVID-19 pandemic. During the summer of 2025, Reece noticed something happening on Martha’s Vineyard that he could no longer ignore. Conversations about ticks and Alpha-Gal Syndrome seemed to be everywhere. That experience became the foundation for Ticking Point, a feature-length, solutions-focused documentary examining how communities are responding to expanding tick populations and Alpha-Gal Syndrome. What Is Ticking Point? Rather than creating what Reece describes as a “doom and gloom” documentary, Ticking Point focuses on people trying to solve the problem. The film follows residents, scientists, hunters, public health professionals, and advocates as communities confront questions surrounding: Lone star tick expansion Alpha-Gal Syndrome Deer populations and tick ecology Community-wide tick management Tick-bite prevention Emerging scientific research Public health policy Ecological interventions The challenges of balancing competing community priorities Martha’s Vineyard provides a fascinating case study because it combines a significant tick problem with an engaged year-round community actively searching for solutions. The question behind the film is much bigger than one island: If Martha’s Vineyard can find ways to meaningfully reduce its tick problem, could those lessons help other communities? Alpha-Gal Syndrome and the Lone Star Tick Much of the conversation focuses on growing concern surrounding Alpha-Gal Syndrome (AGS), an allergy associated in the United States primarily with bites from lone star ticks. Reece discusses stories he has encountered while making the documentary, including people whose reactions extend far beyond simply avoiding steak or hamburgers. For some patients, mammalian-derived ingredients, dairy products, medications containing certain animal-derived ingredients, or even exposure to cooking fumes can become concerns. The unpredictable nature of Alpha-Gal Syndrome is one reason Reece believes more research is urgently needed. Two people can experience tick exposure and have dramatically different outcomes—and researchers are still working to understand why. The Rise of the Lone Star Tick Reece describes the lone star tick as a particularly formidable challenge. Unlike the more passive questing behavior people often associate with blacklegged ticks, lone star ticks can actively move toward potential hosts. The conversation explores their behavior, expanding presence across parts of the Northeast, and what that expansion could mean for communities already dealing with Lyme disease and other tick-borne illnesses. Alpha-Gal Syndrome is also only part of the discussion. Matt, Rich, and Reece discuss other conditions associated with lone star ticks, including ehrlichiosis, tularemia, and Southern Tick-Associated Rash Illness (STARI). Filming a Long Island Tick Drag with Monica Cipriani This interview was recorded at the end of an extraordinary day in the field. Before sitting down for the podcast, Reece joined Tick Boot Camp and researcher Monica Cipriani on Long Island to film tick-dragging footage for Ticking Point. The results demonstrated just how significant local lone star tick populations can become. The team encountered large numbers of lone star ticks, including dense clusters of larvae commonly called “tick bombs.” Reece filmed the fieldwork and plans to use footage from the day in his documentary. See what we discovered during our Long Island tick drag with Monica Cipriani and Reece Robinson. Searching for Solutions to the Tick Problem One of the most important themes of Ticking Point is that there probably won't be one solution to the growing tick problem. Reece is documenting approaches that address the issue from multiple directions, including: Deer population management Habitat and landscape management Tick-bite prevention Scientific research Public education Community-based interventions Research into the human immune response Potential future technologies designed to interrupt tick-borne disease transmission The conversation also explores the social and political challenges surrounding interventions such as deer management and controlled burns. Solutions that may appear straightforward scientifically can become much more complicated when implemented across real communities. Can We Prevent Tick-Borne Disease Before the Bite Leads to Illness? Reece also discusses scientists exploring entirely new approaches to tick-borne disease prevention. That includes research involving genetically modified mice designed to interrupt the transmission cycle of Lyme disease, as well as investigations into immune responses that could someday help researchers better understand how the body responds to tick feeding. These ideas remain areas of research rather than immediate solutions, but they illustrate a broader question driving Ticking Point: Can we change the environment, ecology, or transmission cycle in ways that prevent people from becoming sick in the first place? A Filmmaker With a Personal Connection to Lyme Disease Although Reece does not identify as a tick-borne disease patient himself, his brother's experience gives him a perspective familiar to many families in the Lyme community. He remembers his brother experiencing Bell’s palsy, severe pain, memory problems, prolonged illness, IV antibiotics, and numerous approaches to treatment. That experience now intersects with Reece’s career as a documentary filmmaker. His goal with Ticking Point isn't simply to show how frightening ticks can be. It is to document people trying to understand the problem, challenge it, and build solutions. Support and Follow Ticking Point Ticking Point is currently an independent documentary project, and Reece is looking for people affected by Alpha-Gal Syndrome, researchers, advocates, communities working on tick-control initiatives, and others with meaningful stories to share. The project is also accepting tax-deductible financial support through its fiscal sponsor. Learn more about Ticking Point, watch the documentary teaser, join the mailing list, or contact Reece Robinson. Learn More About Reece Robinson Reece Robinson is an Emmy-winning documentary filmmaker whose work focuses on human stories and social issues. His credits include work as a field producer on National Geographic’s The First Wave, documenting the earliest months of the COVID-19 pandemic inside a New York hospital. Learn more about Reece Robinson and explore his filmmaking work. More From Tick Boot Camp Want to continue learning about Lyme disease, Alpha-Gal Syndrome, ticks, and the people working to solve these complex problems? Explore more Tick Boot Camp Podcast interviews with patients, doctors, researchers, and advocates. If you've recently found a tick or experienced a tick bite, start with the Tick Boot Camp Tick Bite Blueprint. And don't miss our behind-the-scenes look at the fieldwork featured in Reece's documentary: Long Island Tick Drag: Tick Bombs, Lone Star Ticks & an Invasive Tick.

  • S1 · E608
    October 23 · 20 min

    Episode 608: Can Lyme Disease Contribute to Heart Disease? – Dr. Tom Haidt | LIVE from ILADS

    Could Lyme disease and other tick-borne infections be overlooked contributors to arterial inflammation, heart disease, and stroke risk? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich reconnects with Dr. H. Thomas “Tom” Hight, MD, a board-certified internal medicine physician and clinical lipidologist specializing in cardiovascular disease prevention and arterial health. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores a provocative question: Could certain infections contribute to cardiovascular inflammation in ways that conventional heart disease evaluations don't routinely investigate? Dr. Hight shares observations from his Atlanta-based practice, where he monitors arterial health using serial ultrasound examinations and cardiovascular biomarkers. He describes patients whose arterial measurements worsened despite improvements in traditional risk factors, prompting him to investigate additional possible contributors, including chronic viral infections and tick-borne illnesses. The discussion covers Lyme disease, Bartonella, endothelial inflammation, atherosclerosis, plaque regression, heart attacks, strokes, Lyme carditis, and emerging research into vascular health and dementia. Dr. Hight also explains why he believes cardiovascular prevention should look beyond cholesterol and blood pressure while emphasizing the importance of addressing all relevant risk factors. His observations raise important research questions, although a direct causal relationship between persistent tick-borne infection and coronary atherosclerosis has not been established. Meet Dr. Tom Hight, MD Dr. H. Thomas Hight, MD is a physician specializing in cardiovascular risk reduction, arterial disease, and clinical lipidology. Based in Atlanta, Georgia, he has spent years working with patients who have experienced heart attacks, strokes, and other serious cardiovascular events. Dr. Hight developed an ultrasound-based approach to monitoring changes in arterial health over time. His practice, CardioSound, focuses on identifying and addressing factors that may contribute to cardiovascular disease progression. His growing interest in Lyme disease began after observing unexpected changes in patients whose cardiovascular risk factors appeared to be improving. He attended an ILADS conference in Boston to learn more about tick-borne illnesses and their possible cardiovascular implications. This interview follows his earlier appearance on Tick Boot Camp, where he first discussed the potential relationship between Lyme disease and cardiovascular risk. Why Dr. Hight Started Investigating Lyme Disease in Heart Patients Dr. Hight explains that his practice regularly monitors patients who have already experienced cardiovascular events. These patients face increased risks of subsequent heart attacks, strokes, and other complications. His approach includes repeat arterial ultrasound studies approximately every three to four months, alongside laboratory testing and comprehensive risk-factor management. He looks for evidence that arterial disease is stabilizing or improving. However, following the COVID-19 pandemic, he noticed an unexpected pattern. Some patients who had previously shown improvements began experiencing worsening arterial findings. This prompted him to reconsider whether additional inflammatory or infectious factors might be contributing to their cardiovascular risk. He began evaluating selected patients for chronic viral illnesses and tick-borne infections. Dr. Hight reports that some patients subsequently showed improvements in inflammatory biomarkers and arterial measurements during treatment. These observations motivated his continued interest in the relationship between infectious disease and cardiovascular health. Lyme Disease, Bartonella, and Endothelial Inflammation A central theme of the conversation is the endothelium, the thin layer of cells lining the inside of blood vessels. Endothelial cells play important roles in vascular function, blood flow, inflammation, and clotting. Dr. Hight discusses how certain infections may affect vascular tissues and potentially contribute to inflammatory processes. He is particularly interested in Borrelia, the bacteria responsible for Lyme disease, and Bartonella species. Both infections have recognized cardiovascular manifestations under certain circumstances, although their mechanisms and clinical presentations differ. Dr. Hight believes further research is needed to determine whether some tick-borne infections contribute to the progression of atherosclerosis. Does Treating Infections Improve Arterial Health? Dr. Hight reports observing reductions in inflammatory biomarkers followed by improvements in arterial ultrasound findings among some patients receiving treatment. He emphasizes that infection management is only one part of his cardiovascular approach. His patients also receive attention to cholesterol, blood pressure, metabolic health, and other established cardiovascular risk factors. Because multiple interventions may occur together, these clinical observations cannot determine which intervention caused the improvements. Dr. Hight acknowledges that more research is necessary to establish cause-and-effect relationships. Understanding Atherosclerosis and Plaque Regression Atherosclerosis develops when plaque accumulates within artery walls. Plaque contains lipids, inflammatory cells, connective tissue, and other materials. Over time, atherosclerosis can restrict blood flow or contribute to events such as heart attacks and strokes. Dr. Hight explains that he uses repeated ultrasound studies to evaluate changes in arterial disease. He discusses plaque regression, which refers to a reduction in atherosclerotic plaque burden. He believes monitoring arterial changes over time provides valuable information about whether a patient's cardiovascular risk-management plan is working. Although plaque regression can occur with effective treatment, interpreting ultrasound changes requires appropriate measurement techniques and clinical context. Dr. Hight also describes strong survival outcomes in his own practice. These are self-reported clinical observations, not independently verified results from a controlled study. Beyond Cholesterol: More Than 20 Modifiable Heart Disease Risk Factors Dr. Hight argues that cardiovascular medicine should consider a wider range of potentially modifiable risk factors. He explains that many routine discussions focus primarily on: Cholesterol Blood pressure Diabetes Smoking Obesity These are important, well-established cardiovascular risk factors. However, Dr. Hight believes clinicians should also investigate other contributors when patients experience unexpected disease progression. He describes evaluating more than 20 modifiable factors in his practice. His broader approach includes inflammatory markers and, in selected circumstances, possible infectious contributors. The conversation emphasizes that patients who have experienced a heart attack or stroke benefit from comprehensive secondary prevention, including evidence-based medication, lifestyle management, and appropriate specialist follow-up. Cardiovascular Biomarkers: Troponin T, NT-proBNP, and IL-6 Dr. Hight discusses several laboratory markers that helped prompt his investigation into additional inflammatory processes. These include: High-sensitivity troponin T: A biomarker associated with heart muscle injury. Interpretation depends on the clinical situation and the degree and pattern of elevation. NT-proBNP: A biomarker commonly used in the evaluation of heart failure and cardiac stress. Interleukin-6 (IL-6): An inflammatory signaling molecule involved in immune responses and multiple disease processes. Dr. Hight reports seeing changes in certain markers alongside changes in arterial health. He believes these measurements may provide clues when investigating patients whose cardiovascular disease is not improving as expected. However, these biomarkers are not specific tests for Lyme disease, Bartonella infection, or infection-related atherosclerosis. Lyme Carditis vs. Coronary Artery Disease Rich and Dr. Hight discuss the distinction between established cardiac complications of Lyme disease and the broader possibility of infection-associated atherosclerosis. Lyme carditis is a recognized manifestation of Lyme disease that can affect the heart's electrical conduction system, sometimes causing atrioventricular block. Symptoms may include palpitations, dizziness, fainting, shortness of breath, and chest discomfort. Coronary artery disease is different. It generally involves atherosclerotic plaque buildup in arteries supplying the heart muscle. Dr. Hight believes more research should investigate whether tick-borne infections contribute to coronary artery disease in selected patients. However, Lyme carditis does not establish that Lyme disease is a common cause of atherosclerosis. For a related conversation, listen to Tick Boot Camp's interview with Dr. Medeya Tsnobiladze about the neurological and cardiovascular impacts of Lyme disease. Should Heart Attack Patients Be Tested for Lyme Disease? Rich asks whether tick-borne disease testing should become part of routine cardiovascular evaluations. Dr. Hight believes infectious contributors deserve more consideration, particularly when a patient's clinical history raises relevant questions. He acknowledges that evidence establishing the relationship between Lyme disease and atherosclerosis remains incomplete. Currently, routine Lyme disease testing for every heart attack patient is not an established standard of care. Testing decisions should consider symptoms, possible tick exposure, geographic risk, and the likelihood that results will meaningfully guide medical management. The discussion also addresses the financial burden of specialty testing and the importance of determining whether additional tests offer meaningful clinical value. Do Patients Always Need Coronary Stents? Dr. Hight discusses the role of coronary stents in treating certain forms of heart disease. He acknowledges that stents can be lifesaving when appropriately used. However, he questions whether some patients with stable coronary artery disease undergo procedures that may not improve their long-term outcomes. He references two major clinical trials: COURAGE Trial: Investigated optimal medical therapy with or without percutaneous coronary intervention in selected patients with stable coronary artery disease. ISCHEMIA Trial: Compared an initial invasive strategy with a conservative strategy in patients with stable ischemic heart disease. These studies helped clarify the benefits and limitations of invasive procedures in particular patient populations. The findings do not mean stents are unnecessary for all patients without symptoms or that medical treatment can replace urgent intervention during a heart attack. Treatment decisions depend on the patient's clinical condition, coronary anatomy, symptoms, and overall risk. Could Vascular Inflammation Contribute to Dementia? Near the end of the interview, Dr. Hight discusses his interest in the relationship between large-vessel disease, small-vessel disease, and cognitive health. He explains that vascular problems can affect both the heart and brain. Large-vessel disease can contribute to heart attacks and strokes, while cerebral small-vessel disease can contribute to cognitive impairment and vascular dementia. Dr. Hight hopes future research will identify better biomarkers and interventions that help clinicians recognize and manage vascular disease earlier. He raises the possibility that improved understanding of inflammatory mechanisms could benefit both cardiovascular and neurological health. This is a research goal, not evidence that treating Lyme disease reverses dementia. The Future: Better Biomarkers, Research, and Prevention Dr. Hight hopes to continue studying the potential relationship between tick-borne infections and cardiovascular disease. He expresses interest in presenting his clinical observations at a future ILADS conference. His broader goal is to develop better tools that help healthcare professionals identify risk factors, monitor arterial health, and intervene before serious cardiovascular events occur. Rich encourages him to share his findings with the wider medical community. Both agree that research, collaboration, and education are essential for answering questions about the possible cardiovascular consequences of tick-borne infections. Key Takeaways Lyme disease has recognized cardiac complications. Lyme carditis can affect the heart's electrical conduction system. The relationship between Lyme disease and atherosclerosis remains uncertain. Dr. Hight's clinical observations raise questions that require controlled research. Endothelial health matters. The inner lining of blood vessels plays a central role in vascular function and inflammation. Heart disease prevention involves multiple risk factors. Cholesterol, blood pressure, diabetes, smoking, and other established risks remain essential treatment targets. Serial arterial imaging may help monitor selected patients. Dr. Hight uses ultrasound to evaluate changes in arterial disease over time. Biomarkers can provide important clinical information. Troponin T, NT-proBNP, and IL-6 have different uses and limitations. Coronary stents have an important but specific role. Their benefits depend on the clinical situation. Vascular health and cognitive health are connected. Research into cerebral small-vessel disease may improve understanding of vascular dementia. Further research is needed. Dr. Hight hopes to investigate whether selected tick-borne infections contribute to cardiovascular disease progression. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this interview reunites Rich with Dr. Tom Hight for an update on his clinical observations and cardiovascular research interests. The conversation explores Lyme disease, Bartonella, arterial inflammation, atherosclerosis, heart attack prevention, plaque regression, and the possibility of improved vascular health through comprehensive risk-factor management. Explore additional interviews with healthcare professionals and researchers through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E607
    October 22 · 29 min

    Episode 607: Lyme Disease, Medical Gaslighting & Finding Hope – Anne Desjardins | LIVE from ILADS

    For seven years, Anne Desjardins struggled with unexplained symptoms, medical dismissal, depression, and thoughts of suicide before finally receiving a Lyme disease diagnosis. Today, she's helping others find the hope she once desperately needed. In this LIVE from ILADS interview, Tick Boot Camp co-host Rich sits down with Anne Desjardins, a Pennsylvania Lyme disease advocate, Ayurvedic practitioner, support group leader, and host of The Silver Lyming podcast. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, their conversation explores delayed Lyme disease diagnosis, neurological symptoms, medical gaslighting, mental health, integrative healing, financial hardship, and the power of sharing patient recovery stories. Anne opens up about losing her independence, struggling to remember people's names, and reaching a point where she no longer wanted to live. She also shares how her diagnosis, treatment, lifestyle changes, and supportive community helped her rebuild her life and discover a new purpose. Her story is a reminder that a difficult chapter doesn't have to be the final chapter—and that hearing someone else's recovery story can help make hope feel possible again. Seven Years of Symptoms Before a Lyme Disease Diagnosis Anne believes she contracted Lyme disease in Pennsylvania, one of the states most heavily affected by tick-borne illness. She began noticing symptoms around age 30, but her initial attempts to find medical answers were unsuccessful. Healthcare professionals repeatedly attributed her symptoms to stress, depression, or being overly emotional. Anne remembers trying to explain that she was becoming depressed because she felt physically ill every day—not the other way around. Over time, her symptoms became increasingly disruptive: Hearing loss in her left ear Heart palpitations and episodes of fluttering Severe dizziness, particularly when turning her head Memory loss, confusion, and difficulty concentrating Speech problems, including stuttering Overwhelming fatigue and reduced ability to perform daily activities Depression, social withdrawal, and suicidal thoughts She eventually became concerned that she might have a brain tumor. After years of unsuccessful medical appointments, a physician finally suspected Lyme disease and ordered testing. When the result came back positive, Anne felt an overwhelming sense of relief. She finally had a diagnosis that could help guide her next steps. Medical Gaslighting, Depression, and the Mental Health Impact of Chronic Illness Anne describes how repeated dismissal affected her confidence, relationships, and emotional well-being. When doctors told her nothing was wrong, she began questioning herself. She became embarrassed by her cognitive symptoms and increasingly avoided social situations. At one event, she introduced herself to the same person twice within minutes because she couldn't remember their first interaction. Daily activities such as showering, doing laundry, cleaning, or visiting friends became difficult. Anne also discusses using alcohol to cope with years of physical and emotional suffering. Eventually, she experienced suicidal thoughts and wondered whether she would ever regain her life. Rich asks whether those thoughts were driven by the illness itself, the prolonged diagnostic journey, or the hopelessness that developed along the way. Anne believes multiple factors contributed. She describes feeling disconnected from herself and eventually learning to recognize that distressing thoughts did not define her identity. Her experience highlights why mental health support and compassionate medical care are important for people living with disabling chronic symptoms. If you're struggling with thoughts of suicide, you deserve immediate support. In the United States, call or text 988 to reach the Suicide & Crisis Lifeline. For additional conversations about the psychological impact of Lyme disease, explore Tick Boot Camp's mental health and Lyme disease interview with therapist Christina Kantzavelos. Lyme Disease Treatment and Anne's Personal Healing Journey After receiving her diagnosis, Anne began antibiotic treatment through her family physician. She initially experienced significant improvement, describing the experience as finally feeling human again. However, some neurological and cognitive symptoms returned during treatment. She received additional antibiotics and eventually began working with a clinician experienced in treating Lyme disease. Anne describes approximately two and a half additional years of antibiotic treatment, alongside herbal supplements and other supportive approaches. One influential resource was Unlocking Lyme by Dr. Bill Rawls, MD. Unable to comfortably read at the time because of her cognitive symptoms, Anne listened to the audiobook and found encouragement in Dr. Rawls' recovery story. She gradually incorporated additional changes into her daily routine, including: Dietary adjustments and avoiding foods she personally felt worsened her symptoms Eliminating alcohol and caffeine Herbal approaches discussed with her healthcare provider Hot yoga and regular movement Mindfulness, spirituality, and self-reflection Exploring Ayurveda and holistic wellness practices Anne credits these combined changes with helping her regain function and improve her quality of life. She emphasizes that her transformation happened gradually over several years. Her experiences reflect an individualized recovery journey rather than a treatment protocol proven to work for everyone. In particular, hot yoga, restrictive diets, and herbal products have not been established as cures for Lyme disease, and prolonged heat exposure can pose risks for some patients. Discovering Ayurveda and a New Perspective on Health As Anne's health improved, she became increasingly interested in Ayurveda, a traditional system of medicine originating in India. She was drawn to its emphasis on daily routines, seasonal changes, nutrition, and the relationship between physical and emotional well-being. Anne eventually pursued formal education to become an Ayurvedic practitioner. She describes this experience as part of a broader personal transformation. Rather than viewing recovery solely as the absence of symptoms, she began exploring how her experience had changed her priorities, relationships, and understanding of herself. Anne acknowledges that she would never have chosen the suffering she experienced, but she now values the perspective and sense of purpose that emerged from it. Turning Pain Into Purpose Through Pennsylvania Lyme Advocacy As Anne regained her health, she became determined to help others avoid the isolation and confusion she had experienced. She began leading a support group through the PA Lyme Resource Network, a volunteer-driven nonprofit focused on tick-borne disease education, prevention, patient support, and advocacy. Anne is associated with the organization's Berks County region and has participated in community outreach and prevention education. She also discusses becoming involved in Pennsylvania's public education efforts connected to Act 83, the state's Lyme and Related Tick-Borne Disease Surveillance, Education, Prevention and Treatment Act. Her advocacy focuses on helping people recognize potential tick-borne disease symptoms, understand prevention strategies, and find supportive resources. The Financial Burden of Lyme Disease Anne speaks candidly about the financial challenges many patients face. Her own treatment journey was expensive, and she describes hearing from people who struggle to afford testing, appointments, treatment, housing, or basic necessities. She also raises concerns about insurance coverage and access to knowledgeable healthcare professionals. Rich and Anne agree that patients should not have to face financial devastation while searching for answers. For Pennsylvania residents seeking community support or practitioner referrals, the PA Lyme Resource Network's patient resources provide a starting point. The Silver Lyming: A Podcast Dedicated to Hope and Healing Anne eventually transformed her advocacy into a podcast called The Silver Lyming. The title reflects her belief that meaningful growth, connection, and purpose can sometimes emerge from extremely difficult experiences. At the time of this interview, Anne had recently released her 75th episode. Her podcast features people who share their experiences with Lyme disease, tick-borne infections, chronic illness, and recovery. Rather than focusing exclusively on symptoms and suffering, Anne seeks out stories that demonstrate different paths toward improved health and renewed purpose. She believes hearing from people who have made progress can help listeners feel less isolated and more hopeful about their own futures. Anne also discovered that podcasting benefits the guests themselves. Several have told her that sharing their experiences publicly helped them process what they had endured. For Anne, the podcast has become a place where people can speak openly, feel heard, and connect with others who understand. Listen to The Silver Lyming with Anne Desjardins on Apple Podcasts. Why Positive Lyme Disease Communities Matter Rich and Anne discuss the importance of finding supportive spaces during chronic illness. Both recognize that patients need opportunities to express frustration, grief, anger, and disappointment. However, Anne explains that when she was seriously ill, she actively searched for stories of people who had improved. She found those stories encouraging at a time when her future felt uncertain. Rich emphasizes the value of multiple patient-led podcasts and advocacy platforms. Different hosts bring different perspectives, ask different questions, and connect with different audiences. He explains that Tick Boot Camp wants people to discover whatever resources best meet their needs, even when those resources come from another podcast. Their conversation reinforces an important principle: Community should make people feel seen, supported, and empowered—not pressured to follow someone else's healing journey. Being surrounded by illness-related discussions does not cause someone to remain sick, but choosing supportive communities can improve emotional well-being. Finding Purpose After Chronic Illness Near the end of the interview, Anne and Rich reflect on the relationship between suffering, identity, and purpose. Anne explains that Lyme disease changed nearly every aspect of her life. She lost years to debilitating symptoms, but she also developed new relationships, pursued education, became an advocate, and created a platform to support others. One of her favorite questions to ask podcast guests is what positive change, if any, emerged from their experience with Lyme disease. The answers vary. Some people would never choose to experience the illness again. Others recognize meaningful personal growth alongside the suffering. Anne believes both perspectives deserve space. Her story demonstrates that finding purpose after illness does not require being grateful for the illness itself. People can acknowledge profound losses while still discovering new possibilities for their future. Key Takeaways Delayed Lyme disease diagnosis can have far-reaching consequences. Anne experienced years of neurological, cognitive, physical, and emotional symptoms before receiving answers. Medical dismissal can deepen isolation. Being told symptoms are caused by stress or depression may leave patients feeling unheard. Mental health deserves attention. Anne openly discusses suicidal thoughts, depression, and the emotional toll of prolonged illness. Recovery experiences vary. Her journey involved medical treatment, lifestyle changes, integrative practices, and community support. Financial barriers remain a major concern. Testing, treatment, and lost income can create serious hardship for patients and families. Patient advocacy creates connection. Anne's work with PA Lyme Resource Network helps people access education and support. Stories of improvement can inspire hope. Through The Silver Lyming, Anne helps others see that progress and meaningful life changes are possible. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this conversation introduces Anne Desjardins to the Tick Boot Camp community. Rich and Anne discuss her seven-year diagnostic journey, Lyme disease treatment experiences, mental health struggles, Pennsylvania advocacy work, and the creation of The Silver Lyming podcast. They also discuss collaborating on future long-form interviews to explore Anne's healing journey in greater depth. Discover more patient, physician, researcher, and advocate conversations through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E606
    October 21 · 25 min

    Episode 606: Neurological Lyme, Seizures & Misdiagnosis – Dr. Pamela Cipriano | LIVE from ILADS

    What happens when Lyme disease patients develop seizures, neurological symptoms, or serious complications—and the treatments they're receiving aren't working? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich reconnects with Dr. Pamela Cipriano, DNP, APRN, a Connecticut nurse practitioner specializing in Lyme disease, tick-borne infections, and complex chronic illness. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, their conversation explores neurological Lyme disease, persistent seizures, suspected autoimmune encephalitis, Bartonella, Babesia, chronic urinary tract infections, and the challenges of caring for patients with complicated medical histories. Dr. Cipriano shares two neurological case studies involving a 25-year-old man and a 14-year-old girl, discusses why some healthcare professionals hesitate to consider alternative diagnoses, and explains her efforts to improve Lyme disease education. She also reflects on her personal journey into tick-borne disease medicine, her son's illness, her training with Dr. Richard Horowitz, and her candidacy for the ILADS Board of Directors. Throughout the conversation, one message stands out: Patients with persistent, unexplained symptoms deserve continued investigation, compassionate care, and healthcare professionals willing to collaborate. Meet Dr. Pamela Cipriano, DNP, APRN Dr. Pamela Cipriano is a Connecticut-based advanced practice registered nurse with a Doctor of Nursing Practice degree. Her professional background includes hospital medicine, critical care, pharmaceutical sales, and the evaluation of patients with Lyme disease and other complex health conditions. She joined ILADS in 2018 and has attended nearly every annual conference since becoming a member. Dr. Cipriano explains that ILADS conferences expose her to research and clinical discussions involving tick-borne pathogens, immune function, environmental exposures, and different treatment approaches. She emphasizes her interest in integrative medicine and individualized patient care. Her decision to enter the field was deeply personal. After her son developed significant health problems, including chronic bladder symptoms, she began investigating Lyme disease and associated infections. That experience ultimately helped shape her professional focus. Neurological Lyme Disease: Two Patients With Persistent Seizures One of the most important parts of the interview focuses on two patients featured in Dr. Cipriano's ILADS poster presentation. The cases involve a 25-year-old man and a 14-year-old girl experiencing serious neurological complications. Dr. Cipriano describes both patients as having neuroborreliosis-related concerns. She explains that the patients developed seizures after beginning antibiotic treatment for Lyme disease. The cases became particularly challenging because the patients continued experiencing neurological symptoms despite receiving anticonvulsant medications. The 25-year-old patient, she reports, was taking three seizure medications and still experiencing seizures. Dr. Cipriano began questioning whether an inflammatory or autoimmune neurological process might be contributing to his symptoms. She discusses researching autoimmune encephalitis and sharing relevant literature with the patients' neurologists. Could Autoimmune Encephalitis Be Overlooked? Autoimmune encephalitis occurs when the immune system attacks components of the brain, potentially causing seizures, behavioral changes, memory problems, and other neurological symptoms. Dr. Cipriano raises concerns that clinicians may sometimes focus on controlling seizures without sufficiently investigating their underlying causes. She discusses corticosteroids as one possible treatment used for certain inflammatory neurological disorders. However, persistent seizures do not automatically indicate autoimmune encephalitis or neurological Lyme disease. Both conditions require careful diagnostic evaluation, and corticosteroids are not appropriate for every seizure disorder or infection. New seizures, prolonged seizures, or repeated seizures without recovery are medical emergencies. Patients should receive prompt neurological evaluation and appropriate treatment. When Patients and Families Find Support Through Shared Experiences Dr. Cipriano explains that the two neurological patients eventually met through their treatment schedules. Although they had not previously known one another, their families began connecting during appointments. They shared experiences, asked about each other's progress, and developed a sense of understanding. For families navigating severe neurological illness, these connections can provide meaningful emotional support. Their experiences also illustrate why community matters when patients face prolonged diagnostic uncertainty. Knowing another family understands the challenges can reduce isolation, even when their medical situations are different. Why Some Doctors Hesitate to Explore Unfamiliar Diagnoses Rich asks Dr. Cipriano why healthcare professionals sometimes resist investigating conditions outside their established areas of expertise. She believes medical training, professional expectations, and concerns about colleagues' opinions may influence clinical decisions. Dr. Cipriano reflects on her previous work as a hospitalist and explains that she has always been willing to question established approaches when patients are not improving. She believes clinicians should remain open to additional evidence and consultation when a treatment plan is unsuccessful. Rich also discusses the professional and regulatory pressures faced by physicians who treat complicated tick-borne disease cases. They reference the history of Dr. Joseph Burrascano, whose work in Lyme disease has been influential within the ILADS community. Their discussion highlights the importance of balancing professional responsibility, patient safety, scientific evidence, and clinical judgment. A Lyme Disease Education Survey With Only 26 Responses Dr. Cipriano describes an effort to understand how much local healthcare professionals know about Lyme disease. She distributed 300 surveys to physicians, nurse practitioners, physician assistants, chiropractors, and naturopathic practitioners. Only 26 responses were returned. That represents a response rate of approximately 8.7%. Dr. Cipriano found the limited participation discouraging. She also shares that a former colleague contacted her privately to express support for her educational efforts. The experience reinforced her belief that healthcare professionals need more opportunities to discuss Lyme disease openly and constructively. Although the response rate does not establish what clinicians know or believe about Lyme disease, it illustrates the challenges Dr. Cipriano encountered while trying to encourage professional engagement. Why Dr. Cipriano Ran for the ILADS Board of Directors During the interview, Dr. Cipriano announces that she is running for the ILADS Board of Directors. Her motivation is to expand membership, improve communication, and encourage more healthcare professionals to participate in Lyme disease education. She believes her previous career in pharmaceutical sales provides skills that could help. Before focusing on tick-borne disease care, Dr. Cipriano spent approximately 14 years in pharmaceutical sales and marketing. She describes working with hospitals and medical decision-makers to explain treatment options and develop professional relationships. One of the medications she represented was ceftriaxone, commonly known by the brand name Rocephin. Ceftriaxone is an antibiotic used for certain serious bacterial infections, including selected neurological and cardiac manifestations of Lyme disease. Dr. Cipriano believes her communication experience could help ILADS reach healthcare professionals who are unfamiliar with its work. Her goal is to build relationships rather than create confrontation. She wants clinicians to better understand the experiences of patients with complex tick-borne illnesses and the research being discussed within the ILADS community. From Her Son's Illness to Lyme Disease Practitioner Dr. Cipriano explains that she began treating Lyme disease around 2017. Her son's illness played a major role in that transition. Initially, she focused on Lyme disease after his testing identified Borrelia. When his symptoms did not improve as expected, she began considering other possible infections. She later pursued additional education through ILADS and trained with Dr. Richard Horowitz, MD. Dr. Cipriano credits that training with helping her develop a broader approach to evaluating patients with complicated symptoms. She also discusses her son's reported improvement after treatment that addressed suspected additional infections. His experience remains a personal clinical account and does not establish that every patient with persistent Lyme disease symptoms has Bartonella or Babesia. The Three Bs and Four Bs of Tick-Borne Illness Rich and Dr. Cipriano discuss how the Lyme disease community increasingly talks about multiple infections rather than Borrelia alone. They reference the three Bs: Borrelia: The bacteria responsible for Lyme disease Bartonella: A group of bacteria associated with several human infections Babesia: Parasites that infect red blood cells and cause babesiosis Dr. Cipriano also mentions a fourth category involving other Borrelia species associated with tick-borne relapsing fever. She reports encountering more patients with laboratory findings suggesting multiple infections. Rich asks whether this reflects improvements in testing, increased clinical awareness, or changes in tick-borne pathogen exposure. Dr. Cipriano believes several factors may be involved. However, the presence of multiple microorganisms in ticks does not mean every organism can infect humans or that every tick bite transmits multiple diseases. Appropriate testing should be guided by symptoms, exposure history, geography, and validated diagnostic methods. Parasites, Specialty Laboratories, and Diagnostic Challenges Dr. Cipriano describes patients who have presented with suspected parasitic infections. She discusses the challenges of identifying organisms through laboratory testing and her experience seeking additional evaluations when initial results were inconclusive. She also raises concerns about the cost of specialty testing, particularly when patients must pay out of pocket. Her examples include suspected intestinal parasites and other organisms that require identification by qualified laboratories. During the conversation, Dr. Cipriano expresses her belief that some of these infections may be associated with tick exposure. Identifying a suspected parasite requires appropriate clinical evaluation and laboratory confirmation. Visual appearance alone may not establish a diagnosis. The discussion illustrates the frustration patients and clinicians can experience when trying to understand unusual or difficult-to-identify findings. Mold, Heavy Metals, and Environmental Testing Dr. Cipriano also discusses evaluating patients for possible environmental exposures. She mentions mold-related concerns, mycotoxins, and heavy metals as areas she considers in selected cases. She explains that different laboratories use different testing methods and that she sometimes turns to specialty laboratories when investigating complicated presentations. However, the accuracy and clinical usefulness of tests vary. Urine mycotoxin testing is not established as a reliable method for diagnosing illness caused by indoor mold exposure, and heavy metal testing should be selected according to credible exposure history and validated medical standards. The interview underscores the importance of interpreting laboratory findings carefully rather than assuming every positive result identifies the cause of a patient's symptoms. Caring for Patients Other Practitioners Consider Too Complicated Dr. Cipriano shares that some patients arrive after being turned away by other healthcare professionals. She recalls a mother who contacted numerous Lyme disease practitioners before finding someone willing to evaluate her adult child's complicated case. Dr. Cipriano explains that her background in critical care has made her comfortable working with medically complex patients. She also acknowledges the significant time commitment involved. Her patients may require extensive follow-up, ongoing reassessment, and coordination with other specialists. She describes working long days and frequently thinking about difficult cases outside normal office hours. Her commitment reflects a central theme of the conversation: patients with complicated illnesses need clinicians who are willing to investigate, communicate, and continue reassessing their care. Looking Ahead: Better Education and More Hope for Patients Near the end of the interview, Rich asks Dr. Cipriano what she hopes will change over the following year. She expects to encounter more patients with complex illnesses and hopes to continue expanding her educational outreach. Most importantly, she wants fewer patients to hear that their symptoms are simply imagined. She encourages healthcare professionals to remain curious, seek additional education, and acknowledge when a condition falls outside their expertise. Dr. Cipriano also discusses sharing information through her website, social media, and YouTube channel. She clarifies that she does not currently host her own podcast but participates in interviews with other organizations. Rich encourages her to continue sharing her perspective because patients benefit from hearing different voices within the medical community. Their conversation ends with a shared hope for greater understanding, collaboration, and improved access to knowledgeable care. Key Takeaways Neurological symptoms deserve careful evaluation. Dr. Cipriano discusses two patients with persistent seizures and suspected inflammatory neurological complications. Autoimmune encephalitis is an important differential diagnosis. Certain patients with unexplained seizures may require investigation beyond routine epilepsy management. Professional education remains a challenge. Her Lyme disease survey received 26 responses from 300 invitations. ILADS plays an important role in her career. She has been a member since 2018 and was running for its Board of Directors at the time of the interview. Her son's illness influenced her medical career. Personal experience led her to pursue additional training in Lyme disease and associated infections. Tick-borne illnesses extend beyond Borrelia. The discussion includes Bartonella, Babesia, and tick-borne relapsing fever. Unusual laboratory findings require careful interpretation. Specialty testing can be useful in selected situations, but accuracy and clinical validation matter. Patients with complex symptoms deserve compassionate care. Dr. Cipriano emphasizes persistence, communication, and continued investigation when appropriate. About This LIVE from ILADS Interview This conversation was recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas. Rich welcomes Dr. Pamela Cipriano back to Tick Boot Camp for a discussion about neurological Lyme disease, persistent seizures, suspected autoimmune encephalitis, tick-borne co-infections, diagnostic challenges, and medical advocacy. The interview also explores the professional pressures facing Lyme disease practitioners and Dr. Cipriano's efforts to expand education through ILADS. Explore more interviews with healthcare professionals, researchers, and advocates through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E605
    October 20 · 15 min

    Episode 605: Lyme Disease, Immune Dysfunction & Hidden Environmental Bacteria – Jacki Meinhardt | LIVE from ILADS

    Could overlooked environmental bacteria, immune dysfunction, and mitochondrial health help explain why some Lyme disease patients remain sick despite years of treatment? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich welcomes back Jacquelyn “Jacki” Meinhardt, DNP, FNP-BC, a nurse practitioner at Amen Clinics in Northern Virginia, to explore the complex relationship between Lyme disease, tick-borne co-infections, environmental exposures, inflammation, and persistent symptoms. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores why some patients struggle to improve after seeing numerous healthcare professionals—and why listening, comprehensive evaluation, and patient-centered care are so important. Jacki discusses medical gaslighting, the growing recognition of Anaplasma and Ehrlichia infections, cardiovascular complications of tick-borne diseases, and an often-overlooked environmental concern: actinomycetes, a group of bacteria that can be found in indoor environments. She also previews her work on mitochondrial medicine, including cellular energy production, NAD metabolism, inflammation, and the possible relationship between mitochondrial dysfunction and chronic fatigue. Throughout the interview, Jacki emphasizes a principle that resonates deeply with the Lyme disease community: Patients deserve to be heard, believed, and thoroughly evaluated—even when their symptoms remain unexplained. Meet Jacquelyn “Jacki” Meinhardt, DNP, FNP-BC Jacquelyn “Jacki” Meinhardt is a doctorally prepared, board-certified family nurse practitioner whose clinical interests include neuroinflammation, immune dysfunction, tick-borne infections, environmental illness, and complex chronic health conditions. At the time of this interview, she had worked at Amen Clinics in Northern Virginia, outside Washington, D.C., for approximately four years. Jacki also teaches at Georgetown University, bringing her clinical and academic experience to discussions about medical education and emerging research. During the interview, she shares that she had been nominated for the ILADS Board of Directors. Since this conversation was recorded, Jacki has joined the ILADS Board, becoming its first nurse practitioner board member. Her involvement reflects her interest in expanding interdisciplinary collaboration, improving education, and helping healthcare professionals better understand patients with complex chronic illnesses. Learn more about her work through her Amen Clinics professional profile. Why Some Patients Remain Sick After Seeing 20 Doctors Jacki explains that many patients arrive at Amen Clinics after extensive medical journeys. Some have consulted as many as 20 healthcare professionals, including functional medicine practitioners, without achieving meaningful improvement. They may have undergone numerous laboratory tests, received multiple diagnoses, and tried different treatment plans. Rather than immediately recommending another intervention, Jacki begins by asking questions. She reviews previous testing, medical history, symptoms, treatment responses, and possible environmental exposures. Her goal is to identify what may have been overlooked. She also emphasizes the importance of treatment sequencing. Sometimes patients have received several reasonable recommendations, but Jacki believes the order in which interventions are introduced may affect how well they tolerate or respond to care. Her approach focuses on understanding the individual patient's circumstances rather than automatically adding more treatments. Medical Gaslighting, Medical Trauma, and the Power of Being Believed One of the most meaningful moments in the interview occurs when Jacki discusses the emotional consequences of prolonged diagnostic uncertainty. She describes patients who have repeatedly been told that their test results are normal or that nothing is medically wrong. After years of symptoms and unsuccessful treatments, some become fearful that another healthcare professional will dismiss their concerns. Jacki describes this experience as a form of medical trauma. She explains that one of the first things she tells patients is: “I believe you.” That reassurance can help patients feel safe enough to share their experiences and participate in a productive medical conversation. Rich asks whether medical gaslighting always involves intentional dismissal or whether some situations reflect limitations in medical education and diagnostic tools. Jacki emphasizes education rather than assigning blame. She believes healthcare professionals can improve patient care by communicating more effectively, remaining curious, and recognizing the limitations of their knowledge. The discussion reinforces an important message: Unexplained symptoms are still real symptoms, and patients deserve compassionate medical attention. Immune Dysfunction: Finding Common Ground Across Medical Specialties Jacki explains that she frequently uses the term immune dysfunction when communicating with clinicians who may be unfamiliar with some of the terminology used in Lyme disease and environmental medicine. Rather than beginning with a discussion of Borrelia, Bartonella, Babesia, mold, or other specific organisms, she focuses on how the immune system may be functioning. She believes this approach creates opportunities for collaboration across medical specialties. Jacki also discusses how the COVID-19 pandemic increased public awareness of immune responses, inflammation, and cytokines. She views the resulting research and medical conversations as opportunities to improve understanding of other complex illnesses. However, immune dysfunction is a broad concept, not a single diagnosis. Specific immune disorders require appropriate clinical evaluation, and not every chronic symptom is caused by an abnormal immune response. Lyme Disease Co-Infections: Beyond Borrelia, Bartonella, and Babesia Rich asks Jacki whether she is seeing changes in the types of infections identified among patients with Lyme disease. He describes Tick Boot Camp's observations of patients reporting combinations of Borrelia, Bartonella, and Babesia. Jacki explains that she has considered multiple tick-borne infections in her clinical evaluations for many years. She also discusses other pathogens that may be relevant depending on a patient's symptoms and exposure history. These include: Borrelia: Bacteria responsible for Lyme disease and certain relapsing fever illnesses Babesia: Parasites that infect red blood cells and cause babesiosis Bartonella: Bacteria associated with several human diseases Anaplasma: Bacteria responsible for anaplasmosis Ehrlichia: Bacteria responsible for ehrlichiosis Rickettsia: Bacteria associated with spotted fever illnesses, including Rocky Mountain spotted fever Jacki reports encountering more Anaplasma and Ehrlichia in her practice over the preceding two years. She acknowledges that she cannot determine whether this reflects changing infection patterns, improved diagnostic testing, or increased clinical awareness. Her experience highlights the importance of considering other tick-borne infections when a patient's history and symptoms warrant investigation. It does not mean that every person with Lyme disease has multiple infections. Cardiovascular Symptoms and Tick-Borne Disease Jacki discusses her interest in cardiovascular and circulatory health. She explains that when evaluating patients with certain cardiac abnormalities, she considers whether an infectious disease could be contributing to their symptoms. The conversation includes heart block, atrial fibrillation, and tick-borne infections that may require further investigation. Lyme carditis is a recognized complication of Lyme disease that can disrupt electrical signaling in the heart. Other tick-borne infections may also produce serious systemic complications. Jacki emphasizes reviewing which infections have already been investigated and whether additional testing is appropriate. New chest pain, fainting, significant palpitations, or suspected heart block require prompt medical attention. For another discussion of Lyme disease's neurological and cardiovascular effects, explore Tick Boot Camp's interview with Dr. Medeya Tsnobiladze. Environmental Actinomycetes: Could There Be More Than Mold in Water-Damaged Buildings? One of the most distinctive parts of this interview focuses on environmental actinomycetes. Jacki explains that patients investigating building-related health concerns frequently focus on mold. However, she believes certain bacteria present in indoor environments deserve additional attention. Actinomycetes are a diverse group of bacteria found in soil, water, and other environments. Some are also normal members of the human microbiome. Jacki discusses how these organisms can enter buildings through shoes, clothing, pets, and ordinary outdoor exposure. She explains that moisture and environmental conditions may influence microbial growth. Her clinical interest includes evaluating possible environmental exposures in patients with persistent symptoms and complex medical histories. Actinomycetes, Biofilms, and Indoor Environments Jacki describes actinomycetes as organisms capable of contributing to biofilm formation under certain conditions. She discusses how investigating bacterial contamination may differ from evaluating fungal contamination. She also references research she reports publishing with Dr. Ritchie Shoemaker in 2019 concerning environmental organisms and chronic inflammatory illness. According to Jacki, understanding these exposures may help clinicians investigate cases where patients continue experiencing symptoms after addressing suspected mold problems. She also describes considering culture results from different body sites when evaluating selected patients. Scientific context: The presence of actinomycetes in a building or clinical sample does not automatically establish that they are causing illness. Their proposed role in chronic inflammatory conditions remains under investigation, and laboratory findings require careful interpretation. Mold, Environmental Testing, and Chemical Sensitivities Jacki explains that she considers the patient's broader environment when reviewing complicated cases. Homes, schools, and workplaces can have different environmental conditions, including moisture problems, microbial contamination, and other potential exposures. Some patients arrive with previous environmental testing results that may need further interpretation. Jacki believes clinicians should review these findings alongside medical history and symptoms rather than assuming a single exposure explains every health problem. She also discusses how certain patients report sensitivity to fragrances or cleaning products. For these individuals, she emphasizes considering cleaning methods and product tolerability when developing practical recommendations. The conversation illustrates the importance of investigating documented environmental problems without assuming that every detected organism represents a health hazard. Mitochondrial Medicine: Understanding Energy Production and Chronic Fatigue Near the end of the interview, Jacki reveals that she is preparing to present on mitochondrial medicine at ILADS. Mitochondria are cellular structures responsible for producing much of the energy used by the body. Jacki is interested in how energy metabolism may relate to inflammation, vascular health, and persistent symptoms. Her presentation explores: Mitochondrial function and cellular energy production The Krebs cycle Pyruvate and lactate metabolism NAD and its role in cellular processes Endothelial function and blood vessel health Inflammatory signaling and metabolic changes Rich connects this discussion to the profound fatigue frequently reported by people living with Lyme disease. Jacki believes research into cellular energy pathways may help clinicians better understand some aspects of complex chronic illness. However, fatigue has many possible causes. It cannot automatically be attributed to mitochondrial dysfunction, and research into energy metabolism does not establish that NAD supplementation or other mitochondrial therapies treat Lyme disease. Why Medical Education Must Evolve Faster Jacki expresses frustration that new research findings can take years to reach everyday clinical practice. She believes physicians, nurse practitioners, physician assistants, and other healthcare professionals need opportunities to learn about emerging evidence more quickly. Her involvement with ILADS reflects that commitment to continuing education. Rich agrees that greater collaboration between clinicians, researchers, and advocates can improve awareness and patient care. Their conversation emphasizes the importance of evaluating new research carefully while helping healthcare professionals remain informed about developments relevant to complex chronic illness. Key Takeaways Patients deserve validation. Jacki emphasizes listening carefully to people who have experienced years of medical dismissal. Complex cases require comprehensive evaluation. Reviewing medical history, previous testing, and environmental exposures may reveal overlooked information. Immune dysfunction is an important area of investigation. Understanding specific immune abnormalities requires appropriate medical assessment. Tick-borne infections extend beyond Lyme disease. Jacki discusses Babesia, Bartonella, Anaplasma, Ehrlichia, and other infections. Cardiovascular symptoms warrant careful attention. Certain tick-borne infections can cause serious cardiac complications. Environmental actinomycetes are an emerging research topic. Their proposed relationship with chronic inflammatory illness requires further validation. Mitochondrial health may provide insights into persistent fatigue. Research into cellular energy metabolism continues to evolve. Medical education can help improve care. Jacki advocates for collaboration, research awareness, and better communication across specialties. About This LIVE from ILADS Interview This conversation was recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas. Rich welcomes Jacquelyn “Jacki” Meinhardt, DNP, FNP-BC, back to Tick Boot Camp to discuss Lyme disease, immune dysfunction, environmental actinomycetes, and mitochondrial medicine. During the interview, Jacki discusses her nomination to the ILADS Board of Directors. She has since joined the board, becoming its first nurse practitioner member. Explore more conversations with physicians, researchers, and advocates through Tick Boot Camp's LIVE from ILADS interview series.

  • S1 · E604
    October 19 · 22 min

    Episode 604: Lyme 3.0: Beyond Killing Infections to Healing the Body – Dr. Todd Maderis | LIVE from ILADS

    What if treating Lyme disease is only part of the recovery process—and the next frontier is helping the body repair the damage left behind? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich sits down with Dr. Todd Maderis, ND, founder of Marin Natural Medicine Clinic in Northern California, to explore what he calls “Lyme 3.0”—an evolving approach to complex chronic illness that looks beyond infections to consider immune function, environmental exposures, cellular repair, and long-term recovery. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores why some patients continue experiencing fatigue, brain fog, and neurological symptoms even after receiving treatment for Lyme disease and associated infections. Dr. Maderis discusses the challenges of diagnosing multiple tick-borne infections, the possible roles of mold exposure and heavy metals, the relationship between long COVID and viral reactivation, and how his approach to treating complex chronic illness has evolved since 2012. The interview also examines emerging diagnostic technologies, including testing from IGeneX, T-Lab, and Galaxy Diagnostics, along with Babesia, Bartonella, alpha-gal syndrome, and practical strategies for preventing tick bites. His central message: Recovery may require more than identifying and treating infections. For some patients, understanding the factors contributing to persistent symptoms and supporting rehabilitation may be equally important. Meet Dr. Todd Maderis, ND Dr. Todd Maderis, ND is the founder and medical director of Marin Natural Medicine Clinic in Marin County, California, just north of San Francisco. He began focusing on Lyme disease and tick-borne infections in 2012. Over time, his practice expanded to include patients with complicated medical histories involving several overlapping health conditions. His areas of clinical interest include: Lyme disease, Babesia, Bartonella, and other tick-borne infections Mold-related illness and environmental exposures Mast cell activation syndrome (MCAS) Chronic viral infections, including Epstein-Barr virus (EBV) Long COVID Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Autoimmune conditions Persistent fatigue, pain, and cognitive symptoms Dr. Maderis explains that his approach has evolved as he has encountered patients with increasingly complicated combinations of symptoms and diagnoses. He also shares research and educational information through social media to help patients better understand emerging developments in complex chronic illness. What Is Lyme 3.0? One of the most compelling parts of this conversation is Dr. Maderis's explanation of how Lyme disease treatment has evolved. He describes three stages in the development of his clinical thinking. Lyme 1.0: Focusing on the Infection Early treatment approaches primarily emphasized identifying and treating the infectious organisms responsible for Lyme disease and associated conditions. Dr. Maderis explains that clinicians initially focused heavily on reducing the infectious burden. Antimicrobial treatment remains essential when a patient has an active infection requiring treatment. However, he began questioning whether infection-focused interventions alone could explain every patient's ongoing symptoms. Lyme 2.0: Recognizing Additional Health Conditions As his practice evolved, Dr. Maderis increasingly evaluated patients for other medical problems occurring alongside tick-borne infections. These included mold-related concerns, mast cell activation syndrome, chronic viral infections, and autoimmune conditions. He describes learning about mold-related illness at an ILADS conference around 2013 as a turning point in his clinical career. That presentation encouraged him to consider environmental exposures in patients whose symptoms were not fully explained by their existing diagnoses. Lyme 3.0: Recovery, Repair, and Rehabilitation Dr. Maderis believes the next stage involves understanding what patients may need after appropriate treatment of infections and other identified medical conditions. He points to people who continue experiencing symptoms such as: Persistent fatigue Brain fog and cognitive difficulties Reduced physical endurance Neurological complaints Difficulty returning to previous activities He discusses cellular and mitochondrial health as areas of interest when considering why some patients struggle to regain their previous level of functioning. His concept of Lyme 3.0 emphasizes the importance of rehabilitation and recovery rather than viewing treatment exclusively as an effort to eliminate pathogens. This is Dr. Maderis's framework, not an established medical classification or a validated treatment protocol. Persistent symptoms after Lyme disease treatment can have multiple causes and require individualized medical evaluation. Why Some Lyme Patients Have Multiple Contributing Health Problems Rich asks Dr. Maderis why clinicians appear to be identifying more complicated cases involving several infections or overlapping medical conditions. Dr. Maderis believes several developments may be contributing to this observation. Diagnostic technologies have evolved, clinicians have become more aware of tick-borne co-infections, and geographic patterns of tick exposure continue to change. He also discusses environmental exposures and the possible effects of other illnesses on immune function. Dr. Maderis groups the factors he considers into three broad categories: Infectious factors: Tick-borne infections and other clinically relevant infectious diseases. Environmental factors: Mold exposure, toxic metals, and other exposures that may warrant investigation. Traumatic factors: Physical injuries, including head trauma, and psychological stress or trauma that may affect health and recovery. He explains that some patients arrive with several potential contributing conditions rather than one straightforward diagnosis. His challenge is determining which findings are clinically significant and which require treatment. The conversation highlights why complex cases benefit from careful differential diagnosis rather than assuming every symptom has the same underlying cause. Lyme Disease, Long COVID, and Epstein-Barr Virus Reactivation Rich and Dr. Maderis discuss whether COVID-19 can influence previously controlled infections. Dr. Maderis references research investigating the relationship between SARS-CoV-2 infection, immune changes, and Epstein-Barr virus reactivation. Some studies have identified associations between EBV reactivation markers and long COVID. He raises the possibility that changes in immune function following COVID-19 could also affect other infections. However, the extent to which SARS-CoV-2 may cause reactivation of Borrelia infection remains uncertain. The discussion illustrates an important research question: How do multiple infections and immune responses interact in patients experiencing prolonged symptoms? Dr. Maderis believes clinicians should remain aware of emerging findings while recognizing that the science continues to develop. Why a Positive Lyme Antibody Test Doesn't Always Mean Active Infection Rich and Dr. Maderis discuss the distinction between detecting an infection and detecting evidence of a previous immune response. Antibody tests measure the immune system's response to an organism rather than directly identifying whether that organism is currently present. Antibodies against Borrelia can remain detectable for months or years after successful treatment. This means a positive antibody test does not necessarily establish an active infection. Conversely, testing early in an infection can produce negative results before detectable antibodies have developed. Dr. Maderis believes clinicians must interpret results alongside symptoms, medical history, exposure risk, and other clinical findings. This distinction is particularly important for patients who undergo repeated testing while trying to understand persistent symptoms. Advanced Lyme Disease and Co-Infection Testing Dr. Maderis explains that he uses several specialty laboratories when evaluating patients for Lyme disease and associated infections. He discusses how different testing methods may provide different types of information. IGeneX: Lyme Disease and Co-Infection Panels Dr. Maderis describes IGeneX as one of the foundational laboratories he uses when evaluating patients for tick-borne infections. The laboratory offers testing for Lyme disease and several associated infections. He explains that he frequently orders comprehensive panels during initial evaluations when the patient's history supports investigation for multiple tick-borne pathogens. T-Lab: Direct Detection Methods Dr. Maderis also discusses T-Lab, which uses specialized microscopy and molecular methods intended to detect organisms more directly. He contrasts these methods with antibody-based testing. The potential advantage of direct detection is that it attempts to identify evidence of the organism rather than relying solely on the patient's antibody response. However, the diagnostic accuracy, clinical validation, and appropriate use of individual specialty tests must be evaluated carefully. Galaxy Diagnostics: Bartonella Testing Dr. Maderis identifies Galaxy Diagnostics as another laboratory he uses, particularly when investigating Bartonella infection. He discusses the laboratory's expanded Bartonella testing methods and describes a patient whose infection was detected after earlier testing through other laboratories had been negative. This experience reinforced his belief that different testing methods may sometimes produce different findings. For a deeper exploration of Bartonella diagnostics, Tick Boot Camp previously interviewed Nicole Bell of Galaxy Diagnostics about the challenges of detecting tick-borne infections. No single test can definitively diagnose or exclude every tick-borne disease. Patients should work with qualified clinicians to determine which tests are appropriate and how results should be interpreted. Mold Exposure, Mycotoxins, and Chronic Illness Dr. Maderis explains that environmental medicine became an increasingly important part of his practice after attending an ILADS presentation on mold-related illness. He now considers environmental exposures when evaluating selected patients with complicated symptoms. The interview distinguishes between investigating a patient's environment and assessing possible exposures within the body. Testing the Home for Mold When a patient's history suggests possible mold exposure, Dr. Maderis may recommend an initial home screening. Depending on the findings, he may suggest a more thorough evaluation by a qualified environmental professional. The conversation emphasizes identifying possible sources of exposure rather than relying exclusively on medical testing. Urine Mycotoxin Testing Dr. Maderis explains that he uses urine mycotoxin testing in his practice. Mycotoxins are substances produced by certain molds, and exposure can occur through different environmental and dietary sources. However, the clinical usefulness of urine mycotoxin testing for diagnosing mold-related illness remains uncertain. Such tests are not established as reliable diagnostic tools for determining whether a person's symptoms are caused by indoor mold exposure. A comprehensive assessment should consider exposure history, environmental conditions, symptoms, and established medical diagnoses. Heavy Metals, Immune Function, and Environmental Testing Dr. Maderis also discusses exposure to toxic metals, particularly lead and mercury. He explains that certain metals can remain in the body long after an exposure has ended. Lead and mercury can produce significant health effects, including neurological and other systemic complications. Dr. Maderis considers these exposures when a patient's history or symptoms suggest they may be relevant. He also acknowledges an important limitation: clinicians cannot routinely test for every chemical encountered in the environment. The discussion reinforces the importance of selecting tests based on credible exposure history and established clinical indications. Suspected toxic metal exposure should be evaluated using validated testing methods. Unnecessary testing or unproven detoxification treatments can create additional risks. Babesia on the East Coast and West Coast Rich asks Dr. Maderis whether he has noticed changes in Babesia infections among his California patients. Dr. Maderis explains that clinicians historically associated Babesia microti more strongly with the eastern United States and Babesia duncani with the West Coast. However, he believes geographic assumptions can be misleading. He reports encountering different Babesia species in his practice and mentions growing clinical interest in Babesia odocoilei. Rich shares that he has also observed more Babesia-related concerns in the Lyme disease community on Long Island. Their discussion highlights the importance of considering geography, travel history, tick exposure, and appropriate diagnostic methods. Babesiosis is a potentially serious tick-borne disease, particularly for older adults and people with weakened immune systems. The geographic distribution and human disease significance of individual Babesia species vary, and emerging laboratory findings should not be confused with established population-level prevalence data. Alpha-Gal Syndrome and the Lone Star Tick The conversation shifts to alpha-gal syndrome, a potentially serious allergic condition associated with sensitization to a sugar molecule called alpha-gal. In the United States, alpha-gal syndrome is strongly associated with bites from lone star ticks. Affected individuals may experience delayed allergic reactions after consuming certain mammalian meat products or encountering other alpha-gal-containing substances. Dr. Maderis explains that he had not encountered a confirmed case in his California practice at the time of the interview. Rich contrasts that experience with the prevalence of lone star ticks on Long Island and in other parts of the eastern United States. They also discuss reports of alpha-gal syndrome on Martha's Vineyard and the possibility of changing tick distributions. Because alpha-gal syndrome can cause severe allergic reactions, suspected cases should be evaluated by an appropriately qualified healthcare professional. Could Genetically Modified Mice Help Prevent Lyme Disease? Rich asks Dr. Maderis about a proposed strategy involving genetically modified mice on Martha's Vineyard. The idea involves altering the relationship between mice, ticks, and Borrelia bacteria to potentially reduce the transmission of Lyme disease. Mice are important reservoir hosts for certain tick-borne pathogens, making them a focus of disease-prevention research. Dr. Maderis expresses concern about introducing genetically modified animals into the environment. He favors emphasizing established prevention strategies and public education. This exchange illustrates the broader debate surrounding emerging environmental approaches to reducing tick-borne disease risk. Potential ecological interventions require careful scientific evaluation, environmental oversight, and community engagement. How to Perform a Thorough Tick Check The interview concludes with one of its most practical discussions: preventing tick bites. Dr. Maderis and Rich agree that regular tick checks are an important part of reducing exposure to tick-borne diseases. Rich explains that he checks himself twice daily and emphasizes the importance of using both sight and touch. Dr. Maderis recommends examining the entire body after outdoor activities, particularly when spending time in wooded, grassy, or other tick-prone environments. Important areas to inspect include: Behind the knees Under the arms Around the waist and groin Behind and inside the ears Along the scalp and hairline Around the back and other hard-to-see areas Children may need help from a parent or caregiver, while adults can benefit from a partner checking areas they cannot easily inspect. A shower after outdoor exposure can help remove unattached ticks and provides an opportunity for a thorough examination. Rich also describes using his fingertips to feel for small attached ticks that might be difficult to see. If you find an attached tick, remove it promptly with fine-tipped tweezers, grasping it close to the skin and pulling upward with steady pressure. For a step-by-step guide to prevention, removal, and what to do after a bite, explore the Tick Boot Camp Tick Bite Blueprint. Key Takeaways Lyme 3.0 emphasizes recovery and repair. Dr. Maderis believes some patients need additional evaluation and rehabilitation after treatment of identified infections. Complex chronic illness may involve overlapping conditions. Tick-borne infections, environmental exposures, and other diagnosed medical problems can complicate evaluation. Long COVID and viral reactivation remain important research topics. Their relationship with persistent symptoms continues to be investigated. Testing methods have different strengths and limitations. Dr. Maderis discusses antibody-based testing, direct detection, and specialty laboratories. Mold and toxic metal exposures warrant evidence-based assessment. Testing should be guided by medical history and validated methods. Babesia and alpha-gal syndrome deserve greater awareness. Tick-borne health risks vary by geography and exposure. Persistent symptoms deserve careful evaluation. Continued fatigue or cognitive difficulties do not automatically establish ongoing infection. Prevention remains essential. Regular tick checks and prompt tick removal can reduce the risk of tick-borne illness. About This LIVE from ILADS Interview This conversation was recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas. Rich interviews Dr. Todd Maderis about his evolving approach to Lyme disease and complex chronic illness, including infection-focused treatment, environmental medicine, diagnostic testing, and rehabilitation. The discussion also explores the changing landscape of tick-borne infections and the importance of public education. Discover more interviews with physicians, researchers, and advocates through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E603
    October 18 · 16 min

    Episode 603: Beyond the Lyme Clinic: Herbal Medicine, Education & Advocacy – Dr. Myriah Hinchey | LIVE from ILADS

    What happens when a Lyme disease doctor realizes she can only help so many patients in her office—but millions of people need better information, more treatment options, and access to knowledgeable healthcare professionals? For Dr. Myriah Hinchey, ND, the answer has been to build something bigger than her medical practice. In this LIVE from ILADS interview, Tick Boot Camp co-host Rich reconnects with Dr. Hinchey to discuss how she is expanding Lyme disease education and patient support through her Connecticut naturopathic practice, LymeCore Botanicals, the LymeBytes Symposium, and a new educational course. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, their conversation explores herbal medicine for Lyme disease and co-infections, integrative approaches to complex chronic illness, the importance of continuing medical education, and the challenges of making specialized healthcare accessible. Dr. Hinchey also shares why she created her own botanical medicine company, how her conference connects patients with nonprofit organizations and healthcare professionals, and why she believes education can reach people who may never be able to schedule an appointment with her. The conversation raises an important question: How can one healthcare professional help thousands of people without personally treating every patient? Meet Dr. Myriah Hinchey, ND Dr. Myriah Hinchey is a Connecticut-licensed naturopathic physician specializing in Lyme disease, tick-borne infections, and complex chronic illness. She is the medical director of TAO: Center for Vitality, Longevity & Optimal Health in Hebron, Connecticut. Her clinical work focuses on patients experiencing complicated, often infection-associated health problems. During the interview, Dr. Hinchey explains that her multidisciplinary practice includes: Naturopathic medicine Lyme-informed psychotherapy Acupuncture Massage therapy Support for patients with complex chronic illness She works alongside fellow naturopathic physician Dr. Marisa Hauser, who also focuses on Lyme disease, co-infections, and related health concerns. Beyond her clinical practice, Dr. Hinchey is the founder of LymeCore Botanicals and LymeBytes, an educational platform that brings together healthcare professionals, patients, researchers, and advocacy organizations. Her professional work reflects a philosophy of combining individualized patient care with broader educational initiatives intended to reach the Lyme disease community. Why Dr. Hinchey Continues Attending ILADS Rich begins by asking why Dr. Hinchey regularly participates in ILADS conferences. Her answer centers on the importance of continuous learning. Even though her clinical approach may differ from those of other practitioners, she believes healthcare professionals need to understand emerging research and the treatments their colleagues are using. She explains that patients frequently arrive having already tried different protocols or therapies. Understanding those approaches allows clinicians to evaluate previous treatments, identify potential problems, and make more informed recommendations. Dr. Hinchey also believes no practitioner has every answer. Even after years of clinical experience, she says she regularly learns something new from educational presentations that helps her reconsider a difficult patient case. For her, attending conferences is not simply about learning new protocols. It is about expanding the clinical knowledge available to patients who have complicated medical histories. Why She Created LymeCore Botanicals One of the most interesting parts of this interview is the origin of LymeCore Botanicals, the herbal medicine company Dr. Hinchey co-founded. She explains that the business began more than a decade before this interview because she was frustrated by inconsistent access to the medicinal herbs she used in her practice. Her primary concern was supply reliability. When a clinician develops an individualized treatment plan using botanical products, inconsistent availability can make it difficult to maintain that plan. Dr. Hinchey wanted greater confidence in the sourcing, purity, potency, and consistency of the herbs available to her patients. Over time, the project expanded into developing formulations based on her clinical experience and treatment philosophy. What began as a practical solution for her own patients eventually grew into a resource used by other healthcare professionals. The Role of Herbal Medicine in Her Clinical Approach Dr. Hinchey discusses botanical medicine as one component of her integrative approach to Lyme disease and co-infections. She believes herbal formulations may play a role in addressing different aspects of complex chronic illness, including infection-related concerns and broader physiological dysfunction. Her approach emphasizes considering the patient's overall condition rather than focusing exclusively on antimicrobial treatment. However, herbal products vary considerably in their ingredients, quality, evidence, and potential risks. Some botanical compounds have demonstrated antimicrobial activity in laboratory studies, but these findings do not establish that herbal protocols can cure Lyme disease in humans. Patients should review supplements with qualified healthcare professionals, particularly when taking prescription medications or managing complicated medical conditions. The LymeBytes Symposium: Bringing the Lyme Community Together Dr. Hinchey explains that she created LymeBytes after discovering that nonprofit organizations were helping patients pay for treatment, yet many people—including experienced clinicians—did not know those resources existed. She wanted to create an event that would connect several important parts of the Lyme disease community. Her vision included three major goals. 1. Connect patients with nonprofit resources Dr. Hinchey wanted organizations providing financial assistance, education, and other support to become more visible to people who might benefit from their services. She also wanted to create opportunities to raise money for these organizations. 2. Provide practical medical education Rather than focusing exclusively on research presentations, she wanted clinicians to leave with information they could apply in practice. Her goal was to bring together experienced speakers who could discuss clinical approaches, patient management, and emerging treatment considerations. 3. Introduce patients and practitioners to additional resources The symposium includes companies and organizations involved in diagnostic testing, nutritional supplements, and complementary interventions. Dr. Hinchey mentions hyperbaric oxygen therapy, red light therapy, far-infrared saunas, and other supportive modalities as examples of topics represented at the event. These therapies have varying levels of scientific support and should not be assumed to be effective treatments for Lyme disease. From a Lyme Conference to a Broader Chronic Illness Symposium Dr. Hinchey explains that LymeBytes initially focused on Lyme disease and associated tick-borne infections. Over time, she expanded its educational scope to address other complex health conditions and overlapping symptom presentations. These include: Long COVID Mold-related illness PANS and PANDAS Immune system dysfunction Complex chronic infection-associated conditions Neurological and inflammatory symptoms She believes clinicians benefit from examining these conditions together because some patients experience overlapping symptoms or multiple diagnoses. The symposium is designed for healthcare professionals as well as patients who want to become more informed participants in their medical care. 2026 event update: The next LymeBytes Symposium is scheduled for November 13–14, 2026, in the Fort Lauderdale/Pompano Beach area of Florida, with in-person and virtual attendance options. Why Education Matters When Doctors Have Long Waiting Lists Rich raises a challenge that affects many patients seeking specialized Lyme disease care: limited access to experienced practitioners. Dr. Hinchey shares that her practice once had a waiting list approximately 18 months long. She recalls receiving angry messages from people frustrated that they could not schedule an appointment sooner. While she understood their desperation, she also recognized that she could not personally treat everyone who needed help. She has a family and responsibilities outside her medical practice. Even working longer hours would not solve the broader problem of limited specialist availability. Rich uses her experience to explore how healthcare professionals can serve people beyond traditional appointments. Instead of relying exclusively on one-on-one care, clinicians can share knowledge through conferences, podcasts, educational courses, books, and other resources. These formats allow information to reach people who live far away, cannot afford specialized consultations, or face lengthy appointment delays. Although educational resources cannot replace individualized medical care, they can help patients prepare questions, understand available options, and seek appropriate evaluations. Reaching Patients Through Podcasts and Online Summits Dr. Hinchey explains that she participates in podcasts and educational events because she wants to reach people who are still searching for explanations for their symptoms. She describes her involvement in two Healing Lyme Summit events through DrTalks. At the time, she already had more demand for appointments than her practice could accommodate. Her motivation for participating was not to attract additional patients. Instead, she hoped someone listening might recognize a relevant symptom pattern or learn about an avenue of medical evaluation they had not previously considered. She believes accessible education can encourage patients to ask better questions and seek appropriate clinical assessments. The conversation also addresses the limitations of relying on a single laboratory result when evaluating complex symptoms. Lyme disease testing must be interpreted according to the timing of infection, exposure history, clinical presentation, and the characteristics of the test being used. Educational programs can help patients understand these considerations, but they cannot establish a diagnosis or replace qualified medical assessment. Treating the Whole Patient: Beyond Antimicrobial Protocols Dr. Hinchey describes her approach as rooted in functional and naturopathic medicine. She believes complex chronic illness requires attention to more than the presence of an infectious organism. During the conversation, she discusses the importance of understanding physiological processes that may influence a patient's symptoms and response to treatment. These include immune function, inflammation, and other factors affecting overall health. She also discusses how her conference has evolved to explore possible interactions among tick-borne infections, environmental exposures, and other chronic health concerns. Her perspective is that clinicians should consider the broader medical picture rather than assuming every patient needs the same intervention. While comprehensive evaluation can be valuable, proposed mechanisms and treatment strategies should be assessed according to available scientific evidence. Established Lyme disease treatment recommendations remain important, and complementary interventions should not replace appropriate antimicrobial therapy when indicated. Why Medical Professionals Need to Keep Learning A central theme of this conversation is professional humility. Dr. Hinchey explains that even when she has heard a speaker present many times, she may learn something that changes how she thinks about a difficult case. She personally selects speakers for LymeBytes based on the topics she believes clinicians and patients need to understand. Her goal is to identify knowledgeable presenters who can share clinically relevant information. She also recognizes that medical knowledge continues to evolve. New research, diagnostic tools, and treatment approaches create opportunities for clinicians to reassess established practices. Rich agrees but adds another dimension: healthcare professionals should also learn how to communicate their knowledge effectively. He argues that sharing expertise through education can help more people than relying exclusively on direct clinical services. Their discussion highlights an opportunity for medical professionals to extend the reach of their experience while continuing to prioritize patient care. Building an Educational Model That Reaches More People Rich introduces the concept of a value ladder to explain how professionals can serve people at different levels of engagement. He describes three approaches: Self-directed learning: People use educational resources to build their understanding independently. Guided learning: Patients or professionals participate in courses, conferences, or structured educational programs. Individualized services: Patients receive direct care from a healthcare professional. Rich believes Dr. Hinchey has developed a model that incorporates all three. Her medical practice provides individualized services, LymeBytes offers structured education, and her podcasts and other resources allow people to learn without becoming patients. He encourages other healthcare professionals to consider similar approaches. The conversation also addresses a gap in professional training. Dr. Hinchey recalls graduating from naturopathic medical school without knowing how to handle important business responsibilities, including insurance billing. Rich observes that physicians, lawyers, and other professionals often receive extensive technical education without comparable training in business operations or public communication. Both believe these skills can help professionals expand the impact of their work. A New Lyme Disease Educational Course Near the end of the interview, Dr. Hinchey reveals another project. She had been developing an educational course for approximately two and a half years. The course is intended for both clinicians and members of the public. Her goal is to organize complex information into a more accessible learning experience for people who cannot attend conferences or receive care at her Connecticut practice. She explains that her attention to detail and desire to create a comprehensive resource had contributed to delays in completing the project. Rich encourages her to prioritize making the information available rather than waiting for perfection. He challenges her to release the course by Christmas 2025. Dr. Hinchey accepts the challenge with some humor, recognizing that the proposed deadline leaves her only about 10 weeks. The course was still in development at the time of this interview. Its current availability should be confirmed through Dr. Hinchey's official channels. Rich and Dr. Hinchey discuss the possibility of another Tick Boot Camp interview dedicated to the course and its educational goals. Key Takeaways Dr. Myriah Hinchey practices in Hebron, Connecticut, where her multidisciplinary clinic focuses on Lyme disease, co-infections, and complex chronic illness. LymeCore Botanicals began as a solution to inconsistent herbal supply, eventually expanding into a company serving other healthcare professionals. LymeBytes connects patients, clinicians, nonprofits, and educational resources through an annual symposium. Her approach emphasizes integrative care, including consideration of infection-related concerns and broader health factors. Medical education should continue throughout a clinician's career, particularly as research and treatment approaches evolve. Specialist shortages create barriers to care, making accessible educational resources increasingly important. Podcasts, summits, and courses can extend a clinician's reach without requiring every person to become a patient. Dr. Hinchey is developing additional educational resources intended to help clinicians and patients navigate complex chronic illness. About This LIVE from ILADS Interview This conversation was recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas. Rich reconnects with Dr. Myriah Hinchey to explore her clinical practice, herbal medicine company, educational conference, and broader mission to improve access to Lyme disease information. The interview emphasizes innovation, continuing education, patient empowerment, and the importance of sharing clinical knowledge beyond the walls of a medical office. For another in-depth conversation with Dr. Hinchey, listen to Episode 524: From Lyme Patient to Pioneer – an interview with Myriah Hinchey. Explore more physician interviews, research discussions, and advocacy conversations through Tick Boot Camp's LIVE from ILADS series.

  • S1 · E602
    October 17 · 21 min

    Episode 602: When Lyme Disease Is Misdiagnosed: 12 Stories of Hope – Terri McCormick | LIVE from ILADS

    What happens when a child spends 10 years searching for a diagnosis, sees 21 doctors, and continues getting sicker while medical tests come back negative? For author and Lyme disease advocate Terri McCormick, this isn't a hypothetical question. It's part of her family's story—and the experience that inspired her to help others navigate the devastating consequences of delayed and missed diagnoses. In this LIVE from ILADS interview, Tick Boot Camp co-host Rich sits down with Terri to discuss her book, Being Misdiagnosed: Stories That Reveal the Hidden Epidemic of Lyme Disease, which shares 12 real-life stories of people whose illnesses were initially attributed to other medical conditions. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores the limitations of Lyme disease testing, the emotional toll of medical dismissal, neurological and psychiatric symptoms, and the importance of finding knowledgeable healthcare professionals. Terri also shares her experiences advocating for two seriously ill daughters, the challenges of navigating multiple medical specialists, and why families need to understand that a negative test doesn't always provide a complete answer. At the heart of this conversation is a message for patients and caregivers who feel unheard: Your symptoms deserve to be taken seriously, and you are not alone in searching for answers. Meet Terri McCormick: Mother, Author, and Lyme Disease Advocate Terri McCormick is an author, speaker, patient advocate, and ILADS Ambassador whose work focuses on improving awareness of Lyme disease and other tick-borne illnesses. Her advocacy began when her own children developed serious health problems that remained unexplained for years. Terri describes navigating countless appointments, researching possible explanations, and struggling to find physicians who could connect her daughters' seemingly unrelated symptoms. What began as a mother's determination to help her children eventually became a broader mission to support families facing similar challenges. Today, Terri helps people find educational resources and connect with healthcare professionals experienced in tick-borne diseases. She also serves as an Illinois State Co-Leader for the Center for Lyme Action and contributes to LymeDisease.org. Her experiences inspired her to write Being Misdiagnosed, a collection of patient stories intended to raise awareness about diagnostic delays and the human consequences of medical uncertainty. A Mother's 10-Year Search for Answers One of the most emotional parts of this interview is Terri's account of her daughters' illnesses. Her older daughter developed increasingly debilitating symptoms, including: Severe, recurring migraines Extreme fatigue and prolonged periods in bed Difficulty walking and dragging her legs Unusual rashes on her hands Significant swelling in her hands Symptoms that fluctuated unpredictably Terri explains that repeated Lyme disease tests came back negative. Despite her daughter's worsening condition, the family struggled to find a clear explanation. Some physicians recommended psychiatric evaluations, leaving Terri frustrated that her daughter's physical symptoms were not being adequately addressed. Her younger daughter experienced a different combination of symptoms, including cardiac concerns, skin problems, and similar hand rashes. Her illness eventually became so debilitating that she missed approximately 60% of a school year. Determined to continue her education, she listened to classroom lectures remotely from bed. Terri recalls consulting numerous medical specialists, including neurologists and rheumatologists. She describes seeing 21 doctors during the family's search for answers. Eventually, the family connected with a practitioner who ordered testing through IGeneX, which Terri says helped establish a Lyme disease diagnosis for one of her daughters. Their experience illustrates how difficult it can be for families when symptoms cross multiple medical specialties and no single clinician has a complete picture. Why Can Lyme Disease Be Difficult to Diagnose? Rich and Terri spend considerable time discussing one of the Lyme community's most persistent concerns: diagnostic uncertainty. Many commonly used Lyme disease tests measure antibodies produced by the immune system in response to infection. These tests can be useful, but their accuracy depends on several factors, particularly the timing of testing. Early in infection, a person may not yet have developed detectable antibodies. This means a negative test does not always exclude Lyme disease, especially when symptoms and exposure history strongly suggest an early infection. Terri describes her frustration when negative test results became the primary reason clinicians dismissed Lyme disease as a possibility. She believes doctors should evaluate the full clinical picture, including symptoms, medical history, possible tick exposure, and appropriate laboratory findings. The interview also highlights the challenges associated with interpreting specialized testing and evaluating patients who have been ill for extended periods. For additional information about available testing methods and their limitations, explore Tick Boot Camp's Lyme Disease Testing Guide. When a Negative Test Becomes a Barrier to Care One of Rich's central observations is that negative test results can influence more than medical decisions. They can also affect whether patients are believed. When a person continues experiencing serious symptoms despite inconclusive testing, they may encounter skepticism from healthcare professionals, family members, employers, or friends. Terri explains that this can be especially difficult for people whose symptoms fluctuate. Someone may feel well enough to participate in an activity one day but be unable to get out of bed the next. Without understanding that symptoms can change over time, others may mistakenly question the severity of the illness. Rich and Terri discuss how this dynamic can leave patients feeling isolated, discouraged, and uncertain about their own experiences. Their message is that persistent symptoms deserve thoughtful evaluation, even when the initial medical investigation does not produce a clear answer. A negative Lyme test does not prove that someone is healthy, but it also does not establish that Lyme disease is the cause of their symptoms. A comprehensive evaluation should consider both tick-borne infections and other possible explanations. Being Misdiagnosed: 12 Stories That Reveal the Hidden Epidemic of Lyme Disease Terri's book, Being Misdiagnosed: Stories That Reveal the Hidden Epidemic of Lyme Disease, brings together 12 real-life accounts of people who experienced prolonged diagnostic journeys. The book explores how symptoms associated with tick-borne illness may overlap with those of other medical conditions. Among the diagnoses discussed are: Amyotrophic lateral sclerosis (ALS) Multiple sclerosis (MS) Alzheimer's disease Chronic fatigue syndrome Sleep disorders Psychiatric illnesses, including schizophrenia Other neurological and complex chronic conditions Terri hopes the stories will encourage patients, caregivers, and medical professionals to ask additional questions when an illness remains unexplained or a diagnosis does not fully account for someone's symptoms. The book also addresses the emotional and social consequences of prolonged illness, including family relationships, medical uncertainty, and the importance of advocacy. Publication update: Although Terri discussed a planned January 2026 release during this October 2025 interview, Being Misdiagnosed has since been published and is available through her official website. The Story of David: Decades Without Answers Terri shares the story of David, one of the individuals featured in her book. According to Terri, David began experiencing serious health problems around age 10, when he received a diagnosis of spondylitis. As he grew older, his condition continued to deteriorate. He underwent repeated medical evaluations, yet his symptoms progressed. By age 42, Terri explains, David had accumulated an extensive list of diagnoses and was living with significant chronic illness. She wonders whether earlier recognition of an underlying tick-borne infection could have changed the course of his medical journey. David's experience raises an important question: What happens when physicians treat individual symptoms and diagnoses without reconsidering whether a broader explanation may be missing? His story reflects the book's emphasis on persistence, reevaluation, and the importance of listening to patients whose health continues to decline. When Lyme Disease Symptoms Resemble ALS or Other Neurological Conditions Another story Terri highlights involves a woman who received an ALS diagnosis. According to Terri, the woman was evaluated by neurologists, including specialists at Mayo Clinic, and was given a limited life expectancy. Her daughter subsequently researched other possibilities and helped her pursue an evaluation for Lyme disease. Terri reports that the woman received a positive Lyme test and underwent treatment. She describes substantial improvement, explaining that the woman later returned to working approximately 50 hours per week. Terri presents this experience as an example of why patients facing serious diagnoses may benefit from a careful review of their medical histories and potential alternative or coexisting conditions. Importantly, this individual story does not establish that Lyme disease causes ALS or that Lyme treatment reverses confirmed ALS. Neurological symptoms can overlap across conditions, and accurate diagnosis requires appropriate specialist evaluation. The story illustrates the importance of investigating potentially treatable conditions without assuming that every neurological illness is caused by infection. Neuropsychiatric Lyme Disease and Mental Health Symptoms Terri also discusses the neurological and psychiatric manifestations that may occur in some people with Lyme disease and other infections. While Lyme disease is commonly associated with fatigue, joint pain, and other physical symptoms, certain neurological complications can affect cognition, mood, and nervous system function. Terri explains that two stories in her book involve prominent neuropsychiatric symptoms. One particularly difficult chapter describes a young man who experienced rapidly worsening psychiatric problems and multiple psychiatric hospitalizations. Terri believes the possibility of an underlying infectious illness was not adequately investigated early enough. The story is especially painful because it does not have the hopeful outcome described in many of the other chapters. Rich connects the discussion to Tick Boot Camp's previous conversations with neuropsychologist Dr. Leo Shea III, whose work includes the cognitive, emotional, and behavioral effects of Lyme disease. The interview raises questions about the relationship between infection, inflammation, neurological function, and psychiatric symptoms. Certain infections can cause neuropsychiatric complications, but conditions such as schizophrenia, bipolar disorder, and other mental illnesses have multiple possible causes. They should not automatically be attributed to Lyme disease. People experiencing new or severe neurological or psychiatric symptoms deserve timely, comprehensive medical evaluation. Why Family Support Matters During a Diagnostic Journey Rich suggests that one of the most important audiences for Terri's book may be the families of people living with unexplained chronic illness. When medical testing is inconclusive, loved ones may struggle to understand why someone remains sick. Parents may question a child's symptoms. Spouses may become frustrated by unpredictable limitations. Friends may withdraw because they do not understand why someone repeatedly cancels plans. Terri explains that these experiences can intensify the isolation already associated with chronic illness. She hopes her book will help families recognize the emotional burden of searching for answers and encourage them to respond with greater understanding. For caregivers, the message is particularly important. You do not need to have every medical answer to believe that someone is suffering and deserves support. The Power of Community and Lyme Disease Support Groups Terri shares that she previously helped run Lyme disease support groups and continues to speak with people searching for information and encouragement. She describes how meaningful it can be when someone finally encounters another person who understands their experience. For people who have spent years explaining symptoms to skeptical listeners, hearing someone acknowledge what they are going through can provide tremendous relief. Terri explains that she regularly receives messages from people asking for guidance. Her advocacy often begins by listening. The conversation reinforces the importance of patient communities, peer support, and opportunities to connect with people who have navigated similar challenges. Support groups cannot replace medical care, but they can help reduce isolation and provide emotional encouragement. Why Lyme Disease Is Called the Great Imitator Rich and Terri discuss Lyme disease's reputation as the great imitator. The phrase reflects the fact that Lyme disease can produce symptoms that overlap with those of other medical conditions. These may include neurological, musculoskeletal, constitutional, and, in certain cases, cardiac manifestations. The diagnostic challenge becomes greater when symptoms fluctuate, evolve, or affect several body systems. Terri's book uses patient experiences to illustrate how complicated these presentations can become. Rich also shares a memorable phrase from LymeLight Foundation founder Phyllis Bedford, who described Lyme as the "supermarket disease." Her observation was that people sometimes receive more recognition of their symptoms from others in their community than they do during medical appointments. The phrase captures a painful reality for some patients: they may feel more understood by people with lived experience than by the professionals they turn to for help. Terri connects with this perspective because she has witnessed the value of patient-to-patient education throughout her advocacy work. Helping Patients Find Knowledgeable Lyme Disease Doctors As an ILADS Ambassador, Terri helps direct people toward educational resources and healthcare professionals with experience in Lyme disease and other tick-borne infections. She explains that finding an appropriately trained clinician can be difficult, particularly in areas with limited specialist availability. Even when knowledgeable practitioners are nearby, long waiting lists may delay appointments. Terri believes medical education is essential to improving this situation. She discusses the role of ILADS conferences in bringing together clinicians, researchers, and advocates who want to improve the recognition and treatment of tick-borne illnesses. Patients seeking care can explore the ILADS website for educational resources and information about finding healthcare professionals. When choosing a clinician, patients should consider professional credentials, diagnostic methods, treatment recommendations, and whether the provider offers an evidence-informed approach that respects patient concerns. Why Terri Believes Awareness Is Creating Hope Despite the difficult experiences described throughout the interview, Terri and Rich conclude on an optimistic note. Rich reflects on changes he has witnessed during years of interviewing Lyme disease patients, physicians, researchers, and advocates. He explains that he now encounters more people actively working to improve awareness, education, testing, and treatment. Terri shares his optimism. She believes patient advocacy, public education, and storytelling can help families recognize when further medical evaluation may be necessary. Her book is part of that effort. By sharing the experiences of people who struggled for years before receiving additional answers, she hopes to encourage more informed conversations between patients, families, and healthcare professionals. The message is not that every unexplained illness is Lyme disease. It is that patients deserve careful investigation, compassion, and the opportunity to pursue answers when their symptoms remain unexplained. Key Takeaways Delayed diagnosis can have serious consequences. Terri's family spent years searching for explanations while her daughters experienced worsening symptoms. Lyme disease testing has limitations. Test results must be interpreted in the context of symptoms, exposure history, timing, and other clinical information. Medical dismissal can deepen suffering. Patients may experience isolation and loss of support when their symptoms are questioned. Lyme disease can affect multiple body systems. Some manifestations overlap with neurological, rheumatological, and other conditions. Families play an important role. Understanding and believing that a loved one's symptoms are real can make a meaningful difference. Patient stories can encourage further investigation. Terri's book highlights the importance of considering additional explanations when a diagnosis remains uncertain. Community provides validation. Support groups and patient advocates can help people feel less alone. Education and advocacy create opportunities for change. Terri hopes her work will improve awareness and encourage earlier recognition of tick-borne illnesses. About This LIVE from ILADS Interview This conversation was recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas. Rich interviews Terri McCormick about her family's diagnostic journey, her work as an ILADS Ambassador, and the experiences that inspired Being Misdiagnosed. The interview explores the challenges of Lyme disease testing, medical dismissal, neurological symptoms, caregiver support, and the importance of patient advocacy. It also highlights the role of community and storytelling in helping people navigate complicated medical experiences. Explore more conversations with physicians, researchers, advocates, and patients in Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E601
    October 16 · 1 hr 45 min

    Episode 601: Ending Chronic Illness: Dr. Richard Horowitz’s Revolutionary New Program to Reverse Inflammation and Heal Persistent Disease

    For more than four decades, Dr. Richard Horowitz has challenged conventional thinking about chronic illness. His work treating more than 13,000 chronically ill patients has led to one of the most influential clinical frameworks in Lyme disease medicine: MSIDS® (Multiple Systemic Infectious Disease Syndrome). Now, in his groundbreaking new book, Ending Chronic Illness: A Revolutionary New Program to Reverse Inflammation and Heal Persistent Disease, Dr. Horowitz expands that framework far beyond Lyme disease. He presents a bold new model suggesting that many of today's most common chronic illnesses—including Alzheimer's disease, Long COVID, autoimmune disorders, chronic fatigue syndrome, cardiovascular disease, autism spectrum disorders, psychiatric illness, and cancer—share common inflammatory pathways and root causes that can be identified and addressed. In this exclusive Tick Boot Camp interview, Matt Sabatello and Rich Johannesen spend more than two hours taking a deep dive into Dr. Horowitz's latest work, exploring the science behind chronic inflammation, the evolution of his MSIDS model, his precision medicine approach to healing, and why he believes medicine must shift from treating symptoms to identifying the multiple factors keeping patients sick. Whether you're living with Lyme disease, another chronic illness, or simply want to understand the future of personalized medicine, this conversation offers one of the most comprehensive discussions Dr. Horowitz has ever shared. You can purchase Ending Chronic Illness: A Revolutionary New Program to Reverse Inflammation and Heal Persistent Disease on Amazon Meet Dr. Richard Horowitz Dr. Richard Horowitz is a board-certified internist, internationally recognized Lyme disease specialist, researcher, educator, and New York Times bestselling author. After beginning his medical career as a traditional internist, he found himself practicing in one of the country's earliest Lyme disease epicenters in New York's Hudson Valley. Over the past 40+ years, Dr. Horowitz has become one of the world's leading clinicians treating chronic Lyme disease and complex chronic illness. His clinical experience treating more than 13,000 patients led him to develop the MSIDS model, a comprehensive framework that looks beyond a single diagnosis to identify multiple overlapping factors driving persistent illness. His previous books, Why Can't I Get Better? and How Can I Get Better?, transformed how many physicians and patients approach chronic Lyme disease. His newest book expands that framework to virtually every major chronic disease. In This Episode, You'll Learn: Why Dr. Horowitz Believes Chronic Disease Needs a New Model Rather than viewing illnesses as isolated diagnoses, Dr. Horowitz argues that chronic diseases often share common inflammatory drivers. He explains why treating a diagnosis alone frequently fails while identifying multiple underlying causes can dramatically improve outcomes. Understanding the MSIDS Model The conversation explores the evolution of MSIDS (Multiple Systemic Infectious Disease Syndrome), which identifies sixteen overlapping contributors to chronic illness. The six primary "drivers of inflammation" include: Chronic infections Environmental toxins Microbiome dysfunction Leaky gut and food sensitivities Vitamin and mineral deficiencies Sleep disorders Dr. Horowitz explains how these root causes create widespread inflammation that then produces additional downstream effects throughout the body. The Three I's: Infection, Inflammation, and Immunity One of the interview's central themes is Dr. Horowitz's "Three I's" framework. He explains how: Persistent infections trigger inflammation Chronic inflammation damages immune function Impaired immunity allows additional infections to thrive Breaking this cycle, he argues, is essential for long-term recovery. Chronic Inflammation: The Common Thread A major focus of the discussion is inflammation. Dr. Horowitz explains why inflammation—not simply infection—may be the underlying mechanism connecting: Lyme disease Long COVID Alzheimer's disease Autoimmune disorders Mood disorders Chronic fatigue syndrome Cardiovascular disease Cancer Autism spectrum disorders The 16 Inflammatory Pathways Building upon the MSIDS model, Dr. Horowitz discusses sixteen major inflammatory pathways that regulate immune function and chronic disease. He explains how pathways such as NF-κB, NRF2, the NLRP3 inflammasome, and prostaglandin signaling interact to sustain inflammation and why targeting these pathways may improve outcomes across numerous diseases. Precision Medicine Instead of One-Size-Fits-All Care Rather than treating everyone identically, Dr. Horowitz advocates for personalized medicine. Every patient presents a unique combination of infections, environmental exposures, immune dysfunction, nutritional deficiencies, hormone imbalances, mitochondrial dysfunction, and other contributing factors. The goal is to identify each person's unique inflammatory burden and systematically remove the factors preventing recovery. Dapsone Combination Therapy Dr. Horowitz explains how years of clinical experience led to the development of his Dapsone Combination Therapy protocols. The discussion covers: Persister bacteria and biofilms Combination antibiotic strategies Reducing Herxheimer reactions Supporting detoxification Managing treatment side effects The importance of antioxidants, probiotics, methylfolate, glutathione, and other supportive therapies He emphasizes that successful treatment involves much more than simply prescribing Dapsone. Lyme Disease, Alzheimer's Disease, and Neuroinflammation The interview also explores Dr. Horowitz's recent work investigating Lyme disease and Alzheimer's disease. He discusses how chronic infections, environmental toxins, and neuroinflammation may contribute to cognitive decline and why reducing inflammation may become an important future direction for neurodegenerative disease research. Emotional Trauma and Chronic Illness Drawing from Chapter 3 of his new book, Dr. Horowitz discusses the biological impact of trauma and chronic stress. He explains why unresolved trauma, limbic system dysfunction, and chronic stress physiology can perpetuate inflammation and why healing often requires addressing both physical and emotional health. Environmental Toxicity Chapter 4 of the book examines the growing role of environmental toxins. Dr. Horowitz discusses: Mold exposure Heavy metals Air pollution Plastics and endocrine disruptors Pesticides Water quality He argues that modern environmental exposures contribute significantly to chronic inflammation and should be evaluated as part of any comprehensive treatment plan. Prevention Matters Although much of the discussion centers on treating chronic illness, Dr. Horowitz emphasizes prevention. He shares many of the lifestyle practices he personally follows, including: Anti-inflammatory nutrition Exercise Sleep optimization Stress reduction Detoxification support Targeted supplementation Reducing environmental toxin exposure His message is simple: protecting health before illness develops may be just as important as treating disease after it appears. Key Takeaways Chronic illness often results from multiple overlapping causes rather than a single diagnosis Inflammation may be the common biological mechanism connecting many seemingly unrelated diseases. The MSIDS model provides a practical framework for identifying and treating these underlying contributors Personalized precision medicine may offer better outcomes than symptom-focused treatment alone Addressing infections, toxins, gut health, nutrition, sleep, immune dysfunction, and emotional health together may dramatically improve recovery Prevention through lifestyle and inflammation reduction should become a central focus of modern medicine. Why This Episode Matters For decades, Dr. Richard Horowitz has challenged traditional assumptions about chronic disease. In Ending Chronic Illness: A Revolutionary New Program to Reverse Inflammation and Heal Persistent Disease, he brings together thousands of patient experiences, years of clinical research, and an evolving understanding of inflammation into one comprehensive roadmap for patients and physicians alike. Whether you agree with every conclusion or simply want to better understand one of today's most influential voices in integrative medicine, this conversation offers an extraordinary look at how the future of chronic illness care may evolve. If you or someone you love is navigating Lyme disease, Long COVID, autoimmune illness, chronic fatigue, persistent inflammation, or another complex chronic condition, this is an episode you won't want to miss.

  • S1 · E600
    October 15 · 18 min

    Episode 600: Lyme Disease Treatment at Sanoviv: Personalized Healing – Dr. Francisco Ulloa | LIVE from ILADS

    Can a multidisciplinary approach to Lyme disease treatment help patients better understand their illness, develop individualized treatment plans, and build a foundation for long-term recovery? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich sits down with Dr. Francisco Ulloa, MD of Sanoviv Medical Institute in Mexico to explore the clinic's approach to integrative Lyme disease treatment, functional medicine, precision-oriented care, and patient education. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation offers an inside look at how Sanoviv brings together physicians, nutritionists, psychologists, and other specialists to evaluate patients and develop coordinated treatment strategies. With approximately 17 years of experience at Sanoviv, Dr. Ulloa explains why he believes treating complex chronic illness requires understanding the individual patient, not simply following a standardized protocol. Rich and Dr. Ulloa also discuss the emotional challenges of chronic illness, the relationship between conventional and functional medicine, and why the habits patients develop during treatment may be important after returning home. For people researching Lyme disease treatment options in Mexico, this interview provides insight into Sanoviv's clinical philosophy, patient evaluation process, and residential care experience. About Dr. Francisco Ulloa, MD Originally from Mexico, Dr. Francisco Ulloa studied and worked in Guadalajara before joining Sanoviv Medical Institute. He first learned about the facility approximately 20 years before this interview through a professional relationship between Sanoviv and the university where he worked. During his initial visit, he was impressed by the environment and its approach to healthcare. He hoped to eventually become part of the medical team. Approximately two years later, he received an invitation to join the institute. By the time of this interview, Dr. Ulloa had spent approximately 17 years working at Sanoviv. His clinical philosophy emphasizes multidisciplinary collaboration, functional medicine, individualized medical planning, and helping patients understand their health. He believes one of the institute's greatest strengths is bringing healthcare professionals from different disciplines together to evaluate complex cases and coordinate patient care. What Makes Sanoviv's Approach to Lyme Disease Different? Located in Rosarito Beach, Baja California, Mexico, Sanoviv Medical Institute offers residential integrative medical programs for patients with a variety of health concerns, including Lyme disease and associated conditions. Dr. Ulloa describes Sanoviv as a functional medicine clinic built around collaboration among multiple healthcare disciplines. Rather than having patients visit specialists independently and attempt to coordinate recommendations themselves, the institute brings those professionals together within one facility. Its team includes medical doctors, nutritionists, psychologists, chiropractors, kinesiologists, fitness professionals, and biological dentistry specialists. Dr. Ulloa explains that the clinic's physicians have training associated with the Institute for Functional Medicine (IFM). Patients typically spend several weeks at the facility, although some extend their stays depending on medical needs, personal goals, and financial circumstances. During that time, the team works to understand each patient's medical history, evaluate current health concerns, and develop a coordinated plan. How the Multidisciplinary Evaluation Process Works One of the most revealing parts of the interview is Dr. Ulloa's description of Sanoviv's medical meetings. When patients arrive, different members of the clinical team evaluate their cases from their respective professional perspectives. The team then meets to discuss findings, compare observations, and determine treatment priorities. Dr. Ulloa explains that the most important issue to address first may not always be the symptom the patient finds most troubling. This is where collaboration becomes particularly valuable. Instead of making decisions based on one professional's perspective, the team considers the patient's broader medical circumstances. Rich describes this as a precision-oriented approach to medicine, where the treatment strategy is developed around the individual rather than applying the same protocol to everyone. Why Lyme Disease Treatment May Need to Be Individualized Dr. Ulloa emphasizes that people with Lyme disease can have very different medical histories, symptoms, and treatment needs. He discusses several factors that may influence the clinical picture, including immune system function, genetics, underlying health conditions, previous treatments, and individual susceptibility. His philosophy is that clinicians should evaluate these differences when developing a treatment strategy. For some patients, this may mean addressing sleep disturbances, nutritional concerns, physical limitations, or other diagnosed medical conditions alongside appropriate treatment for Lyme disease. Dr. Ulloa believes the goal should be to understand the patient as a whole rather than focusing exclusively on one symptom. This approach is especially relevant to people experiencing complex or persistent symptoms who may benefit from coordinated evaluation across multiple medical specialties. Importantly, Lyme disease is caused by infection with Borrelia bacteria. Individualized supportive care does not replace evidence-based diagnosis or appropriate antibiotic treatment. The Power of Helping Patients Understand Their Medical History Dr. Ulloa identifies patient education as one of the most meaningful aspects of the Sanoviv experience. People living with complicated chronic illnesses may arrive after years of searching for explanations. Some have consulted numerous healthcare professionals, undergone extensive testing, or tried multiple treatments without achieving the improvement they hoped for. Dr. Ulloa explains that the medical team works to review each patient's history and communicate its findings in a way the patient can understand. During the first weeks of treatment, patients may interact frequently with physicians and other specialists. These conversations provide opportunities to understand treatment recommendations, discuss priorities, and ask questions. Dr. Ulloa describes how meaningful it can be when a medical team helps patients make sense of their health history. For people who have struggled to feel heard or understood, having their experiences carefully evaluated can provide validation and a clearer path forward. Emotional Support, Hope, and Chronic Illness Rich asks Dr. Ulloa about the relationship between emotional well-being and the treatment experience. Chronic illness can affect much more than physical health. Patients may face uncertainty about their future, changes in employment, financial pressure, disrupted relationships, and the emotional exhaustion of navigating ongoing symptoms. Dr. Ulloa explains that psychological support is an important part of Sanoviv's multidisciplinary approach. He believes clinicians should recognize the emotional challenges associated with illness while helping patients understand their treatment options. The conversation also explores the importance of hope. When patients have experienced years of setbacks, a coordinated medical plan and supportive clinical environment may help them feel more confident about the future. However, emotional outlook does not determine whether someone will recover from Lyme disease. Patients should never be blamed for persistent symptoms or made to feel that they have failed because improvement has been difficult. Hope is most meaningful when accompanied by appropriate medical care, honest communication, and realistic expectations. Why Lifestyle Education Is Central to the Sanoviv Experience A major theme of this interview is what happens after a patient leaves a residential treatment program. Rich raises the concern that some people may expect an intensive medical experience to resolve their health challenges without requiring any changes to their everyday routines. Dr. Ulloa explains that Sanoviv emphasizes lifestyle education because the institute wants patients to continue applying what they learn after returning home. The discussion includes nutrition, sleep, physical activity, emotional well-being, and maintaining appropriate health practices. Dr. Ulloa believes these factors can influence general health and a patient's ability to manage certain medical conditions. He also acknowledges that not every patient is equally interested in a lifestyle-oriented approach. Some people seek a quick intervention, while others are willing to participate in a more comprehensive program. His goal is to help patients understand the reasoning behind recommendations so they can make informed decisions about their ongoing care. Lifestyle changes may support overall wellness and symptom management, but Lyme disease is an infectious illness—not a consequence of unhealthy habits—and these measures are not substitutes for appropriate medical treatment. Can Conventional Medicine and Functional Medicine Work Together? Dr. Ulloa challenges the idea that patients must choose exclusively between pharmaceutical medicine and complementary approaches. He describes encountering people with strongly held beliefs about different types of treatment. Some prefer to avoid prescription medications, while others are skeptical of nutritional or lifestyle-based interventions. His approach is to consider the available options according to the patient's clinical needs. He provides an example involving someone with longstanding sleep difficulties who may benefit from carefully selected short-term medication while other aspects of care are addressed. Dr. Ulloa describes medication in this situation as a temporary support that may help the patient transition toward a broader management plan. The conversation illustrates his belief that treatment should not be limited by rigid philosophical boundaries. Medication decisions must still account for evidence, safety, potential interactions, and the individual patient's condition. Some medications are appropriate for short-term use, while others may be necessary for long-term treatment. Moving Beyond the Expectation of a Quick Cure Rich and Dr. Ulloa discuss the expectations patients may bring to an intensive medical program. Dr. Ulloa believes some people approach treatment hoping for one intervention that will resolve every symptom. He explains that complex health conditions may require a more comprehensive approach and ongoing medical attention. Their discussion includes the distinction between cure and remission. Dr. Ulloa expresses a preference for discussing remission in certain chronic medical situations because he believes it encourages more realistic conversations about sustained improvement. The meaning of these terms varies by disease. For Lyme disease, appropriate antibiotic treatment cures the infection in most patients, although some individuals experience persistent symptoms after treatment. Those symptoms deserve careful evaluation and compassionate medical attention. The broader message of the conversation is that patients benefit from understanding what a treatment program can realistically offer and what additional care may be needed afterward. The Importance of Trust and Shared Decision-Making Dr. Ulloa encourages patients to approach treatment with openness, particularly when recommendations challenge their previous assumptions. He describes the value of allowing medical professionals to explain their approach before rejecting an intervention based on personal beliefs. This part of the conversation raises an important principle: effective healthcare depends on trust and collaboration. Patients should feel comfortable asking questions, discussing concerns, reviewing potential risks, and understanding why a treatment is being recommended. Clinicians, in turn, should respect patients' experiences, preferences, and right to make informed decisions. A strong patient-provider relationship combines professional expertise with the patient's knowledge of their own symptoms and medical history. Exploring Sanoviv's Lyme Disease Treatment Program This interview focuses primarily on the philosophy and medical coordination behind Sanoviv's care. For listeners interested in the specific treatments offered at the facility, Tick Boot Camp previously interviewed Bill Mansell about the institute's residential Lyme disease program. Episode 499: Comprehensive Lyme Disease Treatment at Sanoviv Medical Institute – Bill Mansell explores the program's approach to diagnostic evaluation, antibiotics, whole-body hyperthermia, nutritional support, and aftercare. That conversation provides additional context about the treatments and services discussed by Sanoviv representatives. Some integrative interventions, including whole-body hyperthermia for Lyme disease, are not established standard treatments and may involve significant medical risks. Patients should independently evaluate the evidence and safety of specific procedures. Together, these two interviews offer different perspectives: Bill Mansell discusses the treatment program, while Dr. Ulloa explains the medical philosophy, team collaboration, and patient experience. How to Become a Patient at Sanoviv At the end of the interview, Rich asks Dr. Ulloa how prospective patients can contact the institute. Dr. Ulloa explains that the admissions process begins through Sanoviv's official website. Prospective patients can complete a contact form and communicate with an admissions representative. The admissions team may request medical history, laboratory results, and other relevant documentation. A physician then reviews the available information to help determine which services or programs may be appropriate. Dr. Ulloa explains that Sanoviv receives inquiries from patients in the United States, Canada, Europe, Asia, and other regions. Anyone considering a residential medical program should ask about the proposed treatment plan, supporting evidence, medical risks, total costs, and arrangements for follow-up care before making a decision. Key Takeaways from Dr. Francisco Ulloa Multidisciplinary care: Sanoviv brings together professionals from different healthcare disciplines to evaluate patients and coordinate treatment. Personalized planning: Dr. Ulloa believes complex medical conditions require attention to each patient's individual circumstances. Patient education: Helping patients understand their medical history and treatment recommendations is a major part of the institute's philosophy. Emotional support: Psychological well-being is addressed alongside physical health concerns. Integrative medicine: Dr. Ulloa advocates considering appropriate conventional and supportive interventions rather than relying on one rigid philosophy. Long-term wellness: The clinic emphasizes helping patients develop health practices they can continue after leaving the facility. Shared decision-making: Effective care requires communication, trust, and informed participation. Realistic expectations: Intensive medical programs should be viewed as one possible component of a broader healthcare plan rather than a guaranteed cure. About This LIVE from ILADS Interview This conversation was recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas. The conference brings together healthcare professionals, researchers, and advocates to discuss Lyme disease, associated tick-borne infections, and emerging approaches to patient care. Rich and Dr. Ulloa conclude by discussing the possibility of a future, longer-form Tick Boot Camp interview exploring Sanoviv's work in greater detail. Discover additional conversations with physicians, researchers, and advocates in Tick Boot Camp's LIVE from ILADS interview series.

  • S1 · E599
    October 14 · 17 min

    Episode 599: From Wheelchair to Lyme Remission – Dr. Kristi Hellenbrand | LIVE from ILADS

    What happens when a healthcare professional suddenly loses the ability to walk, struggles to get answers from major medical institutions, and is told Lyme disease doesn't exist where she lives? In this LIVE from ILADS interview, Tick Boot Camp welcomes Dr. Kristi Hellenbrand, DC, a Georgia chiropractor, Lyme disease survivor, author of Let Me Tell You a Secret…She Makes It: A Lyme Survival Story, and Global Lyme Alliance ambassador. In the fall of 2020, Kristi experienced a devastating neurological decline. Within approximately 60 days, she could no longer walk. Migraines, tremors, memory problems, and episodes of disorientation followed. Despite evaluations at major medical institutions, she struggled to obtain a clear explanation for her symptoms. She recalls being told she might have multiple sclerosis and hearing that Lyme disease wasn't a concern in Georgia. Eventually, a local functional medicine physician helped her pursue a different treatment approach. Kristi reports achieving remission in 2021. But her journey didn't end with medical treatment. She also had to rebuild her physical health, process the grief of losing her chiropractic practice, navigate the emotional consequences of chronic illness, and discover a new purpose through Lyme disease education and advocacy. Her story offers a message for people who feel overwhelmed by their diagnosis: Healing is possible, and someone else's recovery story may help you discover questions, resources, and approaches worth exploring with your own healthcare team. When Lyme Disease Changes Everything in 60 Days Before becoming a Lyme disease advocate, Kristi was a practicing chiropractor, mother, wife, and horse owner living south of Atlanta, Georgia. Then, in 2020, her health rapidly deteriorated. Within approximately two months, she lost the ability to walk. Her neurological symptoms included: Severe migraines Tremors Memory lapses Cognitive dysfunction Disorientation in familiar surroundings Significant mobility impairment At one point, she became lost only two miles from home. Kristi describes the fear of watching her body and brain change while struggling to find a physician who could explain what was happening. Her experience became particularly frustrating when she was told that Lyme disease wasn't found in Georgia. For Kristi, the lack of answers became almost as frightening as the symptoms themselves. When a Healthcare Professional Becomes the Patient As a chiropractor, Kristi was already familiar with healthcare. But that didn't make navigating her own unexplained illness easy. She sought evaluations from major medical institutions, including Emory, Piedmont, and Mayo. According to Kristi, those encounters did not produce a clear diagnosis or treatment plan that resolved her illness. She ultimately connected with a local functional medicine physician who was willing to investigate Lyme disease as a possible explanation. That experience reinforced something frequently discussed on Tick Boot Camp: Patients with complicated symptoms need clinicians who listen, investigate, and remain curious when the first explanation doesn't fit. For more information about diagnostic challenges, explore Tick Boot Camp's Lyme disease testing resources. The Treatment Journey: Double-Dose Dapsone Kristi describes pursuing an intensive treatment approach influenced by research from Dr. Richard Horowitz, a physician known for his work with Lyme disease and other tick-borne illnesses. She specifically discusses the double-dose dapsone protocol. Although Kristi did not personally treat with Dr. Horowitz, she and her physician reviewed his published work and incorporated a related approach into her treatment. Kristi recalls that the protocol was challenging and that her physician was initially apprehensive about using such an intensive strategy. Nevertheless, Kristi reports that this period of treatment became an important turning point in her recovery. Her experience is a personal account, not evidence that double-dose dapsone is appropriate or effective for everyone. Dapsone-based multidrug protocols can involve significant medical risks and require careful clinical oversight. Learn more about these approaches through Tick Boot Camp's interviews with Dr. Richard Horowitz. Why Kristi Wrote Let Me Tell You a Secret…She Makes It Kristi's illness forced her to become a student of Lyme disease. While bedridden, she read extensively about the infection, associated conditions, available treatments, and recovery. She remembers needing approximately 20 books simply to begin understanding the basics. That experience inspired an important question: Why should every newly diagnosed patient have to do all this research alone? Her answer was to write a book that combines a personal recovery memoir with practical Lyme disease education. Let Me Tell You a Secret…She Makes It: A Lyme Survival Story was published in 2023. Kristi explains that the book includes educational sections addressing topics such as: Understanding Lyme disease Tick-borne co-infections Treatment options Navigating medical care Financial challenges Finding help Supporting the body during recovery Emotional health and grief Family relationships Rebuilding life after serious illness She began writing before she knew how her own story would end. Originally, part of her motivation was to preserve the experience for her children. Over time, the project became something larger: a resource for other patients and their families. Learn more about Kristi's book and advocacy through Lyme Lives Here. Learning the Language of Lyme Disease Rich and Kristi discuss one of the biggest challenges facing newly diagnosed patients: Lyme disease comes with an unfamiliar vocabulary. Suddenly, patients may be hearing terms such as: Borrelia Bartonella Babesia Co-infections Neuroborreliosis Biofilms Dapsone Herxheimer reactions Nervous-system regulation Rehabilitation Remission Understanding these terms can help patients communicate more effectively with healthcare professionals and evaluate the information they encounter. Kristi designed her memoir to help shorten that learning curve. Rich connects her educational approach with Tick Boot Camp's Tick Bite Blueprint, a resource developed to help people understand practical steps following a tick bite. Putting Out the Fire vs. Rebuilding the Body One of Kristi's central recovery concepts is distinguishing between addressing the active illness and rebuilding afterward. She describes the initial phase of treatment as putting out the fire. Once she felt the immediate crisis had been addressed, she shifted her attention toward rehabilitation. Kristi discusses working on: Digestive health Physical recovery Neurological symptoms Cognitive function Nutrition Emotional health Nervous-system regulation Her perspective is that treatment and rehabilitation are related but not necessarily identical phases. The body may need continued support even after the most severe symptoms improve. This leads to one of the interview's most important connections with Tick Boot Camp's broader healing framework. The Four Phases of Lyme Recovery Rich shares Tick Boot Camp's four-phase model, developed from recurring themes in patient recovery interviews. 1. Prehabilitation Preparing and supporting the body before intensive treatment. 2. Assist Supporting the immune system and addressing microbial burden through an individualized medical plan. 3. Rehabilitation Rebuilding physical, neurological, and functional capacity. 4. Maintenance Developing sustainable habits, monitoring health, and reducing the risk of future tick-borne infections. Kristi recognizes elements of all four phases in her own experience. The conversation illustrates how recovery may involve much more than a single treatment protocol. It also emphasizes that this is a framework for understanding recovery stories, not a universal medical sequence that every patient must follow. The Grief of Losing Your Former Life One of the most emotionally powerful parts of the conversation involves grief. Kristi didn't simply lose physical function. She also lost parts of her identity and independence. She was forced to close her chiropractic practice. She could no longer participate in many of the activities she loved. Her horses remained in the pasture while she recovered. Her children took on additional responsibilities. Her husband helped shoulder the financial burden. Kristi remembers experiencing denial, anger, sadness, loneliness, and fear. She describes the profound isolation that can accompany serious chronic illness, especially when someone feels their life is disappearing piece by piece. Her memoir explores these emotions openly. It also gives family members and caregivers an opportunity to better understand what a loved one may be experiencing. Why Caregivers Need to Hear These Stories Kristi explains that some readers have passed her book to spouses, relatives, and other caregivers. That has become one of its unexpected benefits. Someone living with Lyme disease may struggle to explain the full experience of losing mobility, employment, independence, or hope. A memoir can help communicate those experiences. Kristi's husband initially found the book difficult to read because he had lived through the events alongside her. For other families, however, reading her story has helped open conversations about illness and caregiving. Chronic illness affects the entire family, even when only one person has the diagnosis. Anger, Grief & Finding Hope Kristi is open about the role anger played in her journey. At one point, frustration with her declining health became a powerful motivation to pursue treatment. But she also describes eventually moving toward a quieter emotional place. Her experience wasn't simply about fighting harder. It involved grieving what she had lost and discovering how to live again. Rich connects her story with Tick Boot Camp's discussions about grief, purpose, and the emotional changes people may experience during recovery. The message isn't that everyone must move through grief in the same way. It's that grief deserves recognition. People can experience sadness, anger, fear, and hope at different points—and sometimes simultaneously. DNRS, Neuroplasticity & Nervous-System Regulation During the fall of 2021, Kristi began exploring nervous-system regulation. She discovered Annie Hopper's Dynamic Neural Retraining System (DNRS). Kristi describes the program as helping her shift her identity away from being defined exclusively by illness. She began recognizing that life could contain meaning, beauty, and possibility beyond the struggle to recover. That emotional shift became an important part of her personal journey. Nervous-system and neuroplasticity programs are not substitutes for appropriate medical evaluation or treatment of infection, and their benefits for persistent Lyme symptoms remain an area requiring more research. For related Tick Boot Camp conversations, explore Cathleen King's Primal Trust interview and Lindsay Mitchell's Vital-Side interview. From Lyme Patient to Global Lyme Alliance Ambassador Kristi's recovery eventually led her toward advocacy. She became involved with Global Lyme Alliance, first supporting other patients as a mentor and later serving as a Georgia ambassador. Her advocacy focuses on improving Lyme disease awareness and helping people access information she struggled to find during her own illness. Kristi also describes speaking with healthcare professionals in her community about Lyme disease. She hopes that increased awareness will help more patients receive timely consideration of tick-borne illness when symptoms and exposure histories warrant it. Her work is also connected to Lyme Lives Here, an educational initiative originally established by her daughter, Brooklynn, as a Girl Scout Gold Award project. What began as a family's experience has grown into an effort to educate and support others. Why Georgia Needs Lyme Disease Awareness Kristi's experience challenges the assumption that Lyme disease should automatically be dismissed because a patient lives in the southern United States. She recalls being told that Lyme disease wasn't a concern in Georgia. That message contributed to her frustration during the diagnostic process. Geographic risk varies, and not every tick bite transmits Lyme disease. Nevertheless, clinicians should evaluate a patient's symptoms, travel and exposure history, and the possibility of other locally relevant tick-borne illnesses rather than relying on an overly simplistic geographic assumption. Kristi now uses her experience to encourage greater awareness among patients and healthcare professionals. The Power of a Recovery Memoir Rich explains why Tick Boot Camp values stories from people who have experienced meaningful recovery. A recovery memoir can provide something different from a medical textbook. It can show what one person actually experienced: What they tried. What helped. What didn't. How they handled setbacks. What changed emotionally. How they rebuilt their lives. And what they learned along the way. But Rich also makes an important distinction: Someone else's recovery model doesn't have to become your recovery model. A treatment or approach that helped one person may not work for another. That doesn't mean the patient has failed. It may simply mean they need a different approach, additional investigation, or another member of their healthcare team. Recovery stories can offer ideas and hope without becoming rigid instructions. From Survival to Purpose Kristi's story comes full circle at ILADS. The chiropractor who once struggled to walk is now attending a major Lyme disease conference, meeting clinicians, discussing her book, and helping other patients. She has transformed some of the knowledge gained during her illness into education and advocacy. Her recovery hasn't erased the fear she experienced or the possibility of future health challenges. But she no longer describes her life as being dominated by the severe symptoms she experienced in 2020. And she has found a new purpose. For someone currently bedridden, newly diagnosed, frightened, or struggling to understand what comes next, her story offers a reminder: Your life can change again. Your future doesn't have to look exactly like your present. And you don't have to navigate the journey alone. About Dr. Kristi Hellenbrand, DC Dr. Kristi Hellenbrand is a chiropractor, author, Lyme disease survivor, and Georgia ambassador for Global Lyme Alliance. After experiencing a severe neurological illness beginning in 2020, Kristi pursued treatment for Lyme disease and reports achieving remission in 2021. Her experience inspired her book, Let Me Tell You a Secret…She Makes It: A Lyme Survival Story, which combines memoir, patient education, and reflections on chronic illness, grief, family, and recovery. She also supports Lyme disease awareness through public speaking, education, patient mentorship, and the Lyme Lives Here initiative. Learn more about Global Lyme Alliance's patient support resources. Key Topics in This Episode Lyme disease recovery, Kristi Hellenbrand, Lyme disease remission, neurological Lyme disease, neuroborreliosis, Lyme disease in Georgia, chronic Lyme disease, Lyme disease misdiagnosis, wheelchair-bound Lyme patient, double-dose dapsone, Dr. Richard Horowitz, Horowitz protocol, Lyme disease memoir, Let Me Tell You a Secret She Makes It, Lyme disease treatment, Lyme disease rehabilitation, DNRS, Dynamic Neural Retraining System, neuroplasticity, nervous-system regulation, Lyme disease grief, chronic illness and family, Lyme disease caregivers, Global Lyme Alliance, Lyme Lives Here, Lyme disease advocacy, Tick Boot Camp, ILADS, and healing from Lyme disease. About This LIVE from ILADS Interview This conversation was recorded in person at the 2025 International Lyme and Associated Diseases Society Annual Scientific Conference, From Terrain to Treatment: Advances in Vector-Borne Illness, held October 9–12, 2025, in San Antonio, Texas. Rich and Kristi discuss her personal recovery, her book, and how her experiences relate to Tick Boot Camp's four-phase healing framework. They also discuss the possibility of bringing Kristi back for a longer conversation with Tick Boot Camp co-founder Matt Sabatello. These LIVE from ILADS interviews are short-form conversations recorded on location, offering focused discussions with patients, advocates, clinicians, researchers, and innovators working to improve understanding of Lyme disease. Explore all Tick Boot Camp LIVE from ILADS interviews. More from Tick Boot Camp Explore the Tick Bite Blueprint for education about what to do after a tick bite. Listen to interviews with Dr. Richard Horowitz to learn about his research and approaches to complex Lyme disease treatment. Visit the Tick Boot Camp Podcast for more patient recovery stories, physician interviews, research conversations, and resources for the Lyme disease community. This episode shares one patient's experience for educational purposes. It is not medical advice, and no individual treatment or recovery approach is guaranteed to work for everyone.

  • S1 · E598
    October 13 · 21 min

    Episode 598: Lymphatic Drainage, Lyme Disease & Flowpresso – Freddie Kimmel | LIVE from ILADS

    Could supporting the lymphatic system help people living with Lyme disease feel better, sleep more comfortably, and improve their overall well-being? In this LIVE from ILADS interview, Tick Boot Camp welcomes back Freddie Kimmel, Lyme disease and metastatic cancer survivor, wellness technology educator, host of the Beautifully Broken Podcast, and representative of Flowpresso, for a fascinating conversation about lymphatic drainage, nervous system regulation, infrared heat, compression therapy, and emerging technologies being explored for recovery and wellness. Rich reconnects with Freddie at the 2025 ILADS Conference nearly five years after their original Tick Boot Camp interview. This time, Freddie introduces a technology that has become an important part of his professional work: Flowpresso, a full-body system combining sequential compression, heat, and deep-pressure stimulation. Rich also shares his firsthand experience after trying the device at the conference. He describes feeling deeply relaxed during the session, struggling to stay awake because of how comfortable he felt, and experiencing an unusually restful night of sleep afterward. For patients navigating Lyme disease, persistent fatigue, limited mobility, sleep disturbances, and other complex symptoms, the conversation raises important questions about the role supportive wellness technologies might play alongside individualized medical care. The central question: Can supporting circulation, relaxation, and lymphatic function become another useful part of a comprehensive Lyme disease recovery plan? Freddie Kimmel Returns to Tick Boot Camp Freddie Kimmel is no stranger to the Lyme disease community. A survivor of Lyme disease, metastatic cancer, and mold-related health challenges, Freddie has spent years exploring the intersection of chronic illness, functional health, emerging technology, and personal transformation. His original Tick Boot Camp appearance introduced listeners to his remarkable journey through serious illness and recovery. Listen to Episode 162: The Lyme Polymath – An Interview with Freddie Kimmel to hear his personal story. Since that conversation, Freddie has relocated from New York to Austin, Texas, where he has developed a wellness-focused community and continues exploring technologies intended to support health and recovery. During this interview, he explains that his mission is to help people become healthier versions of themselves by combining information, technology, and practical knowledge. One of the technologies that captured his attention is Flowpresso. What Is Flowpresso? Flowpresso is a full-body therapeutic system developed by New Zealand lymphatic specialist and entrepreneur Desiree De Spong. The system combines three primary components: Sequential compression: Inflatable chambers apply pressure to different parts of the body in a coordinated sequence. Thermotherapy: Integrated heating elements provide warmth during treatment. Deep-pressure stimulation: The full-body garment creates a gentle, enveloping pressure sensation intended to promote comfort and relaxation. Freddie describes the experience as being wrapped in a warm, comforting hug. Unlike smaller compression devices that primarily target the legs, Flowpresso uses multiple garment sections covering the feet, legs, abdomen, arms, and portions of the upper body. A typical session lasts approximately 40 minutes. Flowpresso is marketed as an FDA-cleared Class II medical device intended for use under licensed healthcare practitioner supervision and within its cleared indications. FDA clearance does not establish that Flowpresso treats Lyme disease, eliminates infections, or cures chronic illness. Meet Flowpresso Founder Desiree De Spong Freddie explains that his involvement with Flowpresso began after meeting Desiree De Spong through a mutual connection. Desiree is a New Zealand-based lymphatic specialist, educator, and founder of Flowpresso. Her background includes extensive experience in lymphatic health and therapeutic approaches involving compression and manual lymphatic techniques. Freddie recalls their first conversation lasting approximately an hour. He describes an immediate connection based on their shared interest in wellness, technology, and helping people navigate difficult health challenges. That relationship eventually developed into a professional collaboration. Today, Freddie helps introduce Flowpresso to practitioners, clinics, and wellness communities. Learn more about the Flowpresso team and its founder. Understanding the Lymphatic System One of the most educational parts of this conversation focuses on a body system that often receives less attention than the heart, brain, or digestive tract. The lymphatic system is a network of vessels, lymph nodes, and organs that helps maintain fluid balance, transport certain fats, and support immune function. It collects excess fluid from tissues and returns that fluid to the bloodstream. It also plays an important role in immune surveillance. Lymph nodes contain immune cells that help recognize and respond to potentially harmful substances and infectious organisms. Freddie compares the lymphatic system to a waste-management network that helps the body process material moving through tissues. Although this analogy is useful for understanding some lymphatic functions, the lymphatic system is not a general-purpose detoxification machine, and increasing lymph flow has not been shown to eliminate Lyme bacteria or other infections. Why Movement Matters for Lymphatic Flow Unlike the cardiovascular system, which relies on the heart to circulate blood, the lymphatic system does not have one central pump. Lymph movement is supported by several mechanisms, including: Skeletal muscle contractions Breathing-related pressure changes Contractions within lymphatic vessels One-way valves that help direct fluid movement Normal physical activity Freddie explains that walking, standing, squatting, and other movements can contribute to lymph circulation. This becomes especially relevant when discussing patients with severe fatigue or limited mobility. Some people living with Lyme disease or other chronic illnesses may spend extended periods resting or may be unable to tolerate ordinary exercise. The discussion explores whether supportive therapies could offer additional options for certain patients. However, activity must be adapted to each person's medical condition and physical capacity. Patients with significant exercise intolerance, post-exertional symptom exacerbation, or other limitations may need specialized guidance rather than simply increasing movement. Can Lymphatic Support Help Bedridden Lyme Patients? Rich asks Freddie an important question: What options might exist for people who are too sick to walk or exercise regularly? Freddie explains that Flowpresso provides externally applied sequential compression while the person remains reclined. Rather than requiring the patient to actively contract muscles throughout the session, the device applies pressure through inflatable garment sections. This may be of interest to clinicians evaluating appropriate supportive care for people with mobility limitations. However, there is currently insufficient evidence to conclude that Flowpresso improves Lyme disease outcomes, treats persistent infection, or accelerates recovery from Lyme disease. Compression therapy also has medical contraindications and may be inappropriate for some patients. Anyone considering this technology should consult a qualified healthcare professional, particularly if they have cardiovascular disease, blood-clotting concerns, significant swelling, neuropathy, or other complex medical conditions. How Flowpresso's Sequential Compression Works Freddie describes the Flowpresso system as a series of connected garment sections and inflatable chambers. The chambers are positioned around different areas of the body. During a session, they inflate and release in a coordinated pattern. Freddie compares the process to gently squeezing a tube of toothpaste from one end toward the other. The device uses overlapping compression chambers designed to create a progressive pressure wave. According to Freddie, this wave moves through the system repeatedly during treatment. The intent is to encourage fluid movement and provide a rhythmic, soothing sensation. Sequential pneumatic compression is an established technology used in certain medical settings, including management of selected circulation and swelling conditions. Whether a particular device is appropriate depends on its cleared indications, the patient's condition, and the clinician's assessment. Infrared Heat and Thermotherapy Another feature of Flowpresso is integrated heat. Freddie explains that the device uses warming elements within the garment sections. Unlike a traditional sauna, Flowpresso is not designed primarily to produce intense sweating. Instead, the system provides warmth while the compression chambers operate. Freddie believes this combination may help promote relaxation and complement the mechanical compression experience. Heat can influence local circulation and comfort, but claims that infrared heat directly removes toxins, kills Lyme bacteria, or reverses chronic illness require stronger scientific evidence. For patients with heat intolerance, autonomic dysfunction, impaired temperature sensation, or certain cardiovascular conditions, heat exposure may also present additional considerations. Nervous System Regulation and the Parasympathetic Response Freddie and Rich discuss the relationship between chronic illness, stress, sleep, and the autonomic nervous system. The autonomic nervous system helps regulate functions such as heart rate, breathing, digestion, and vascular activity. Its sympathetic and parasympathetic branches participate in the body's responses to activity, stress, and rest. Freddie believes the combination of warmth, rhythmic compression, and deep-pressure stimulation may help some people feel calmer and more relaxed. He describes Flowpresso as creating a sensation of comfort and security. For patients experiencing persistent stress, poor sleep, or difficulty relaxing, that experience may be meaningful. However, subjective relaxation does not necessarily demonstrate correction of autonomic dysfunction or improvement in the underlying causes of Lyme disease symptoms. Rich Tries Flowpresso at ILADS One of the most memorable moments in the interview is Rich's description of personally trying Flowpresso. He explains that getting into the full-body garment initially felt unusual. The device reminded him of being secured inside a spacesuit. But once the session began, his experience changed. Rich describes the rhythmic compression and warmth as extremely comfortable. He felt so relaxed that staying awake became difficult. Afterward, he reported feeling refreshed. Most notably, Rich says he slept better that night than he had in a long time. He had been traveling, adjusting to a different time zone, and experiencing disrupted sleep before the session. Although he personally credits Flowpresso for helping him rest, a single experience cannot establish that the device caused the improvement. Nevertheless, his reaction provides an interesting firsthand perspective on what a Flowpresso session feels like. Could Flowpresso Improve Sleep? Sleep becomes a major theme during the conversation. Freddie describes research conducted in New Zealand involving first responders who participated in a series of Flowpresso sessions. He reports that participants experienced substantial improvements in sleep-related outcomes. The company has promoted findings involving improved sleep quality following repeated sessions. These are company-reported results, and the specific study design, measurements, comparison groups, and peer-reviewed evidence should be evaluated before drawing conclusions about clinical effectiveness. Rich's own experience raises an interesting question about whether relaxation-oriented technologies might help some patients sleep more comfortably. Sleep is essential for cognitive function, emotional regulation, immune health, and overall recovery. But better sleep after a wellness session does not demonstrate treatment of Lyme disease or removal of infectious organisms. The Lymphatic System, Immune Function, and Chronic Illness Freddie also discusses how lymphatic function relates to the immune system. Lymph nodes help filter lymph and provide sites where immune cells encounter antigens and coordinate immune responses. This relationship makes the lymphatic system an important part of normal immune function. Freddie raises the possibility that chronic illness, reduced mobility, and other physiological stressors may influence lymphatic health. He also introduces the concept of the exposome, which broadly refers to environmental exposures experienced throughout life. The discussion touches on mold, infections, environmental substances, and other factors that may influence health. These topics are complex and should not be reduced to a single explanation involving toxin accumulation or impaired lymphatic drainage. Walking, Breathing, and Everyday Lymphatic Health Beyond technology, Freddie emphasizes simple practices that can support normal physiology. He highlights three areas: Movement: Walking and appropriate physical activity engage muscles that help move lymphatic fluid. Breathing: Changes in pressure during breathing contribute to fluid movement through the body. Rest and relaxation: Adequate sleep and stress management support overall well-being. Rich also references a previous conversation with Dr. Bill Rawls about the role walking played in his personal recovery journey. The takeaway is not that every patient should follow the same exercise routine. Rather, movement and other supportive practices should be individualized according to symptoms, physical capacity, and medical guidance. Dry Brushing, Rebounding, and At-Home Wellness Practices Rich and Freddie briefly discuss several practices commonly promoted in wellness communities. These include dry brushing, rebounding, walking, breathing exercises, and massage-oriented techniques. Some patients find these activities relaxing or enjoyable. However, the scientific evidence supporting specific claims about detoxification or treatment of chronic infections varies considerably. Dry brushing, for example, has not been established as a treatment for Lyme disease or as a reliable method of increasing deep lymphatic drainage. Freddie emphasizes that no single device or technique should replace broader attention to everyday health habits. Flowpresso for Recovery and Rehabilitation Freddie explains that Flowpresso has attracted interest beyond the Lyme disease community. He discusses potential applications in: Wellness and relaxation Physical recovery Selected rehabilitation settings Postoperative care Sports recovery Clinical environments where compression therapy may be appropriate He describes introducing the technology to professional sports organizations and practitioners interested in recovery-oriented equipment. The interview also references its use in settings involving breast implant removal and postoperative recovery. These examples reflect the applications discussed by Freddie, not proof that the device produces superior surgical outcomes or replaces standard postoperative care. Decisions about compression, drainage, and postoperative management should remain with qualified treating clinicians. Freddie's Personal Connection to Lymphatic Health Freddie's interest in lymphatic function is deeply personal. During his experience with metastatic cancer, he underwent extensive surgery involving lymph nodes in his abdomen. He describes a retroperitoneal lymph node dissection and numerous surgical clips remaining from that procedure. Those experiences influenced his curiosity about the lymphatic system and the potential role of compression-based therapies. He explains that he did not fully appreciate the system's complexity during his earlier health challenges. Now, lymphatic education has become a central part of his work. His experiences provide valuable context for understanding his enthusiasm, while his personal results and observations should be distinguished from controlled clinical evidence. Is Flowpresso Available for Home Use? Freddie explains that Flowpresso is primarily a practitioner-oriented system. He discusses how clinics may offer sessions and how some patients with mobility limitations may explore home-based access under appropriate professional supervision. Availability varies by location. The company maintains a directory of participating providers. Find a Flowpresso provider near you. Healthcare professionals interested in learning more can visit the official Flowpresso website. Because the device is intended for supervised use, patients should discuss suitability, contraindications, and realistic expectations with a qualified healthcare professional. What Research Is Still Needed? While the interview highlights enthusiasm about Flowpresso, important questions remain. For Lyme disease patients specifically, research would need to investigate whether this technology produces measurable benefits beyond relaxation or general comfort. Potential research questions include: Does Flowpresso improve validated measures of sleep quality? Can it help selected patients experiencing clinically significant swelling? Does it improve quality of life in people with limited mobility? How do outcomes compare with established compression therapies? Which patients are most likely to benefit? What adverse effects or contraindications should clinicians consider? Are any benefits sustained after treatment sessions end? Controlled clinical trials would be needed to determine whether Flowpresso offers disease-specific benefits for Lyme disease or persistent symptoms following treatment. About Freddie Kimmel Freddie Kimmel is a wellness technology educator, speaker, podcaster, and survivor of metastatic cancer, Lyme disease, and mold-related health challenges. He hosts the Beautifully Broken Podcast, where he explores health, recovery, wellness technology, and personal transformation. Before entering the wellness field, Freddie worked professionally in musical theater, including performances in major theatrical productions. His personal health experiences inspired him to explore functional health, emerging technologies, and approaches intended to support overall well-being. Freddie currently works with Flowpresso, helping educate practitioners and consumers about lymphatic health and compression-based wellness technology. Hear his original Tick Boot Camp interview: Episode 162: The Lyme Polymath – Freddie Kimmel. Key Takeaways The lymphatic system plays important roles in fluid balance and immune function. Movement, breathing, and contractions within lymphatic vessels contribute to normal lymph circulation. Flowpresso combines sequential compression, heat, and deep-pressure stimulation. Rich personally experienced substantial relaxation and reported improved sleep after trying the device. Freddie believes supportive wellness technologies may have a role in individualized recovery plans. Flowpresso is not an established treatment for Lyme disease or persistent Lyme-related symptoms. Patients should evaluate potential benefits, risks, and contraindications with qualified healthcare professionals. More independent clinical research is needed to determine the device's effectiveness for specific health conditions. Key Topics in This Episode Freddie Kimmel, Flowpresso, Lyme disease lymphatic drainage, lymphatic system, chronic Lyme disease, lymphatic health, Lyme disease recovery, infrared therapy, sequential compression therapy, pneumatic compression, lymphatic drainage suit, thermotherapy, nervous system regulation, parasympathetic nervous system, Lyme disease fatigue, Lyme disease sleep problems, chronic illness recovery, wellness technology, Desiree De Spong, Beautifully Broken Podcast, metastatic cancer survivor, Lyme disease rehabilitation, sleep quality, physical recovery, functional health, ILADS, and Tick Boot Camp. About This LIVE from ILADS Interview This conversation was recorded in person at the 2025 International Lyme and Associated Diseases Society Annual Scientific Conference, From Terrain to Treatment: Advances in Vector-Borne Illness, held October 9–12, 2025, in San Antonio, Texas. Rich reconnects with Freddie Kimmel nearly five years after their original Tick Boot Camp interview. They explore Freddie's latest work with Flowpresso, the fundamentals of lymphatic function, compression therapy, infrared heat, and the relationship between relaxation and sleep. Rich also shares his firsthand experience trying Flowpresso at the conference. The two discuss the possibility of a future long-form conversation examining lymphatic health, lifestyle practices, and the technology in greater detail. Explore all Tick Boot Camp LIVE from ILADS interviews. Resources Mentioned Flowpresso Official Website Learn about the technology, its intended uses, and the company behind it. Find a Flowpresso Provider Explore the company's provider directory to identify participating locations. Desiree De Spong Learn more about the founder of Flowpresso and her work in lymphatic education. Freddie Kimmel – Beautifully Broken Podcast Explore Freddie's podcast and wellness education resources. More from Tick Boot Camp Episode 162: The Lyme Polymath – An Interview with Freddie Kimmel Discover Freddie's personal story of surviving metastatic cancer, Lyme disease, and mold-related health challenges. Dr. Bill Rawls, MD – Lyme Disease and Natural Healing Explore Dr. Rawls' perspective on Lyme disease recovery, lifestyle practices, herbal medicine, and supporting overall health. Tick Boot Camp LIVE from ILADS Watch and listen to interviews with doctors, researchers, advocates, and innovators discussing Lyme disease and tick-borne illness. Tick Boot Camp Podcast Explore more patient recovery stories, medical interviews, research discussions, and conversations about healing and hope.

  • S1 · E597
    October 12 · 16 min

    Episode 597: Finding Hope After Lyme Disease – Tanya's Story of Recovery & Advocacy | LIVE from ILADS

    What happens when seven years of undiagnosed Lyme disease, debilitating symptoms, and medical dismissal push someone to the point of losing hope—and that person eventually becomes a voice of hope for others? In this LIVE from ILADS interview, Tick Boot Camp welcomes Tanya, host of Lyme and Beyond with Tanya, for an emotional and inspiring conversation about Lyme disease recovery, medical gaslighting, mental health, suicidal thoughts, patient advocacy, and the power of sharing stories of healing. After spending years searching for answers, Tanya experienced severe physical and cognitive symptoms that disrupted her independence and quality of life. Repeatedly told that her symptoms were caused by stress or psychological problems, she reached a point where she struggled to imagine continuing her life without answers. But Tanya's story didn't end there. Her recovery journey eventually inspired her to become a Lyme disease advocate and podcast host, creating a platform dedicated to sharing stories of people who have experienced meaningful healing. Today, her mission is to remind people living with Lyme disease and other tick-borne illnesses that they are seen, heard, understood, and not alone. This episode explores why finding the right community, hearing recovery stories, and discovering a personal reason to keep moving forward can make such a meaningful difference during chronic illness. Meet Tanya: Host of Lyme and Beyond with Tanya Tanya brings a unique perspective to the Lyme disease community. She describes approximately 13 years of personal experience navigating Lyme disease and many additional years supporting and advocating for patients. Her podcasting journey began when her former Lyme disease physician suggested they start a podcast together. At the time, Tanya barely knew what a podcast was. Nevertheless, she agreed to try something completely outside her comfort zone. After approximately three and a half years of podcasting with her former physician, she launched her independent show, Lyme and Beyond with Tanya. Her mission has remained consistent throughout that journey: Give hope and inspiration to people living with Lyme disease. Unlike podcasts that primarily focus on emerging treatments, medical research, or ongoing patient struggles, Tanya emphasizes interviews with people who have experienced meaningful recovery. She wants listeners to hear from individuals who were once bedridden, wheelchair-bound, or severely debilitated but eventually regained their independence and quality of life. These stories help demonstrate that illness does not necessarily define someone's future. Seven Years of Medical Gaslighting Tanya describes spending approximately seven years without receiving an explanation that adequately accounted for her symptoms. During that time, she repeatedly heard suggestions that she was simply working too much, experiencing excessive stress, or dealing with psychological problems. She recalls being told she needed therapy rather than additional medical investigation. Meanwhile, her physical and cognitive symptoms continued. She experienced significant pain and memory problems that interfered with everyday activities. At times, she became disoriented while driving. She describes returning from the grocery store and forgetting that she had groceries in her vehicle. These experiences were frightening, frustrating, and increasingly isolating. For Tanya, the absence of a clear diagnosis made it difficult to know what she was fighting or how to move forward. Her story highlights why patients with persistent, unexplained symptoms need thoughtful medical evaluation, compassion, and a willingness to investigate possible causes. When Chronic Illness Leads to Suicidal Thoughts One of the most important moments in this conversation occurs when Tanya openly discusses experiencing suicidal thoughts during her illness. She explains that years of physical suffering, uncertainty, and feeling dismissed by healthcare professionals gradually eroded her hope. She had previously felt ashamed of this part of her story. Today, she shares it because she wants other patients experiencing similar emotional distress to understand that they are not alone and that support is available. Tanya also reflects on the loss of her brother, who died from a health condition at age 22. She was only 19 at the time. During her darkest moments, she struggled with thoughts about how her family would respond to another loss. Eventually, her niece and nephew became especially important sources of connection and motivation. They helped her reconnect with reasons to keep seeking help and working toward recovery. Suicidal thoughts are a serious health concern, not a personal failure or something patients should have to overcome through determination alone. Anyone experiencing these thoughts deserves compassionate, immediate support from qualified professionals and trusted people. In the United States, the 988 Suicide & Crisis Lifeline is available by calling or texting 988. Finding Your Why During Lyme Disease Recovery Tanya emphasizes the importance of finding a personal reason to continue moving forward. For her, that reason was her niece and nephew. Other patients may find meaning in relationships, creative interests, future goals, faith, community, or the possibility of rebuilding a life they value. Tanya describes how reconnecting with the people she loved helped her move through a particularly difficult period. Her experience illustrates the importance of emotional support alongside appropriate medical care. A person's reasons for living can provide meaningful motivation, but they are not a substitute for professional mental health treatment when needed. Why Lyme Recovery Stories Matter Rich and Tanya discuss the value of hearing stories from people who have experienced significant improvement after Lyme disease. For someone who has been sick for months or years, it can be difficult to imagine a different future. Symptoms may change unpredictably. Treatment may involve setbacks. Financial pressures can become overwhelming. Relationships and careers may be affected. Hearing from someone who once faced similar challenges and eventually experienced meaningful recovery can help restore a sense of possibility. This is the foundation of Tanya's podcast. She intentionally features guests who can share what life looked like during their illness, what changed during recovery, and what their lives look like now. Her goal isn't to suggest that every patient will follow the same path. It's to offer examples of what may be possible. Different Lyme Podcasts, Different Perspectives One of the central themes of this interview is collaboration within the Lyme disease podcasting community. Rich explains that Tick Boot Camp does not view other Lyme disease podcasts as competitors. Instead, different platforms can serve different needs. Two podcasters might interview the same guest and uncover entirely different parts of that person's experience. A patient's perspective may also change depending on where they are in their journey. Someone newly diagnosed may need basic education and guidance. Someone undergoing treatment may be looking for discussions about symptoms, treatment decisions, or navigating setbacks. Someone rebuilding their life may benefit from conversations about rehabilitation, relationships, emotional recovery, and purpose. Tanya's podcast adds another valuable voice to this broader educational community. She also shares that her listeners regularly recommend guests they have discovered through Tick Boot Camp. The exchange of stories and resources helps both communities. The goal isn't to build competing audiences. It's to help patients find the information, encouragement, and community they need. Why Women's Perspectives Matter in Lyme Disease Rich and Tanya also discuss the importance of bringing different lived experiences into Lyme disease conversations. Women may face concerns related to fertility, pregnancy, breastfeeding, family planning, caregiving, and other aspects of health that deserve thoughtful attention. Tanya acknowledges that she cannot personally speak to every experience. She shares that she was unable to have children and that certain topics, including mold-related illness, were not central to her own journey. Rather than attempting to provide answers about experiences she hasn't lived, she welcomes guests who can offer those perspectives. Her approach emphasizes curiosity, humility, and continued learning. The conversation reinforces why Lyme disease education benefits from a diversity of patient voices and qualified medical experts. The Emotional Isolation of Lyme Disease Tanya describes Lyme disease as an intensely isolating experience. Even though she had supportive family members and friends, she often felt alone. That distinction is important. Someone can be surrounded by people who care about them and still feel misunderstood. Family members may struggle to understand symptoms they cannot see. Friends may not recognize how much energy ordinary activities require. Patients may find it exhausting to repeatedly explain their experiences. Connecting with others who have lived through similar challenges can provide a different kind of support. Tanya believes that shared understanding is one of the most valuable aspects of the Lyme disease community. Faith, Grief & Finding Purpose Faith is another important part of Tanya's personal story. She openly discusses experiencing a complicated relationship with God during her illness. At times, she questioned why she was suffering and struggled to reconcile her experience with her beliefs. Over time, her faith became an important source of meaning and comfort. She now views her advocacy as part of the purpose she discovered through her recovery journey. Tanya is grateful for the friendships, relationships, and opportunities that emerged from her experiences. She also acknowledges how painful and financially difficult the journey was. Her story shows that gratitude and grief can coexist. A person can find meaning after illness without minimizing what they endured. And patients who do not find a larger purpose in their illness deserve the same compassion, dignity, and support. Choosing Healthy Lyme Disease Support Communities Toward the end of the interview, Rich and Tanya discuss the influence of online Lyme disease support groups. Both recognize how valuable these communities can be. They connect people who might otherwise feel isolated and provide opportunities to exchange experiences, resources, and encouragement. However, Tanya also cautions that not every group will be helpful for every person. She raises concerns about medical misinformation, unsupported treatment recommendations, and interactions that leave patients feeling more frightened or discouraged. Her advice is to be selective. Rather than joining every available group, consider participating in a few communities and evaluating how they affect your well-being. Ask yourself: Do I feel heard and respected? Are different patient experiences welcomed? Are medical claims presented responsibly? Does the community encourage appropriate professional care? Can people share difficult emotions without being judged? Do I leave feeling supported rather than overwhelmed? Tanya encourages patients to seek communities that provide validation, accurate information, and constructive support. Positivity Without Dismissing Pain Tanya emphasizes positivity throughout the interview, but her own story makes clear that recovery can involve profound suffering. She knows what it means to experience fear, isolation, depression, and uncertainty. Her message is not that patients must feel positive every day. She acknowledges that difficult days are part of the experience. Instead, she encourages people to look for sources of encouragement when they can and to remember that a difficult day does not necessarily determine what comes next. It's also important to recognize that symptom flares do not automatically indicate healing, and patients should discuss new or worsening symptoms with their healthcare professionals. Hope is most meaningful when it leaves room for honesty. How Podcasts Can Become Virtual Mentors Rich explains that Tick Boot Camp frequently encourages people to learn from recovery stories. A patient may not have access to a personal mentor who has navigated Lyme disease. But listening to someone describe their experiences can provide a form of virtual mentorship. Patients can learn about questions to ask, resources to investigate, and approaches to discuss with their clinicians. They may also discover people whose experiences resemble their own. Tanya's podcast is designed to provide that kind of connection. By sharing recovery stories, she hopes to offer listeners both emotional validation and examples of people who have rebuilt their lives. Why the Lyme Community Is Stronger Together Rich and Tanya close their conversation by emphasizing cooperation rather than competition. No single podcast, advocacy organization, support group, or medical professional can meet every patient's needs. The Lyme disease community benefits when people share resources, amplify one another's work, and introduce patients to new perspectives. For Tanya, meeting fellow advocates and podcasters at ILADS is especially meaningful. Many of these relationships began online. Now she has opportunities to meet those people face-to-face, exchange ideas, and strengthen the community. What began as an unexpected invitation to start podcasting has become an important part of her life. About Tanya and Lyme and Beyond with Tanya Tanya is a Lyme disease survivor, patient advocate, and host of Lyme and Beyond with Tanya, a podcast dedicated to sharing stories of recovery, hope, and inspiration. After years of unexplained symptoms and medical dismissal, Tanya began advocating for people affected by Lyme disease and other tick-borne illnesses. Her podcasting career began through a collaboration with her former Lyme disease physician. She later launched her own show to focus on individuals who have experienced meaningful recovery and reclaimed their lives after illness. Her work emphasizes patient validation, community support, mental health awareness, and the belief that healing is possible. Listen to Lyme and Beyond with Tanya on Apple Podcasts or Spotify. Key Takeaways Medical dismissal and prolonged diagnostic uncertainty can have serious physical and emotional consequences. Mental health challenges, including suicidal thoughts, deserve compassionate attention and appropriate professional support. Recovery stories can help patients imagine possibilities beyond their current circumstances. Different Lyme disease podcasts offer valuable perspectives and serve different needs. Support communities should provide validation without spreading medical misinformation. Finding meaningful connections and personal goals can support emotional resilience. Difficult days do not erase progress or determine the future. The Lyme disease community is stronger when advocates, patients, clinicians, and podcasters collaborate. Key Topics in This Episode Lyme and Beyond with Tanya, Lyme disease recovery stories, Lyme disease podcast, chronic Lyme disease, Lyme disease medical gaslighting, undiagnosed Lyme disease, Lyme disease mental health, Lyme disease depression, suicidal thoughts and chronic illness, Lyme disease advocacy, Lyme disease support groups, Lyme disease isolation, finding hope with Lyme disease, Lyme disease healing stories, patient empowerment, Lyme disease community, women and Lyme disease, chronic illness and faith, Lyme disease recovery inspiration, ILADS, and Tick Boot Camp. About This LIVE from ILADS Interview This conversation was recorded in person at the 2025 International Lyme and Associated Diseases Society Annual Scientific Conference, From Terrain to Treatment: Advances in Vector-Borne Illness, held October 9–12, 2025, in San Antonio, Texas. Rich welcomes Tanya to Tick Boot Camp for a conversation about her personal Lyme disease journey, the creation of Lyme and Beyond with Tanya, and why multiple patient-centered podcasts can work together to educate and support the community. The interview also explores medical gaslighting, emotional health, finding purpose, and choosing supportive online communities. Explore all Tick Boot Camp LIVE from ILADS interviews. More from Tick Boot Camp Tick Boot Camp Podcast Explore patient recovery stories, interviews with doctors and researchers, and conversations with advocates helping others navigate Lyme disease. Mental Health & Lyme Disease – Christina Kantzavelos Hear a conversation about mental health, chronic illness, emotional support, and navigating the psychological challenges of Lyme disease. Tick Bite Blueprint Explore practical educational resources for people navigating a recent tick bite and the early stages of seeking answers. LIVE from ILADS Discover more in-person conversations with Lyme disease doctors, researchers, advocates, and other voices working to advance education, treatment, and patient support.

  • S1 · E596
    October 11 · 18 min

    Episode 596: $500 Million for Lyme Research & the Fight for Federal Action – Megan Bradshaw | LIVE from ILADS

    Can a Lyme disease patient who spent three years bedridden help change federal health policy for millions of people? In this LIVE from ILADS interview, Tick Boot Camp reunites with Meghan Bradshaw, MPH, Lyme disease survivor, public health advocate, and leader at Center for Lyme Action, for an inspiring conversation about Lyme disease advocacy, federal research funding, proposed legislation, and the power of turning personal suffering into lasting change. After years of misdiagnosis and debilitating tick-borne illness, Meghan spent approximately three years bedridden, underwent numerous orthopedic surgeries, and experienced profound losses of independence and mobility. Yet while rebuilding her body, she returned to school, pursued a career in public health, and became a federal lobbyist working to prevent other patients from experiencing the same suffering. At the time of this October 2025 interview, Meghan served as Government Relations Manager at Center for Lyme Action. She subsequently became the organization's Executive Director in January 2026. During this conversation, Meghan discusses how Center for Lyme Action grew to more than 10,000 advocates, helped secure over $500 million in cumulative federal funding increases, and began advancing legislative proposals that could improve Lyme disease prevention, diagnostics, research, and public health policy. Her message is powerful: You don't have to be healthy, wealthy, politically connected, or even able to leave your bed to help change the future of Lyme disease. For the complete story of Meghan's personal battle with Lyme disease, listen to Episode 196: The Bionic Woman – An Interview with Meghan Bradshaw. From Lyme Disease Patient to Federal Lobbyist Before becoming a national health policy advocate, Meghan Bradshaw was a patient fighting to survive. She describes experiencing devastating physical and emotional consequences after years of misdiagnosis and delayed treatment. At her worst, Meghan spent approximately three years bedridden. Her illness was associated with extensive joint damage, repeated surgeries, and significant loss of mobility. She describes undergoing major orthopedic procedures approximately every three months during part of her recovery. Her body was being reconstructed with titanium and cobalt. But as she explains to Rich, the emotional consequences were equally profound. She had lost her independence, autonomy, and much of the life she previously recognized. Still, she believed she could build a meaningful future. That belief eventually led her toward public health and federal policy. Hear Meghan's complete journey in The Bionic Woman – Episode 196. Why Meghan Went Back to School During Lyme Treatment While recovering from surgery and undergoing treatment, Meghan made a decision that would change her life. She returned to school. As her cognitive symptoms improved, she became increasingly interested in understanding why so many patients experienced similar problems with diagnosis, treatment, and access to care. She didn't believe those patterns were simply coincidences. She wanted to understand the underlying systems and identify opportunities to change them. Meghan pursued graduate education in public health, developing the knowledge and skills needed to address Lyme disease through research, advocacy, and policy. For Meghan, education became more than a career investment. It became a source of purpose during recovery. She wanted to help build a healthcare system in which future patients wouldn't have to endure the same suffering. What Is Center for Lyme Action? Center for Lyme Action is a national 501(c)(4) nonprofit organization dedicated to increasing federal funding and advancing policy solutions for Lyme disease and other tick-borne illnesses. Its work focuses on strengthening the federal government's ability to: Prevent tick-borne diseases Improve disease detection and diagnosis Support research into better treatments Expand public health surveillance Improve education and awareness Fund scientific innovation Respond to emerging vector-borne health threats As a 501(c)(4) organization, Center for Lyme Action can engage extensively in lobbying activities. Meghan explains that she works directly with members of Congress, congressional staff, and federal agencies to communicate the needs of patients and the scientific community. The goal is to translate patient experiences into federal policies and funding decisions that can improve public health. Meet Center for Lyme Action Founder Bonnie Crater To understand how this advocacy movement began, listen to Episode 378: Center for Lyme Action – An Interview with Bonnie Crater. In that conversation, Tick Boot Camp explores the organization's origins, mission, and strategy for increasing federal investment in Lyme disease and tick-borne illness research. Together, Bonnie's and Meghan's interviews illustrate how a growing network of advocates is working to turn patient experiences into measurable policy progress. More Than $500 Million in Federal Funding Increases One of the most significant milestones discussed in this interview is Center for Lyme Action's role in securing increased federal investment. Meghan reports that the organization's collective advocacy efforts helped generate more than $500 million in cumulative increases in federal funding for Lyme disease and other tick-borne conditions over several years. This represents funding increases across federal programs, not a single grant or one research project. Federal funding supports many different activities, including scientific research, prevention, public health infrastructure, surveillance, and efforts to develop better diagnostics and treatments. Meghan credits the organization's advocates, partner organizations, researchers, clinicians, and congressional allies for helping make this progress possible. She believes these achievements demonstrate what coordinated, persistent advocacy can accomplish. A National Network of More Than 10,000 Lyme Advocates Center for Lyme Action's advocacy network had grown to more than 10,000 participants at the time of this interview. Meghan explains that advocates represented all 50 states, Washington, D.C., and Puerto Rico. These participants help communicate directly with elected officials about how Lyme disease and other tick-borne illnesses affect their communities. Some share personal stories. Others participate in letter-writing campaigns. Some meet with congressional offices. Others join virtual advocacy events. Together, these voices help demonstrate that tick-borne diseases are national public health concerns requiring sustained attention. How Lyme Patients Can Advocate From Bed One of the most important parts of this conversation addresses people who are still severely ill. Rich asks how someone who is bedridden, cognitively impaired, or struggling with overwhelming fatigue can contribute to advocacy. Meghan understands that challenge personally. She knows what it feels like to have limited energy and little capacity for additional responsibilities. That's why Center for Lyme Action works to make participation accessible. Advocates can use prepared letters, talking points, scripts, and virtual opportunities rather than having to develop everything themselves. For example, a patient may be able to enter basic contact information into an advocacy campaign and send a prepared message to their elected representatives. Meghan emphasizes that people shouldn't have to expend precious energy figuring out how to communicate complicated policy issues. The organization works to make those steps easier. Even a small action can contribute to a much larger collective effort. Explore Center for Lyme Action's advocacy opportunities. Five Federal Legislative Priorities Discussed at ILADS Meghan highlights five legislative initiatives being pursued at the time of the October 2025 interview. These proposals address different aspects of the tick-borne disease crisis, from federal research funding to public health technology and food allergen labeling. The proposals discussed were not all enacted laws. Their status may have changed since the interview. 1. Kay Hagan Tick Act Reauthorization The Kay Hagan Tick Act was originally signed into law in 2019 to strengthen the federal response to vector-borne diseases. The legislation supports coordinated efforts involving research, surveillance, prevention, and public health programs. Meghan explains that reauthorization was among Center for Lyme Action's legislative priorities. Continued authorization and appropriations can help sustain the infrastructure needed to respond to Lyme disease and other tick-borne threats. 2. STAMP Act: A Postage Stamp Supporting Lyme Research The proposed STAMP Act would establish a special postage stamp intended to generate additional funding for Lyme disease and tick-borne disease research. Meghan describes the concept as a way to direct proceeds from stamp purchases toward research supported through the National Institutes of Health. The idea creates another potential mechanism for supporting scientific investigation while increasing public awareness. 3. BITE Act: Tick-Borne Disease Risk Alerts The proposed BITE Act would explore using technology to alert people when they are entering areas with elevated vector-borne disease risks. Meghan compares the concept to the alerts people already receive for severe weather or other emergencies. Imagine receiving a notification on your phone warning that your current area presents increased risk for tick-borne or mosquito-borne disease exposure. Such a system could also provide practical prevention guidance. The goal would be to help people make informed decisions before exposure occurs. 4. Tick Identification Pilot Program Act The proposed Tick Identification Pilot Program Act would establish grants supporting state-level tick identification services. Meghan describes a system in which someone could photograph a tick and submit the image to a participating state public health agency. Under the proposal discussed, a public health professional would respond within approximately 72 hours with information about the tick species and diseases it may carry. This could help patients and clinicians better understand potential exposure risks and determine appropriate next steps. Tick identification alone cannot determine whether a person has been infected, but it may provide useful information for clinical evaluation. 5. Alpha-Gal Allergen Inclusion Act The proposed Alpha-Gal Allergen Inclusion Act would improve food labeling for people living with alpha-gal syndrome. Alpha-gal syndrome is a potentially serious allergic condition associated with certain tick bites. Affected individuals may react to mammalian-derived ingredients, making food and product labeling particularly important. Meghan explains that clearer labeling could reduce the burden of deciphering unfamiliar ingredient names and help people avoid potentially dangerous exposures. Why Federal Policy Matters to Lyme Patients For someone living with chronic symptoms, congressional legislation may initially feel far removed from daily life. Meghan explains why the connection is much closer than it appears. Federal decisions influence funding for research, public health programs, disease surveillance, diagnostic innovation, prevention, and clinical studies. These decisions can affect the resources available to researchers and the tools eventually available to clinicians and patients. Meghan's own experiences shaped her understanding of what was missing from the healthcare system. She believes stronger policies, better diagnostics, and greater clinical awareness could have changed the trajectory of her illness. Now she is working to make those resources more accessible to others. Turning Pain Into Purpose Rich and Meghan have known each other for years. Their relationship began when Meghan was sharing her personal Lyme disease story and developing her voice as an advocate. Since then, Rich has watched her return to school, expand her public health expertise, and become a national policy leader. During the interview, he reflects on how meaningful it has been to witness younger advocates transform their experiences into service. Meghan describes advocacy as part of her own healing. She cannot undo everything that happened to her. But she can work to change the systems that contributed to her suffering. That gives her a sense of agency and purpose. She explains that illness clarified what matters most to her and helped shape the work she wants to do with her life. Rebuilding a Life After Severe Lyme Disease Meghan is candid about the fact that her life did not simply return to what it was before illness. She experienced lasting physical consequences and underwent extensive orthopedic reconstruction. Her recovery required adapting to a different reality. But she also came to believe that a changed life could still be meaningful. Returning to school, developing her career, and serving other patients helped her rebuild a sense of identity. Her story challenges the idea that recovery must mean returning to every aspect of a person's previous life. For some people, healing also involves discovering new possibilities, new roles, and new ways to contribute. Why Every Advocate's Talent Matters Meghan emphasizes that there is no single correct way to advocate. Some people are gifted storytellers. Others understand science. Some are experienced communicators, organizers, or healthcare professionals. Others have skills in fundraising, research, education, or public policy. Meghan mentions advocates including Ali Moresco, Nicole Bell, and Lindsay Keys as examples of people bringing different talents to the community. Her message is that progress becomes possible when people contribute what they can. Not everyone needs to become a lobbyist. Not everyone needs to speak publicly. And not everyone needs to devote their career to advocacy. There is value in every contribution. Patient Stories Can Influence Congress Meghan shares that many congressional offices have personal connections to Lyme disease or other tick-borne illnesses. During meetings, lawmakers or staff members have sometimes revealed that they or close family members have been affected. Those experiences can help create understanding across political and geographic differences. Meghan believes productive, respectful conversations are essential. The objective is not simply to demand attention. It is to help elected officials understand the scale of the problem, the gaps in the current response, and the opportunities for meaningful action. That includes explaining what patients are experiencing and why federal investments matter. Why Bipartisan Lyme Advocacy Matters Tick-borne diseases do not distinguish between political affiliations. They affect people across the country, regardless of party, income, age, or background. Center for Lyme Action emphasizes a bipartisan approach to federal advocacy. Meghan's work involves communicating with members of Congress and federal officials who may hold different political views but share concerns about public health, scientific research, and disease prevention. Building those relationships can help create durable support for Lyme disease priorities. The goal is progress that can continue across changing political administrations and congressional sessions. Two Ways Patients Can Contribute to Progress Rich highlights two accessible opportunities that Tick Boot Camp frequently encourages patients to explore. 1. Contribute to MyLymeData The MyLymeData patient-powered research registry allows patients to share information about their experiences with Lyme disease. Aggregated patient-reported information can help researchers better understand symptoms, diagnostic challenges, treatment experiences, and quality of life. 2. Participate in Center for Lyme Action Through Center for Lyme Action, patients and supporters can participate in advocacy campaigns, communicate with elected officials, and help support efforts to increase federal investment. Meghan explains that membership is available, but paid membership is not required to participate in the organization's advocacy activities. These opportunities allow people to contribute through either patient-powered research or federal advocacy—or both. The Future of Lyme Disease Research and Treatment Meghan is optimistic about the momentum building around Lyme disease. She points to increased federal funding, expanding advocacy networks, growing attention from policymakers, and proposed legislation as signs of meaningful progress. She also emphasizes that significant work remains. Patients still need better diagnostics. Researchers need greater support. Clinicians need improved tools. And people experiencing persistent symptoms need more effective, evidence-based treatment options. The progress Meghan describes does not mean these problems have been solved. It means advocates are helping create conditions in which better solutions may become possible. About Meghan Bradshaw, MPH Meghan Bradshaw, MPH is a Lyme disease and tick-borne illness advocate and Executive Director of Center for Lyme Action. At the time of this October 2025 interview, she served as the organization's Government Relations Manager. She became Executive Director in January 2026. After experiencing severe tick-borne illness, years of misdiagnosis, and extensive orthopedic surgeries, Meghan dedicated herself to improving the systems responsible for prevention, diagnosis, treatment, and research. She pursued graduate education in public health and has participated in federal tick-borne disease policy and research initiatives. Her advocacy includes working with Congress, federal agencies, patient organizations, researchers, and clinicians to increase federal investment and strengthen the national response to Lyme disease and other tick-borne illnesses. Read more about Meghan's personal story and Center for Lyme Action's mission. Key Topics in This Episode Meghan Bradshaw, Center for Lyme Action, Lyme disease advocacy, Lyme disease federal funding, $500 million Lyme funding, Lyme disease research funding, Lyme disease legislation, Kay Hagan Tick Act, STAMP Act, BITE Act, Tick Identification Pilot Program Act, Alpha-Gal Allergen Inclusion Act, alpha-gal syndrome, Lyme disease prevention, tick-borne disease public policy, Lyme disease Congress, federal Lyme research, Lyme disease patient advocacy, Lyme disease recovery, patient-powered research, MyLymeData, Lyme disease misdiagnosis, tick-borne disease research, public health, Lyme disease clinical trials, ILADS, and Tick Boot Camp. About This LIVE from ILADS Interview This conversation was recorded in person at the 2025 International Lyme and Associated Diseases Society Annual Scientific Conference, From Terrain to Treatment: Advances in Vector-Borne Illness, held October 9–12, 2025, in San Antonio, Texas. Rich and Meghan reconnect nearly five years after their first Tick Boot Camp interview. They reflect on their longstanding friendship, their recent participation in a Lyme awareness fashion event, Meghan's personal transformation, and the expanding role of Center for Lyme Action in federal policy. The discussion highlights how patient experiences can influence research priorities, legislation, public health funding, and the future of Lyme disease care. Explore all Tick Boot Camp LIVE from ILADS interviews. More from Tick Boot Camp Episode 196: The Bionic Woman – An Interview with Meghan Bradshaw Hear Meghan's full personal story, including her devastating Lyme disease journey, extensive surgeries, recovery, and the experiences that inspired her to become a national advocate. Episode 378: Center for Lyme Action – An Interview with Bonnie Crater Meet Center for Lyme Action founder Bonnie Crater and learn about the organization's origins, mission, and strategy for increasing federal funding for Lyme disease and tick-borne illness research. LIVE from ILADS Conference Interviews Explore more in-person conversations with leading doctors, researchers, advocates, and innovators advancing Lyme disease awareness, science, and treatment. Tick Boot Camp Podcast Discover patient recovery stories and conversations with the people working to improve Lyme disease education, research, treatment, and advocacy. Legislative proposals and funding figures are discussed in their historical context. For current bill status and advocacy opportunities, consult Center for Lyme Action and official congressional sources.

  • S1 · E595
    October 10 · 1 hr 28 min

    Episode 595: Can Lyme Affect Folate in the Brain? Dr. Lindsey Wells on Autism, PANS/PANDAS & FRAA

    What if some of the depression, anxiety, brain fog, cognitive dysfunction, OCD, speech changes, and other neuropsychiatric symptoms experienced by people with Lyme and other vector-borne diseases involve more than the infection itself? In this episode of the Tick Boot Camp Podcast, Matt Sabatello sits down with Dr. Lindsey Wells, ND, a Connecticut naturopathic physician whose work focuses heavily on children with Lyme Disease, PANS/PANDAS, autism spectrum disorder, neurodevelopmental conditions, and other vector-borne diseases. The centerpiece of the conversation is Dr. Wells' newly published research, “Folate Receptor Alpha Autoantibodies in Vector-Borne Disease Populations.” Her study explored an intriguing question: could some people with Lyme disease, Bartonella, Babesia, or other vector-borne infections also have an immune-mediated problem that prevents enough folate from reaching the brain? The findings open an important new area of investigation. What Are Folate Receptor Alpha Autoantibodies? Folate is essential for neurological function, neurotransmitter production, mitochondrial health, methylation, and numerous other biological processes. But having adequate folate in the bloodstream does not necessarily mean enough folate is reaching the brain. Dr. Wells explains how folate receptor alpha autoantibodies, commonly abbreviated FRAAs, can interfere with the folate receptor responsible for helping transport folate across the blood-brain barrier. These autoantibodies can either block folate from attaching to the receptor or bind to the receptor and interfere with its normal function. The result may contribute to a condition known as cerebral folate deficiency, where folate availability inside the central nervous system is inadequate despite seemingly normal blood levels. A Surprising Finding in Vector-Borne Disease Patients Dr. Wells and her colleagues examined patients with confirmed evidence of vector-borne infections. Their study found that 61.8% of the vector-borne disease-positive patients tested positive for folate receptor alpha autoantibodies. That finding immediately raises bigger questions. Are vector-borne infections contributing to the development or elevation of these autoantibodies? Can Lyme or another infection be treated while FRAAs remain elevated? Could persistent FRAAs contribute to symptoms that patients and clinicians continue attributing entirely to infection? The Borrelia Finding That Caught Dr. Wells' Attention One of the most intriguing findings involved the soluble folate receptor, an abnormal finding seen much less frequently than standard binding or blocking FRAAs. Eight patients in the study were positive for soluble folate receptor. Seven of those eight had confirmed evidence of Borrelia species infection, while the remaining patient had an indeterminate result involving relapsing fever Borrelia. Dr. Wells discusses why this observation raises questions about whether Borrelia infection, immune activation, inflammation, or another biological mechanism could influence folate receptor function. Bartonella, PANS/PANDAS and Severe Neuropsychiatric Symptoms The conversation also goes deep into Bartonella. In Dr. Wells' clinical experience, Bartonella frequently appears in some of the more complex children she treats with PANS/PANDAS, particularly those experiencing symptoms such as: Severe anxiety OCD Rage and aggression Irritability Sensory sensitivities Cognitive or behavioral regression Persistent neuropsychiatric flares Among FRAA-positive patients in her vector-borne disease study, Bartonella was also the most common individual infection identified. Dr. Wells explains why she believes clinicians evaluating children with unusually severe or persistent PANS/PANDAS symptoms should consider looking beyond traditional triggers such as strep. Can Infection Trigger an Autoimmune Process That Continues Afterwards? One of the most important parts of the interview explores what happens after an infection. Dr. Wells describes how an infection can activate the immune system, but in susceptible patients the immune response may not simply return to baseline once the original infection improves. Immune dysregulation and molecular mimicry may potentially allow inflammatory or autoimmune processes to continue. That creates an important question for Lyme disease: Could a patient successfully reduce or address an infectious burden but continue experiencing symptoms because another downstream immune or metabolic problem remains? What Causes FRAAs? Dr. Wells discusses several factors associated with FRAAs. One is a non-genetic hereditary pattern in which autoantibodies may be transmitted from a parent. Another important area is animal dairy consumption. She discusses research suggesting that proteins associated with animal dairy may share similarities with folate receptor structures. Through a molecular mimicry mechanism, antibodies generated against those proteins could potentially cross-react with folate receptors. Dr. Wells therefore commonly incorporates dairy removal when addressing FRAA-positive patients. She also discusses clinical observations suggesting that FRAA levels can fluctuate and may rise during periods of infection or physiological stress. The FRAT Test Patients cannot determine FRAA status through a routine folate blood test. Dr. Wells discusses the FRAT Folate Receptor Autoantibody Test, a specialty blood test designed to detect autoantibodies to folate receptor alpha. The test evaluates binding and blocking autoantibodies and can also identify the soluble folate receptor finding discussed in Dr. Wells' research.https://www.fratnow.com/ Folinic Acid and Leucovorin If FRAAs are interfering with one pathway responsible for transporting folate into the brain, Dr. Wells explains that another approach may be to use an alternative transportation pathway. That is where folinic acid, including the prescription form leucovorin, enters the discussion. Rather than eliminating the autoantibodies themselves, folinic acid can utilize another folate transport mechanism to help deliver folate into the central nervous system. Dr. Wells discusses improvements she has observed clinically in areas such as anxiety, OCD, cognitive function, communication, speech fluency, and other neuropsychiatric symptoms. Importantly, she emphasizes that dosing needs to be individualized and gradually increased under the guidance of a knowledgeable practitioner. People interested in the supplemental form discussed during the episode can learn more about Emephysis HI-FOLINIC.https://emephysis.com/products/hi-folinic Treating More Than the Infection One of the themes throughout this conversation is that complex chronic illness rarely comes down to one intervention. Dr. Wells describes a three-part approach to many of her complex pediatric patients: Address the microbial burden. Depending upon the individual patient, this may include vector-borne infections and other infectious triggers. Address immune dysregulation and inflammation. This may involve anti-inflammatory and immunomodulatory strategies. Support the symptoms affecting daily life. Helping a child function, communicate, sleep, attend school, interact socially, and experience less anxiety or OCD matters while deeper underlying issues are being addressed. It is an approach that recognizes both the biology of chronic illness and the reality of the person living through it. Learn More About Dr. Lindsey Wells Dr. Lindsey Wells practices naturopathic medicine in Trumbull, Connecticut, with a major focus on complex pediatric conditions including PANS/PANDAS, autism, neurodevelopmental disorders, and vector-borne diseases. Learn more about Dr. Wells and her practice.https://lindseywellsnd.com/about/ Read Dr. Wells' Research Folate Receptor Alpha Autoantibodies in Vector-Borne Disease Populations

Showing 21–40 of 79 episodes